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Appendicitis is the most common surgical condition, but its diagnosis can be 
challenging. The practice of early appendicectomy to minimise morbidity and 
mortality has resulted in an increase of histologically "normal" appendices (HNA) 
being resected. Even, in the laparoscopic era, the removal of a macroscopically 
normal appendix in a symptomatic patient remains a clinical dilemma. The 
discrepancy between the clinical and histological diagnosis could suggest that an 
unknown pathology exists. This study compared the in-situ expression of key 




The study retrospectively included 448 appendix specimens allocated in 4 groups. 
Group I (n=120) included specimens with histologically confirmed uncomplicated 
appendicitis, Group II (n=118) included samples with histologically confirmed 
complicated appendicitis (gangrene/perforation), and Group III (n=104) included 
appendices with no evidence of inflammation on conventional histology (HNA). The 
control group (n=106) consisted of appendices removed as part of the resected colon 
following elective colectomy. The expressions of TNF-α, IL-6, IL-2R and serotonin 
were studied with immunohistochemistry. Clinical data on signs and symptoms, 
routine laboratory tests and intraoperative findings were collected from the patient 





TNF-α expression in HNA was significantly increased compared with the control and 
inflamed appendices (p<0.05). HNA also demonstrated significantly increased IL-6 
expression in the epithelial cells compared with the control as well as inflamed 
samples (p<0.05). The IL-2R expression of the HNA was significantly increased 
compared with the control appendices (p<0.05) but not as high as in the inflamed 
samples (p<0.05). HNA did not demonstrate significantly different serotonin contents 
of enterochromaffin cells compared with the control group (p=0.60). The inflamed 
samples were significantly depleted (p<0.05). Patients with HNA demonstrated 
significantly elevated white cell count compared with the control group (p<0.05) but 
not as high as in patients with inflamed samples (p<0.05). Of patients with HNA 23% 
reported previous episodes of RIF pain compared with 14% and 4% of patients with 
uncomplicated and complicated appendicitis respectively, whereas the severity of RIF 
pain did not vary between the three groups of patients. Localised peritonism was 
present in 56% of patients with HNA compared with 73% of patients with inflamed 
samples. The neutrophil to lymphocyte ratio and C-reactive protein concentrations 
of patients with HNA were significantly lower compared with the control group as 
well as patients with inflamed appendices (p<0.05). Faecoliths were found in 27% of 
HNA compared with 11% and 28% of uncomplicated and complicated appendicitis 
samples respectively. Intraoperatively, 51% of the HNA were thought to be inflamed. 
The expression of the studied markers between samples with and without faecolith 






It was demonstrated that histologically "normal" appendices resected following a 
clinical diagnosis of acute appendicitis exhibited increased levels of TNF-α, IL-6 and 
IL-2R that could indicate an active inflammatory response. Signs and symptoms as 
well as routine laboratory results that help clinicians in the diagnosis of appendicitis 
were also abnormal in patients with HNA. These observations could either represent 
an inflammatory response at such an early stage that could not be detected with 
conventional microscopy or could indicate an abnormally long inflammatory 
response with features of chronicity. In addition to this, the fundamental differences 
between samples with complicated and uncomplicated appendicitis could suggest 
that the different degrees of inflammation in the appendicitis spectrum could be due 
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ACTH adrenocorticotropic hormone 
APC antigen presenting cells 
ARP actin related proteins 
CCK cholecystokinin 
CD Crohn’s disease 
CGRP calcitonin gene related peptide 
COX cyclooxygenase  
CRP C-reactive protein 
CTL cytotoxic T lymphocyte 
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CHAPTER 1: Introduction 
1.1 The human immune system 
The human immune system comprises humoral and cellular components, which play 
a vital role not only in the protection of the host from invading pathogens but also in 
the recognition and elimination of damaged or malignant-transformed cells. 
Antibodies, cytokines and the complement system constitute the main elements of 
the humoral component. The different leukocyte subsets constitute the cellular 
component.  
 
The leukocytes, erythrocytes and thrombocytes are derived from the same 
progenitor cells (haematopoietic stem cells) in the bone marrow. Two common 
specific progenitors, which are the common myeloid and the common lymphoid 
progenitor cells, are derived from pluripotent stem cells. The myeloid lineage gives 
rise to erythrocytes, thrombocytes, mast cells, granulocytes (neutrophils, eosinophils 
and basophils), monocytes, macrophages and dendritic cells following development 
and differentiation in the bone marrow. The lymphoid lineage is developed into 
lymphocytes, which are distinguished by their site of maturation and subsequent 
differentiation. B lymphocytes develop and mature in the bone marrow whereas T 
lymphocytes and natural killer (NK) cells develop and mature in thymus. 
 
The immune system comprises two distinct components, the innate and adaptive 
immunity. The innate immune component includes cellular-epithelial barriers (skin, 
mucosa), soluble components (complement system proteins, cytokines, chemokines, 
acute-phase proteins) and specific innate cell subpopulations (monocytes, 
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macrophages, neutrophils, dendritic cells, NK cells, platelets). The surface of the 
innate immune cell subsets possesses germ line-encoded receptors called pattern 
recognition receptors (PRRs). Some examples of PRRs are the toll-like receptors 
(TLRs), nucleotide-biding domain (NOD)-like receptors (NLRs) and retinoic-acid-
inducible gene 1 receptors (PLRs). PRRs have the ability to recognise a variety of 
pathogen structures [pathogen-associated molecular patterns (PAMPs)] and trigger 
an immediate response. These receptors can also recognise products of damaged, 
injured or stressed host cells [danger (or damage)-associated molecular patterns 
(DAMPs)] such as heat shock protein (HSPs), S100 proteins, DNA, human group box 
protein 1 (HMGB1). Unlike the innate immune system, the adaptive immune system 
utilises a large selection of receptors encoded by rearranging genes to recognise a 
range of specific pathogen molecular structures. The adaptive immune system also 
displays immunological memory for previously encountered pathogens which 
confers a long-lasting immunity.  Nevertheless, there is a delay in the initiation of an 
adaptive immune response due to the period of time that is required for the small 
number of specific B and T lymphocytes to undergo clonal expansion and become 
effector cells [B lymphocytes (plasma cells) producing antibodies, cytotoxic T 
lymphocytes (CTLs, T helper (Th) cells] to specifically remove the targeted antigen. 
Therefore, the innate immunity mediates the immediate and early immune 
responses, while the adaptive immunity mediates late and specific immune 
responses. However, the removal of an antigen is the collaborative result of the 
interaction between the innate and adaptive immunity. Cells and cytokines of the 
activated innate component of the immune system make a significant contribution 
to optimal activation of the adaptive component of the immune system. 
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Macrophages act as antigen presenting cells (APCs) and have a vital role in facilitating 
the immune responses to antigens. A summary of the main functions of the cellular 
and soluble components of the innate and adaptive immune systems can be found in 
Tables 1.1 and 1.2 respectively.   
 
The lymphatic organs are an integral part of the immune system. They are composed 
of lymphoid tissue organised into anatomical and functional compartments 
containing lymphocytes as well as other immune cells. The primary or central 
lymphoid organs, which are the bone marrow and the thymus, generate lymphocytes 
from common lymphoid progenitor cells. The secondary or peripheral lymphoid 
organs which include the lymph nodes and the spleen, maintain mature naïve B and 
T lymphocytes and initiate adaptive immune responses. A series of different 
compartments can be identified within the secondary or peripheral lymphoid organs. 
The lymph nodes and the spleen respond to antigens that have entered the blood 
stream or the tissues and travelled via the lymphatics. The mucosal immune system 
[mucosal-associated lymphoid tissue (MALT)], part of which is the gut-associated 
lymphoid tissue (GALT), responds to antigens that attempt to breach the mucosa 




Table 1.1 Innate immune system: Components and functions  
Innate immune system 
Cellular components Principal functions 
Epithelial cells Physical barrier 
Neutrophils Phagocytosis, killing of bacteria 
Basophils Killing of parasites, release of histamine 
Eosinophils Killing of antibody-coated parasites 
Mast cells Release histamine 




Phagocytosis, killing of bacteria, antigen 
presentation 
Dendritic cells 
Phagocytosis, killing of bacteria, antigen 
presentation 
Humoral components Principal functions 
Complement system 
Opsonisation, killing of antibody-coated 
pathogens (classical pathway), chemotaxis 
Cytokines 
Induce, enhance or inhibit cellular 
responses 
Chemokines 
Act as a chemoattractant to direct the 
migration of cells, recruit monocytes, 
neutrophils and other immune cells from 
blood to affected tissue  
Acute-phase proteins 
Destroy or inhibit growth of microbes, 
affect coagulation, recruit immune cells to 











Table 1.2 Adaptive immune system: Components and functions 
Adaptive immune system 
Cellular components Principal functions 
Dendritic cells Antigen presenting cells (APCs) 
T helper (Th) cells Modify immune responses: 
Th1 cells activate macrophages, CTLs and 
NK cells 
Th2 cells activate B cells, provide 
immunological memory 
Th17 cells mediate inflammation and 
autoimmunity through the CTL response in 
cancer and autoimmune diseases  
Cytotoxic T lymphocytes (CTL) Induce apoptosis, provide immunological 
memory 
T regulatory cells (Tregs) Inhibit generation of CTL responses, 
downgrade activated T lymphocytes, 
prevent autoimmunity by inhibiting self-
reactive CTLs 
B lymphocyte/plasma cells Production and release of antibodies, 
induction of immunological memory 
Humoral components Principal functions 
Antibodies Opsonisation, neutralisation and 
complement activation 






1.2 Gastrointestinal environment and inflammation 
1.2.1 Overview  
The gastrointestinal tract (GI) has the largest surface area between the body and the 
outside environment [5]. It is widely accepted that it does not only play a vital role in 
the digestion and absorption of food, but it also contributes to homeostasis [6, 7]. It 
is believed that it accommodates 1000 different types of bacteria with a total number 
of approximately 1014. This number is equal to ten times the total number of the cells 
of the human body and can weigh up to 2 kg, making the human GI tract one of the 
most immensely populated microbial environments on the planet [7-10]. Therefore, 
the mucosa of the GI tract has to be able to not only tolerate a vast number of 
potentially harmful bacteria and dietary antigens, but also to recognise and even 
attack small numbers of infrequently intruding pathogens [5, 11]. On the other hand, 
GI microbes, whose collective number of genes is 100-fold greater than the total 
human genome [6, 8, 9], play a pivotal role in nutrition, metabolism, host defence 
and immune system development [6, 12]. However, the GI tract, in order to harness 
the benefits and also overcome the challenges of possessing such a large population 
of commensal bacteria, has evolved into the largest and most complex immune organ 
in the entire human body. It also possesses a widespread system of secondary 
lymphoid organs and a mammoth number of lymphocytes [5, 11, 13]. Thus, the GI 
immune system is crucial in regulating the dynamic interaction between host 
immunity and microbes with the aim to maintain homeostasis [5]. This fine balance 
is mediated by several cell populations, with some of them being unique to the GI 
tract, that following activation can initiate a series of immune functions. Failure to 
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preserve immune homeostasis will result in either acute or chronic GI inflammation 
[11, 14].  
 
1.2.2 Anatomy of the GI mucosa 
The GI tract functions as a dynamic barrier that has the ability to govern the 
movement of several substances between the lumen and the body. It allows the 
passage of water, electrolytes, and dietary substances but resists a potentially 
harmful invasion of commensal flora and their toxins [15, 16]. The main component 
of this barrier is characterised by the epithelial surface which comprises different 
populations of cells that are called intestinal epithelial cells (IEC) and include 
absorbent enterocytes, goblet cells, Paneth cells, neuroendocrine cells, dendritic cells  
and intraepithelial lymphocytes [6, 17]. The IECs form a single, polarised columnar 
layer that separates the intestinal flora from the underlying lamina propria [11, 18]. 
The mechanical cohesion between these cells and the control of paracellular 
permeability are safeguarded by different types of protein complexes forming tight 
junctions, adherence junctions and desmosomes [6, 15, 16]. Moreover, the IECs can 
also function as signal transducers due to their ability to sense luminal contents and 
release regulatory mediators that can initiate an appropriate response in the lamina 
propria [19]. The epithelial barrier is supported by a protective layer of mucin that 
prevents intestinal flora from invading the mucosa. This mucin is secreted by goblet 
cells and is primarily formed by glycoproteins.  The colon has a dual layer of mucin, 
with the inner being much denser compared with the outer layer, preventing 
microbial motility and adhesion to the epithelium [11, 20, 21]. The dynamic intestinal 
mucosa is further supported by antigen-presenting cells (APCs) such as macrophages 
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and dendritic cells. Intestinal macrophages, characterised by the lack of CD14 
expression, have been shown to exhibit phagocytic and bactericidal function [22]. 
Moreover, they can limit pro-inflammatory responses by suppressing Th1 and Th-17 
immune reactions as well as produce anti-inflammatory cytokines e.g. IL-10 [23]. 
However, it has been shown that in patients with Crohn’s disease macrophages can 
express pro-inflammatory cytokines such as IL-23, TNF-α and IL-6 [24]. Dendritic cells 
apart from being antigen-presenting cells that can stimulate T cells and promote their 
differentiation into inflammatory phenotypes can also prevent T cell mediated colitis 
as well as promote intestinal homeostasis [25-28]. 
 
1.2.3 Gut-associated lymphoid tissue 
The GI tract is supported by different types of lymphoid organs that are jointly called 
gut-associated lymphoid tissue (GALT) [5]. It has been estimated that the intestinal 
lymphoid tissue constitutes almost one-quarter of the intestinal mucosa which 
means that approximately 70% of the entire population of immunocytes in the 
human body is found in the GI tract [29]. Peyer’s patches and the isolated lymphoid 
follicles (ILFs) are closely associated with the mucosa, whereas mesenteric lymph 
nodes (MLN) are found in the mesentery [5]. Peyer’s patches are well defined 
secondary lymphoid organs that are found in the small bowel  and comprise 200-400 
lymphoid follicles with each one consisting of a germinal centre surrounded by B and 
T lymphocytes and APCs which are further surrounded by follicle associated 
epithelium (FAE) containing M cells [29]. On the other hand, ILFs can be found along 
the entire intestinal tract [30, 31]. ILFs have similar anatomy to the lymphoid follicles 
of the Peyer’s patches but they are highly dynamic as their number increases during 
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inflammatory responses and stimulate synthesis of IgA according to changes in the 
intestinal flora [5, 31-34]. Harmful bacteria or disruption of the epithelial barrier can 
activate dendritic cells, promoting their transport to MLN where they trigger 
differentiation of naïve T lymphocytes into effector and regulatory T lymphocytes. 
Therefore, the cytokines expressed by dendritic cells are able to drive the 
differentiation of naïve CD4+ T lymphocytes towards T helper (Th) 1, Th2, Th17 or 
regulatory T lymphocyte subsets [35]. Hence, GALT has evolved to such a degree that 
it is not only able to rapidly defend against invading bacteria but also to limit the 
inflammatory response to the gut environment while it allows the mucosa to 
efficiently absorb nutrients [31, 33].  
 
1.2.4 Causes of GI inflammation 
1.2.4.1 Overview 
Several causative factors have been identified to be able to trigger an inflammatory 
response in the gastrointestinal track. Although the different factors could be broadly 
categorised in five broad categories as discussed below (disruption of the barrier, 
defective immunoregulatory mechanisms, intestinal flora, overexpression of 
proinflammatory factors and inappropriate host immune response), they frequently 
co-exist or more than one is required for the inflammatory response to result in 
clinical manifestations.  
 
1.2.4.2 Disruption of the barrier 
Disruption of the epithelial barrier in experimental models of intestinal inflammation 
has been demonstrated to be an important causative factor [36-38]. Panwala et al. 
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[37], using mice deficient for the Multiple Drug Resistance Gene 1a (mdr1a), showed 
that a defective non-immune component of the mucosal barrier can lead to 
inflammation of the colon. It is known that mdr1a is expressed by the colonic 
epithelial cells where it pumps toxins administered orally actively into the intestinal 
lumen [39]. Irradiated mdr1a deficient mice reconstituted with wild-type bone 
marrow spontaneously developed colitis, whereas, irradiated wild-type mice 
reconstituted with mdra1a-deficient bone marrow cells did not develop colitis. This 
study demonstrated that defective epithelial cells were responsible for the 
susceptibility to colitis in mdr1a deficient mice and not malfunctioning immune cells. 
The authors also demonstrated that the inflammatory response had features of 
ulcerative colitis and was characterised by dysregulated epithelial cell growth, 
ulcerations, crypt abscesses and lymphocytic infiltration of the mucosa. Interestingly, 
it was shown that oral administration of broad spectrum antibiotics could prevent 
colitis in mdr1a deficient mice which means that intestinal flora plays a vital role not 
only in the initiation but also in the perpetuation of colitis [37].  
 
1.2.4.3 Defective immunoregulatory mechanisms  
Defective immunoregulatory mechanisms have been implicated in the pathogenesis 
of intestinal inflammation. Chronic enterocolitis was identified in IL-10 deficient mice 
at the age of 4-8 weeks and was lethal for most animals. The presence of 
inflammatory infiltrates in the intestinal mucosa, fibrinoid and IgA deposits as well as 
abnormal expression of MCH II suggested a significant role of the immune system in 
the pathogenesis of the enterocolitis. IL-10 is known to be able to suppress cytokine 
synthesis in macrophages, natural killer (NK) cells and T lymphocytes. Therefore, 
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since the intestinal lumen is full of foreign antigens originating from food and bacteria 
that keep the intestinal immune system in a constantly active status, intestinal 
inflammation in IL-10 deficient mice could indicate a loss of control of the typical 
intestinal immune responses against intestinal pathogens leading to chronic 
inflammation due to overproduction of TNF-α, IL-1 and IFN-γ [40]. It was also 
demonstrated that the intestinal inflammation also perpetuated by the chronic 
overexpression of cytokines as administration of IL-10 temporarily cured the disease. 
Moreover, it was noted that the IL-10 deficient mice developed a less severe disease 
when kept in an environment with a defined microbial population. This finding 
suggested that the immune response in IL-10 deficient mice was prompted by 
microbial antigens, the composition of which determined the severity of the 
inflammation [40].  
 
Moreover, deficient production of TGF-β has been shown to lead to colonic 
inflammation. TGF-β is a pleiotropic cytokine that can exhibit both anti-inflammatory 
and proinflammatory functions [41, 42]. Mice with TGF-β deficiency exhibited 
widespread inflammation in multiple organs [43, 44]. It was noted that this 
inflammation was not more prominent in mucosa than other tissues. Moreover, 
disruption of TGF-β signalling has been implicated in the development of 
inflammation in the colon amongst other organs [45, 46]. The development of colitis 
suggests that TGF-β has also been implicated in the regulation of epithelial cell 
function and in its absence the colonic mucosa is prone to stimulation by microbial 




1.2.4.4 Intestinal flora  
Several studies have implicated the mucosal microflora in the pathogenesis of GI 
inflammation not only in the initiation of the inflammation but also in the 
perpetuation of the inflammatory process. Sadlack et al. [47] demonstrated that IL-2 
deficient mice developed aggressive ulcerative colitis-like colitis when kept under 
conventional conditions. However, when the mutant mice were bred in a germ-free 
(GF) environment they did not show any clinical or histological features of colitis [47]. 
However, when they were transferred to a facility with restricted and defined 
microbial environment (SPF) the mutant mice developed mild inflammatory bowel 
disease evident on histological and immunological analysis [47]. These results 
strongly suggested that colitis was a direct consequence of an abnormal response of 
the mucosa to the intestinal bacterial flora. Similar results were reported in a study 
conducted by Contractor et al. [48]. However, the authors attributed the mild 
inflammation and anaemia seen in the SPF IL-2 deficient mice to uncontrolled 
responses to endogenous and not to environmental antigens. On the other hand, 
Schultz et al. [49] showed that older IL-2 deficient mice suffered from of mild, focal 
and subclinical GI inflammation even when they were bred in GF facilities. 
Nonetheless, SPF mutant mice showed a much more severe clinical picture 
confirming the vital role of intraluminal bacteria in the pathogenesis of GI 
inflammation [49].  
 
In addition to the aforementioned studies, further evidence that implicated the 
bacterial flora in the GI inflammation originated from studies demonstrating that T 
lymphocytes in the mouse lamina propria did not react against their own intestinal 
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flora but they did react to the microflora of other mice even from the same strain [50, 
51]. This tolerance towards self-antigens was both local and systemic and it was 
disrupted by a model of experimental colitis [trinitrobenzenesulfonic acid (TNBS)] 
where mice lost their non-responsiveness to their own flora but they regained it 
when the colitis was resolved [51]. This evidence suggested that colitis was at least 
partially caused by the foreign antigens of intestinal flora, either due to cross 
reactivity to TNBS or loss of tolerance to intestinal antigens with the onset of colitis. 
The loss of tolerance to self-microbial antigens was also evident in human 
inflammatory bowel disease (IBD), suggesting that the human disease can also be 
attributed to the loss of tolerance to self-flora [50-52]. 
 
1.2.4.5 Overexpression of proinflammatory factors 
Another important factor that it has been shown to cause GI inflammation is the 
overexpression of proinflammatory cytokines such as TNF-α [53].  Kontoyiannis et al.  
[53] using a TNF DΑRE mouse model that was characterised by disrupted regulation 
of the TNF-α mRNA processing which resulted in overproduction of TNF-α, 
demonstrated that these mice developed a notable mucosal inflammation in the 
terminal ileum and proximal colon. The colitis resembled the features of human 
Crohn’s disease as there was transmural involvement and the infiltrative lesions 
contained rudimental granulomata resembling non-caseating granulomas with 
multinucleated giant cells. It was also shown that the colitis was dependent on the 
presence of T lymphocytes as well as constituents in the bacterial flora that could 
stimulate the production of TNF-α. Nevertheless, TNF DARE mice that were also IL-
12 p40 deficient did not develop colitis which implied that microflora antigens did not 
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directly induce TNF-α production in the absence of IL-12. IL-12 production is 
upregulated in TNF ΔΑRE mice as TNF-α overexpression leads to the development of 
a positive feedback loop between IL-12 and TNF-α [53].  
 
Several studies also demonstrated that IL-23 could promote chronic intestinal 
inflammation by inducing a wide range of inflammatory responses. It has been shown 
that T lymphocyte-mediated colitis was associated with overexpression of 
proinflammatory cytokines such as TNF-α, IFN-γ, IL-6 and IL-17A whose expression 
was significantly downregulated in the absence of IL-23 [54-56]. Analysis of mucosal 
CD4+ T lymphocyte responses in both studies published by Hue et al. [54] and 
Kullberg et al. [55] has shown that IL-23 dependent T lymphocyte-mediated colitis 
was associated with strong Th1 responses with a minor IL-17-expressing cells being 
present. Nevertheless, in the presence of anti-IL-23p19 antibodies the colitis that was 
induced by adoptive transfer of a bacteria reactive CD4+ Th17 cell line, was 
ameliorated. This finding was associated with increased apoptosis of the Th17 cells 
[56]. Interestingly, with complete absence of T lymphocytes, the innate immune 
typhlocolitis triggered by H. hepaticus infection of 129RAG-/- mice was characterised 
by very similar expression of pro-inflammatory cytokines as found in the T 
lymphocyte mediated colitis, which was also attenuated by administration of anti-IL-
23p19 antibodies [54]. This type of innate immune response was characterised by the 
presence of granulocytes and monocytes that were expressing IL-17A [54]. Therefore, 
there is evidence to suggest that IL-23 can induce the expression of proinflammatory 
mediators in both acute innate and pathogenic adaptive responses, which could lead 
to the development of chronic intestinal inflammation.  
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1.2.4.6 Inappropriate host immune response  
Finally, inappropriate immune response of the host to an external factor has been 
shown that could result in GI inflammation. Among the common causes of non-
infectious GI inflammation are the celiac disease and IBD that includes ulcerative 
colitis and Crohn’s disease. Coeliac disease is characterised by the presence of small 
bowel mucosal injury and nutrient malabsorption. It is found in genetically 
susceptible individuals following dietary ingestion of proline and glutamine rich 
protein that are widely called gluten. The symptoms often settle with adoption of 
gluten free diet [57]. Acquired T lymphocyte-mediated immune mechanisms and 
innate immune mechanisms play a significant role in the pathogenesis of celiac 
disease [58]. The main genetic risk factor is a susceptible HLA haplotype, while 
numerous other risk-associated loci map to genes involved in immune function such 
as chemokines and cytokines have been implicated in the pathogenesis of celiac 
disease [59]. 
 
The pathogenesis of IBD has also been shown to have a significant genetic component 
and is believed to be associated with a dysregulated immune response to intestinal 
flora. Polymorphisms in genes of the innate immune system such as NOD2 (which 
encodes nucleotide-binding oligomerisation domain 2), ATG16L1 (which encodes 
autophagy related 16-like protein 1) and IRGAM (which encodes immunity-related 
GTPase family M) are specific to patients with Crohn’s disease but have not been 
described in ulcerative colitis patients. On the other hand, several gene alterations in 
the IL-23 pathway, such as IL-23 receptor, IL-12B (which encodes the p40 subunit of 
IL-12 and IL-23) and STAT3 (which encodes the signal transducer and activator of 
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transcription 3) have been described in both ulcerative colitis and Crohn’s disease. 
Moreover, the homeodomain-containing transcription factor NKX2-3 has also been 
implicated in the pathogenesis of both ulcerative colitis and Crohn’s disease as 
studies in NKX2-3-deficient mice have demonstrated its role in the correct 
localisation of lymphocytes in the spleen for both B lymphocyte maturation and T 
lymphocyte immune responses [25, 35, 60-63]. 
 
Therefore, it is apparent that in the complexity of the intestinal environment, 
gastrointestinal inflammation can often be multifactorial as several causative factors 
need to coexist for the inflammatory response to have a harmful effect to the host 
and consequently to become clinically apparent. Additionally, the enteric nervous 
system and the neuroimmune interactions also play a crucial role in the regulation of 




1.3 Enteric nervous system and neuroimmune interactions 
1.3.1 Overview 
There is increasing evidence on the involvement of the enteric nervous system (ENS) 
in the enteric immunology and regulation of the inflammatory process [64-66]. 
Almost any inflammatory process in the GI tract is associated with abdominal pain as 
products of the immune system sensitise and stimulate peripheral sensory neurons 
following tissue damage [67, 68]. It has been reported that 50%-70% of patients with 
IBD present with abdominal pain [69, 70]. Moreover, patients with IBS can present 
with a variety of functional GI disorders but mainly with abdominal pain and altered 
bowel habits [67, 71].  
 
1.3.2 Innervation of the GI tract 
The wall of the GI tract contains approximately 10⁸ neurons which are divided into 
subpopulations of sensory, interneurons and motor neurons. They are 
interconnected with synapses into integrated circuits forming the myenteric and the 
submucosal plexuses [72-74]. The submucosal plexus mainly supplies the mucosa and 
controls secretion, absorption and blood flow whereas, the myenteric plexus 
principally controls motility [75, 76]. The connection to the CNS is provided by 
extrinsic primary afferent nerve fibres of the GI tract which receive splanchnic and 
vagal innervation along with nerve fibres from the pelvic nerves [77]. Although the 
splanchnic afferents constitute the main nociceptive pathway, vagal as well as pelvic 
nerves have been associated with the preservation of homeostasis and nociception 
of the gut. 
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The vagal afferents primarily control reflexes such as gastric emptying, pancreatic 
secretion and the perception of bloating and nausea. Three types of vagal fibres have 
been identified: mechanical, tension sensitive and chemo-sensitive afferents [78-82]. 
The pelvic afferent fibres respond to colonic distension and hence they transmit 
information on physiological sensation such as urgency and desire to defecate [83]. 
Animal studies have implicated the pelvic afferents in acute and inflammatory pain 
as bilateral pelvic nerve transection eliminated pain associated behaviour [77, 83] 
and administration of chemical irritant to colonic tissue caused sensitisation of the 
pelvic afferents [84]. The splanchnic afferents act as functional complement to the 
vagal and pelvic fibres and they are considered to be the main nociceptive pathway 
as they conduct different modalities of mechanosensory information [83, 85]. The 
vast majority of the splanchnic afferents are found in the serosa and mesenteric 
membranes in close association with mesenteric blood vessels. It is believed that the 
mesenteric and submucosa extrinsic fibres are able to respond to distortion of the 
intestine due to contraction or distension at levels that could cause pain [83, 86, 87]. 
However, the relevance of the extrinsic afferent nerve fibres to pain is due to their 
stimulation by neuropeptides [64].  
 
Although, the large intestine is extensively innervated, a small number of extrinsic 
afferents provides the link of with the central nervous system (CNS) for perception. 
Moreover, the extrinsic colonic afferents supply other organs by organising into 
complex plexuses distributed throughout the abdominal cavity. Therefore, signals 
from multiple abdominal organs, and not only from the colon, congregate to a 
comparatively large number of spinal cord segments [88]. Within the spinal column 
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somatic input also joins the visceral signals and together travel to CNS. This equivocal 
signal transduction from the gut to the brain could explain the poor topological 
relation of the experienced pain in many intra-abdominal conditions which is often 
described as "non-specific" by clinicians. 
 
1.3.3 Neuroimmune interaction in the GI tract 
The ENS closely cooperates with the enteric immune system in order to establish a 
first line defence against noxious agents. Several studies have shown that different 
cell types are in close histoanatomic proximity with enteric neurons, vagal nerve 
fibres and spinal sensory nerves in order to be able to regulate the immune response 
in different ways [89-91].  
 
Enterochromaffin cells are neuroendocrine cells that are strategically positioned 
between the epithelial cells of the GI mucosa where they can sense the intraluminal 
milieu. They are equipped with secretory granules that contain a wide range of 
peptides, such as serotonin, cholecystokinin and secretin that can influence 
peripheral nerve fibres upon their release [92]. Several studies have implicated 
enterochromaffin cell hyperplasia in the pathogenesis of IBS and IBD [65, 93, 94] as 
well as in Th2 inflammatory response [95].  
 
Mast cells are also an integral part of the innate immune system and play a crucial 
role in neuroimmune interactions [64, 96]. They have the ability to act as sensory cells 
activated by different effector cells and release a wide range of active mediators such 
as histamine, serine proteases, proteoglycans as well as prostaglandins, leukotrienes 
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and cytokines (TNF-α, IL-6) [64, 96]. The release of nerve growth factor (NGF) by mast 
cells is stimulated by IL-1β and TNF-α and it can not only excite the afferent neurons 
but also increase neuropeptide expression from the spinal cord sensory terminal and 
is likely to contribute to centrally mediated hyperalgesia [64, 97-99]. Moreover, NGF 
increases neuropeptide expression at peripheral nociceptors terminals and 
proteolytic products of NGF in inflamed tissues can indirectly modulate their 
excitation [97, 100]. Therefore, mast cells can control sensory terminals by modifying 
their sensitivity and amplitude via the release of NGF. As a result, the degree of mast 
cells activation has been directly associated with hyperalgesia and pathological pain 
status in inflammatory conditions [97]. 
 
Another population of cells that contributes to the neuroimmune interactions is the 
peripheral glial cells. They are able to control enteric neurotransmission, 
inflammation and intestinal barrier function as they contain neurotransmitter 
precursors such as γ-aminobutyric acid (GABA) and nitric oxide; express purine 
receptors and produce cytokines (IL-1, IL-6, TNF-α), NGF and neuropeptides (NKA and 
Substance P) following their activation [101]. With regards to neurotransmission, it 
has been shown that GABA transporter GAT2 is mainly expressed by enteric glial cells 
which suggests that glial cells are implicated in the detoxification of GABA via rapid 
GABA-removal from the extracellular space [102]. Moreover, partial ablation of 
enteric glial cells in an animal study showed decreased expression of neuronal VIP 
and NO, further supporting the role of the glial cells in peptidergic and nitrergic 




The enteric glial cells also play a pivotal role in both neuroimmune interactions and 
the function of intestinal barrier. They have been shown to promote intestinal seal 
by releasing soluble factors that interact with the epithelial cells. Ablation of the 
enteric glial cells caused severe colonic inflammation due to breakdown of the 
epithelial barrier. On the other hand, it has also been described that glial cells can 
inhibit the proliferation of the intestinal epithelial, suggesting their role in preventing 
disorganisation and hyperproliferation during an inflammatory process [104-107]. 
The seeming paradox between epithelium conserving and anti-proliferation effects 
could be explained by the observation that glial cells were able to change the 
arrangement of the epithelial cells which flattened and spread out in order to 
enhance epithelial sealing [104, 105, 108] as the intestinal epithelial barrier is a vital 
part of the innate immune system [101, 109, 110]. Moreover, enteric glial cells play 
an important role in attracting inflammatory cells as it has been reported that 
lymphocytic infiltrates in the ENS of patients with Crohn’s disease are associated with 
the expression of major histocompatibility complex (MHC) class II on glial cells [111-
113]. Moreover, co-culture of enteric glial cells, stimulated by TNF-α and interferon 
(IFN) γ in the presence of an antigen and antigen-specific T lymphocytes initiated a 
substantial increase in T lymphocyte proliferation [101]. Thus, it is apparent that 
enteric glial cells are a fundamental part of the enteric immune system as well as the 
ENS and play a pivotal role in GI inflammation. 
 
In conclusion, the ENS in conjunction with several cell populations is in a position 
regulate immune responses. Release of neuropeptides such as Substance P, CGRP 
and VIP can initiate neurogenic inflammation [114]. Release of Substance P 
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stimulates mast cell degradation which causes the release of different inflammatory 
mediators such as cytokines, proteinases, nitric oxide, prostaglandins, leukotrienes 
and thromboxanes [114]. These substances subsequently activate other 
inflammatory cells such as neutrophils, lymphocytes and macrophages whose 
mediators in turn engage in further neuroimmune interactions stimulating the ENS 




CHAPTER 2: Immunological characterisation of inflammatory, 
neuroimmune and histologically "normal" appendicitis 
2.1 Overview 
Acute appendicitis is the most common surgical condition that requires an urgent 
abdominal operation. The number of hospital admissions in England has been 
reported to exceed 40000 per year and is more common in males with a male to 
female ratio of 1.4:1 [116]. The lifetime risk is 8.6% in males and 6.7% in females in 
the USA [116]. The diagnosis of appendicitis is primarily clinical as it is based on the 
history and physical examination. Although, it is fairly easy to diagnose cases with 
classical presentation, this is not always the case and, therefore, the diagnosis can be 
very challenging. Moreover, it is widely accepted that delay in treatment carries 
significant risk and increases post-operative complications [117]. This has led 
clinicians to perform early appendicectomy in patients with suspected appendicitis; 
an approach that has resulted in a reduction of the morbidity. The consequence of 
this practice is that a significant number of appendices are reported as normal 
following conventional histopathological examination [118, 119]. Before the 
laparoscopic era, the rate of histologically "normal" appendices was reported to 
range from 15% to 30% [120, 121]. The introduction of diagnostic laparoscopy in the 
early 1990s has reduced the rate of unnecessary appendicectomy [122, 123]. 
However, even using laparoscopy as a tool to further investigate right iliac fossa pain 
the dilemma of removing a macroscopically normal appendix still remains. As there 
are studies either supporting [124, 125] or opposing [126] the removal of a normal 
looking appendix, the decision rests with the surgeon’s discretion. Despite the 
frequency of occurrence, the pathogenesis of acute appendicitis remains poorly 
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understood. The fact that the clinical presentation is conflicting with the absence of 
definite histological findings combined with the clinical observation that 
appendicectomy relieves right iliac fossa pain in most patients suggests that an 
unknown pathology may exist [127, 128]. Several studies have investigated the 
discrepancy between the clinical and histological diagnosis and have shown that not 
only the inflammatory process can vary considerably but have also highlighted 
different immunological and cellular markers that may be specific for the type and 
pathogenesis of appendicitis (inflammatory/neurogenic) [129-135]. More recently, it 
has been suggested that uncomplicated acute appendicitis may be managed 
successfully with antibiotics rather than surgery [136]. However, the long-term 
consequences of this approach have not been elucidated and it is not known whether 
patients treated with antibiotics may have chronic right iliac fossa pain as a 




2.2 Pathogenesis of appendicitis 
Acute appendicitis was first described as a clinical entity by Reginald Fitz in 1886 who 
attributed its cause to indigestion, jumping, lifting and falling. Nowadays, obstruction 
of the appendiceal lumen is thought to be the cause for the development of acute 
appendicitis and subsequently appendiceal gangrene and finally perforation [137]. 
Overall, obstruction of the lumen can be due to a faecolith, fibrotic stricture, foreign 
body or indigested food. While, over-growth of the lymphatic tissue is a cause of 
acute appendicitis in the young, obstruction of the appendiceal orifice by a caecal 
carcinoma can lead to acute appendicitis in the elderly. Once the luminal obstruction 
is established, the intraluminal pressure increases due to accumulation of secreted 
mucus. As a consequence, the lymphatic drainage is obstructed leading to oedema 
and mucosal ulceration. At this stage of the inflammatory process, complete 
resolution may be possible either spontaneously or due to treatment with antibiotics 
However, in the case the condition progresses, bacterial proliferation continues, and 
the tension rises. The venous drainage is obstructed first followed by arterial supply. 
With the mucosa being ischaemic bacterial invasion takes place resulting in acute 
inflammation. Further progression of the acute inflammatory process in combination 
with compromised arterial supply leads to gangrene and perforation with subsequent 
bacterial contamination of the peritoneal cavity. However, in case the greater 
omentum and the small bowl become adherent to the appendix the acute 
inflammation can be walled off and the result is a phlegmonous mass which will 




2.3 Literature review 
2.3.1 Overview 
Although the aforementioned mechanism is found in the vast majority of surgical 
textbooks, it cannot explain the symptoms of acute appendicitis in patients without 
features of acute inflammation on histological examination of their appendix. The 
cause of the right iliac fossa pain in these patients remains unknown and the clinical 
improvement after appendicectomy cannot be explained. In this context, several 
studies using laboratory-based techniques have tried to explain the role of 
inflammatory mediators and neuroproliferation in causing the clinical picture of 
acute appendicitis without the presence of acute inflammation on conventional 
microscopy [127, 129-135]. 
 
2.3.2 Neurogenic appendicopathy 
The impression that the ENS could be responsible for symptoms mimicking acute 
appendicitis dates back to 1921, when Maresch [138] and Masson [139] 
independently described proliferation of the ENS giving rise to neuromatous lesions 
of the appendix without any features suggesting acute inflammation. Masson [139, 
140] was the first to recognise the close spatial relationship between nerve fibres and 
endocrine cells in the appendiceal mucosa and suggested the term "appendicite 
neurogene" introducing the clinical entity of neurogenic appendicitis. However, this 
term was criticised by Knoflach [89] and therefore the term "neurogenic 
appendicopathy" was suggested by Chiari [90]. Feyrter suggested that abnormal 
communication between the "adeno and neurointestinum"  can potentially cause 
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neurogenic appendicitis [91]. In a later study Feyrter also suggested that the 
pathophysiological mechanism responsible for irregular peristalsis, spasm and 
hyperemia of appendiceal blood vessels is a neurovascular crisis [141]. Aubock and 
Ratzenhofer [142] with the use of electron microscopy were able to demonstrate the 
presence of enterochromaffin cells in the lamina propria of the appendicular mucosa 
and their direct contact with normal or pathologically altered nerve fibres confirming 
Masson’s early theory. In specimens with features of neurogenic appendicopathy the 
number of enterochromaffin cells was increased [142]. In 1980s, Hofler [143, 144] 
suggested the following classification based on nerve proliferation and axonal 
swelling in the mucosa as it was observed by Aubock and Ratzenhofer [142, 145]  with 
the use of electron microscopy: 
 
1. Mucosal neurogenic appendicopathy is the most frequent type with an 
incidence of approximately 10.4% of all excised appendices.  
2. Central or axial neuromas occur following obliteration of the proximal 
appendix and result in a large central nerve bundle, surrounded by the 
muscularis mucosae. In both types the number of endocrine cells in the 
mucosa stroma is increased. 
3. Neuromuscular proliferation is uncommon and is characterised by a striking 
proliferation of smooth muscle fibres and axons close to the mucosa or 
muscularis propria layers resulting in neurovascular tangles. Neuromuscular 





The incidence of neurogenic appendicopathy seemed to vary significantly between 
studies depending on the study design. In an early study which was carried out by 
Doberauer [146] and examined patients older than 60 years of age, the reported 
incidence of neurogenic appendicopathy was 50%,  whereas, Quell and Horvath [147] 
based their study on retrospective data and reported an incidence of 60%. Another 
study which was conducted on postmortem material and examined a series of 237 
appendices for neurogenous hyperplasia using immunohistochemistry [148]. The 
specimens varied from appendices with intact lumens, featuring intramucosal 
neurogenous hyperplasia often with co-existent submucosal and muscular nerve 
growth, to obliterated samples whose axial portions were composed of nerve tangles 
and fibrous tissue. The neurogenic lesions in this study were found to be present in 
more than 80% of all the specimens [148]. The first prospective study which included 
127 appendices confirmed neurogenic appendicopathy in 44.8% of the specimens 
without histological features of acute appendicitis whilst 14.5% of patients with acute 
appendicitis were also found to have features of neurogenic appendicopathy [149].  
 
An additional study by Hofler et al. [150] extended previous knowledge 
demonstrating an increased number of nerve fibres in the mucosa of appendices of 
the mucosal type of neurogenic appendicopathy. The nerve fibres of the mucosal 
plexus and the innermost layers of the submucosa were also significantly enlarged as 
visualised by neuron specific enolase (NSE). A similar staining pattern was 
demonstrated by Substance P whereas nerves with VIP immunoreactivity were also 
numerous but to a lesser extent. It was suggested that Substance P could cause 
spastic contractions and abnormal peristalsis while VIP secretion could be implicated 
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in the mechanism of local hyperaemia. This proposition was in agreement with 
Feyrter’s theory [91, 141] of a neurovascular crisis [150]. In support to this study, Naik 
[151] also reported mucosal and submucosal hyperplasia in 69.34% of the 
histologically "normal" appendices when stained with PTAH. In contrary to the 
findings of the previous studies [150, 151], Dhillon and Rode [152] reported that 
staining for NSE revealed more instances of nerve "hyperplasia" in the control group 
compared with appendices generating abdominal pain without active inflammation 
confuting the clinical entity of neurogenic appendicopathy based on quantitative 
nerve changes. However, the intensity of staining for serotonin in the subepithelial 
neuroendocrine cells was significantly reduced in the painful group suggesting 
discharge from serotonin stores. There were no differences between the two groups 
for VIP and Substance P staining. The authors hypothesised that continuous release 
of serotonin could lead to acute appendicitis [152]. However, both studies by Naik 
[151] and Dhillon and Rode [152] performed a subgroup analysis in patients with 
appendices without signs of acute inflammation. 
 
Franke et al. [153] conducted a prospective multicentre study in an attempt to 
delineate preoperative clinical signs that could differentiate neurogenic 
appendicopathy from acute appendicitis. The authors also examined how reliable 
simple haematoxylin and eosin (H&E) staining was for the histological diagnosis of 
neurogenic appendicopathy. The study evaluated 282 appendices and neurogenic 
appendicopathy was diagnosed by H&E when a focal collection of pale spindle cells 
was found in the lamina propria or in an obliterated appendix. 
Immunohistochemistry with S-100 protein was performed to confirm diagnosis of 
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neurogenic appendicopathy. Clinical data was also collected and analysed. Regarding 
the histological diagnosis, 7 of the 19 patients with acute appendicitis were found to 
have features of mucosal neurogenic appendicopathy by both H&E and S-100 staining. 
H&E staining missed the diagnosis of neurogenic appendicopathy in only 7 of the 96 
histologically " normal" appendices while they were detected by S-100. Therefore, 
the sensitivity of H&E in the histologically "normal" group was reported to be 84% 
with specificity 100%. With regards to clinical findings, evidence emerged that 
patients with neurogenic appendicopathy were more likely to have had similar 
previous episodes compared with acute appendicitis patients. There were no 
differences in the characteristics of the pain, nausea, micturition or gynaecological 
symptoms. Physical signs as well as laboratory tests such as leukocyte count to 
suggest acute inflammation were more frequent in the acute appendicitis group 
compared with the neurogenic appendicopathy group. Thus, this study provided 
evidence that neurogenic appendicopathy could be easily diagnosed by H&E staining 
but could not be differentiated from acute appendicitis based on the  clinical picture 
[153].  
 
However, a recent study by Grebeldinger et al. [154] not only confirmed the findings 
of Franke et al. [153] reinforcing the role of H&E staining in the diagnosis of 
neurogenic appendicopathy but also described clinical parameters that characterised 
neurogenic appendicopathy. This study included 209 individuals aged 4 to 19 with 
clinical diagnosis of acute appendicitis. The negative appendicectomy group 
consisted of two subgroups: with neurogenic appendicopathy and without 
neurogenic appendicopathy. The control group was formed by histologically proven 
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acute appendicitis specimens. A sample was diagnosed as neurogenic 
appendicopathy by H&E staining when a focal collection of pale spindle cells was 
found in the lamina propria mucosa or the lumen was obliterated. The diagnosis of 
neurogenic appendicopathy was confirmed with S-100 staining of the Schwann cells. 
The clinical examination findings were associated with information gathered by 
laboratory and ultrasonography tests. The follow-up of the patients lasted for three 
months after discharge. Thirty-eight % of the macroscopically normal appendices 
reported to have features of neurogenic appendicopathy while the highest incidence 
of neurogenic appendicopathy was at the age of 16 to 19 and most of the patients 
were female (n=14). Patients with neurogenic appendicopathy ware associated with 
the presence of previous episodes mimicking acute appendicitis and they were likely 
to have a characteristic antalgic position when in pain but unlikely to have guarding 
or a coated tongue with low or normal white cell count. Patients with neurogenic and 
non-neurogenic appendicopathy were less likely to have faecoliths compared with 
samples with evidence of acute inflammation. Intraabdominal abscesses were not 
detected in patients with neurogenic appendicopathy whereas free fluid in the right 
iliac fossa was detected in 36.8% of patients with neurogenic appendicopathy, 25.8% 
with non-neurogenic appendicopathy and 32.1% with acute appendicitis. Regarding 
the post-operative follow-up, the number of neurogenic appendicopathy patients 
with pain in the scar, persistent right iliac fossa pain or digestive disorders was smaller 
compared with the non-neurogenic appendicopathy or acute appendicitis groups. 
The reoperation rates were reported to be zero in the neurogenic appendicopathy 
group whereas 3.8% and 6.5% of patients with acute appendicitis and non-
neurogenic appendicopathy groups respectively needed re-operation [154].   
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In a similar study, Sesia et al. [155] retrospectively examined 29 paediatric 
appendices that met the histopathological criteria of neurogenic appendicopathy. 
The intraoperative diagnosis for these 29 appendices was: absence of inflammation 
in 17.2%, acute inflammation in 58%, phlegmonous in 13.8% and perforated 
appendicitis in 10.4% of the specimens. The most common type of neurogenic 
appendicopathy was the submucosal as it was found in 52% of specimens, whereas 
the mucosal was found in 41% and the axial neuroma in 7% of the specimens.  
 
The findings of the previously mentioned studies recognised neurogenic 
appendicopathy as a clinical and histopathological entity in patients who presented 
with signs and symptoms suggesting acute appendicitis and subsequently had 
"negative" appendicectomy. Some differences in the clinical picture of neurogenic 
appendicopathy and acute appendicitis were identified which suggested that the 
diagnosis of neurogenic appendicopathy should be considered in patients with right 
iliac fossa pain, especially in those with recurrent symptoms even if the appendix 
looks normal intraoperatively. However, these studies did not provide evidence on 
the status of the immune system of histologically "normal" appendices as well as on 
possible interactions between the ENS and the immune system.  
 
2.3.3 Neuroimmune appendicitis  
The term "neuroimmune appendicitis" was introduced by Di Sebastiano et al. [130] 
in 1999 implying that disturbed interactions between the ENS and immune cells were 
involved in the pathophysiology of acute right iliac fossa pain in the absence of acute 
inflammation of the appendix on conventional microscopy. The patients involved in 
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this study were recruited prospectively and allocated into three groups. The acute 
appendicitis group was formed by appendices with evidence of acute inflammation 
on conventional microscopy whereas appendices that did not have any of these signs 
formed the histologically "normal" group. The control group was formed by 
appendices obtained from multi-organ donors or patients who had their appendix 
removed as part of an elective abdominal surgery. With the use of 
immunohistochemistry, it was shown that in the control samples, plexuses of nerve 
fibres stained positively for Substance P extended from the submucosal layer to the 
lamina propria of the mucosal layer as well as beyond the outer zone of lymphoid 
follicles being in close contact with mononuclear immune cells. VIP staining showed 
a similar picture. In the acute appendicitis group, the staining for Substance P, VIP 
and GAP-43 was significantly reduced and proportional to the infiltration of immune 
cells. The histologically "normal" appendices showed significantly enlarged lymph 
follicles and well developed germinal centres with nerve fibres to be in contact with 
the marginal layer of the lymph follicles, but they were not detected in the centres. 
A significant increase of nerve fibres stained by Substance P and VIP was observed 
mainly in the basal part of the mucosal layer. Moreover, intrinsic and ganglionic cells 
in the myenteric and submucosa plexus showed strong staining for Substance P and 
also most of the nerve trunks and neurons showed immunoreactivity for GAP 43 and 
PGP 9.5. With the use of quantitative computerised image analysis of mucosal nerve-
fibre density demonstrated that the area with Substance P immunostaining was 
proportionally greater in the histologically "normal" group compared with the acute 
appendicitis and control groups [130]. Interestingly, a significant number of patients 
in the group with histologically "normal" specimens, reported previous attacks of 
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pain whereas only one patient with histologically proven appendicitis had 
experienced right iliac fossa in the past. In the follow-up period, the vast majority of 
patients in the histologically "normal" group were pain free. The latter was in 
agreement with the findings of an earlier study according to which two thirds of 
patients with histologically "normal" appendix were pain free after a mean follow-up 
of 2.9 years [117].  
 
The concept of neuroimmune appendicitis was further evaluated in a small 
retrospective study which involved 19 children allocated in three groups [134]. With 
the use of immunohistochemistry, Substance P was found to be moderately to 
strongly expressed in the epithelium, lamina propria and muscularis in more than 50% 
of the histologically "normal" samples. The expression of VIP demonstrated a similar 
pattern although it was almost absent in the epithelium. According to the authors the 
reported expression of neuropeptides in the histologically "normal" samples was 
analogous to that observed in specimens with acute inflammation. In the control 
group the expression of these neuropeptides was either negative or very weak. In 
contrary to Di Sebastiano et al. [130] the immunoreactivity for GAP-43 was very weak 
and non-specific. After a follow-up period of one year, the right iliac fossa pain was 
settled in all children with histologically "normal" appendices. In agreement with 
observations by other studies, Bouchard et al. [134] noted that some of these 
children experienced previous episodes of right iliac fossa pain.  
 
The studies by Di Sebastiano et al. [130] and Bouchard et al. [134] clearly showed that 
neuroproliferation associated with increased expression of Substance P and VIP 
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neurotransmitters could cause neurogenic inflammation that gave rise to signs and 
symptoms of acute appendicitis without the presence of acute inflammation evident 
on conventional histological examination. Moreover, the increased expression of 
neuronal plasticity marker GAP-43 in the histologically "normal" group indicated that 
the ENS was grossly affected by the inflammatory process. Both studies also 
confirmed the presence of previous right iliac fossa pain episodes that settled with 
appendicectomy. However, several aspects on the nature of the neuroimmune 
interactions and they could regulate the inflammatory response remained to be 
explained.  
 
In an attempt to further investigate the pathogenesis of appendicitis and more 
specifically the cause of symptoms in patients with histologically "normal" 
appendices, Xiong et al. [132] examined the possible association between the ENS 
and mast cells in patients with a clinical diagnosis of acute appendicitis. The study 
was retrospective in nature and included 40 paediatric appendices, 10 of which were 
reported to be histologically "normal". The expression of Schwann cell markers S-100 
protein and 2’2’-cyclic nucleotide 3’ phosphodiesterase (CNPase) as well as neuronal 
markers synaptophysin and neuron-specific enolase (NSE) was assessed with 
immunohistochemistry. The number of mast cells was determined by counting the 
number of cells stained by mast cells tryptase. The acutely inflamed appendices 
demonstrated significantly increased number of nerve fibres and Schwann cells 
throughout the mucosa, submucosa, lamina propria and muscularis externa 
compared with the control group. On the other hand, 4 out of 10 histologically 
"normal" appendices demonstrated a very similar picture to the acutely inflamed 
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appendices with the rest 6 specimens being very similar to the control group. With 
regards to mast cells population, the acutely inflamed appendices showed a 
significantly increased number of mast cells in the lamina propria whereas the 
histologically "normal" appendices did not differ compared with the control group. 
However, in contrary to the results published by Xiong et al. [132], Naik et al. [156] 
also examined mast cell counts in inflamed and histologically "normal" appendices, 
and reported a significantly higher number of mast cells in the histologically "normal" 
samples.  
 
Another study that attempted to investigate the alterations in the ENS and mast cells 
in patients with a clinical diagnosis of acute appendicitis but histologically "normal" 
appendices was conducted by  Amber et al. [135]. The study included 50 specimens 
and immunohistochemistry with S-100 protein and NSE was employed to assess the 
status of ENS whereas mast cells were evaluated with toluidine blue staining. 
Conventional microscopy showed features of acute inflammation in 15 specimens 
whereas the rest 25 were reported as histologically "normal". Ten samples formed 
the control group. The authors reported that NSE stained fine nerve fibres that were 
located near the base and around the crypts of the mucosa. This finding was in 
contradiction with the findings of Xiong et al. who demonstrated fine nerve endings 
close to the epithelium and large nerve fibres near the bottom and between the 
crypts in 40% of histologically "normal" appendices. Neural hyperplasia limited to the 
mucosa only, as observed by Naik et al. [151] was found in only 4% of the 
histologically "normal" appendices. However, significant submucosal and myenteric 
neuronal hyperplasia in acutely inflamed and histologically "normal" appendices was 
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observed by Nemeth et al. [127], Xiong et al. [132] and Naik et al. [151]. In support of 
Di Sebastiano et al. [130] this study confirmed the presence of nerve fibres being in 
contact with the marginal zone of lymphoid follicles with the use of S-100 protein. 
Amber et al. [135] observed mast cells in all tissue layer with highest concentration 
in the submucosa of all groups contradiction. This finding was in contradiction to 
findings of previous studies according to which the highest concentration of mast 
cells was found in the mucosa [132, 156]. This discrepancy was attributed to the 
difficulty in the identification of mast cells in the mucosa due to enlarged lymphoid 
follicles [135]. However, the mean mast cell count was highest in the histologically 
"normal" appendices in all four layers compared with acutely inflamed appendices 
and control group and this was in agreement to the observation made by Naik et al. 
[156]. Xiong et al. [132] reported that the increased mast cell count observed in 
acutely inflamed appendices was associated with increased ganglia and Schwann 
cells whereas Amber et al. [135] reported that acute inflammation was associated 
with reduced mast cell count. This could be explained by a possible reaction of mast 
cells to luminal stimuli by elimination through the mucosa or degranulation and 
subsequent inability to detect them. Finally, in agreement with previous studies, 40% 
of the patients with histologically "normal" appendices reported to suffer from 
chronic abdominal pain [135]. 
 
The striking finding of neuronal hypertrophy in acutely inflamed appendices 
combined with a significantly increased number of mast cells could imply a close 
cooperation between the ENS and mast cells in the pathogenesis of acute 
appendicitis. However, the neuronal hypertrophy could be the consequence of a 
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chronic inflammatory process or repeated episodes of acute inflammation to stimuli. 
This was supported by the finding of increased nerve fibres and Schwann cells in 
histologically "normal" appendices from patients with signs and symptoms of acute 
appendicitis which might imply that these appendices represent a different degree 
of inflammatory response. The increased number of mast cells in both groups of 
acutely inflamed and histologically "normal" appendices could also support the idea 
that repeated episodes of inflammation could play a role to its pathogenesis. 
Moreover, the fact that a significant number of patients with histologically "normal" 
appendices reported previous episodes of right iliac fossa pain which eventually 
settled with appendicectomy, further strengthened the theory that neuronal 
hypertrophy could be the result of a chronic inflammatory process. 
 
Nemeth et al. [127] confirmed the findings of previous studies which showed 
neuronal hypertrophy in histologically "normal" appendices by using whole-mount 
preparation using nicotinamide adenine dinucleotide phosphate (NADPH) 
diaphorase histochemistry and neuronal nitric oxide synthase (nNOS) 
immunohistochemistry. This technique gave the researchers the opportunity for an 
accurate 3D demonstration of the appendicular neuronal network, the relationship 
of branching nerve fibres to each other and neighbouring tissues as well as the 
changes in the neuronal plasticity. The study was conducted on paediatric specimens 
and retrospectively included 28 acutely inflamed appendices, 31 histologically 
"normal" appendices and 23 normal appendices which were removed during an 
elective abdominal surgery and formed the control group. Based on the density of 
the myenteric plexus two different subgroups were identified within the groups of 
54 
 
acutely inflamed and histologically "normal" appendices. In the acute appendicitis 
group 46.5% of the samples showed neuronal density similar to that of the control 
specimens whereas 58% of the histologically "normal" samples showed neuronal 
density similar to that of the control specimens. The rest of the samples were found 
to have thick nerve bundles and high-density neuronal network. The average nerve 
thickness of the histologically "normal" appendices was 101.1 μm whereas it was 96.7 
μm and 58.4 μm in acutely inflamed and normal appendices respectively, clearly 
demonstrating significant changes in the innervation of histologically "normal" 
appendices obtained from patients with a clinical diagnosis of acute appendicitis. The 
authors agreed with the previously proposed theory and concluded that the observed 
neuronal hypertrophy is likely to have developed over a certain period of time due to 
repeated episodes of inflammation or chronic intraluminal obstruction [130, 135]. 
 
New insights into the pathogenesis of symptoms of appendicitis were brought by a 
study that examined the contents of neuroendocrine cells in histologically "normal" 
and acutely inflamed appendices [133]. The study involved 98 appendices from 
patients with a clinical diagnosis of acute appendicitis, 25 specimens had features of 
acute inflammation, 24 had evidence of follicular hyperplasia only and 26 specimens 
were reported to be histologically "normal" on conventional histopathological 
examination. The control group included 23 appendices resected from patients who 
had elective abdominal surgery. Enterochromaffin and subepithelial neuroendocrine 
cells were recognised with the use of immunohistochemistry for serotonin, 
chromogranin and synaptophysin. Immunoreactivity for serotonin and chromogranin 
was observed in the cytoplasm of enterochromaffin cells located at the base of the 
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crypts and in subepithelial neuroendocrine cells within the lamina propria, close to 
the base of the crypts. Synaptophysin was expressed by enterochromaffin and 
subepithelial neuroendocrine cells as well as by ganglion cells and the neural network 
within the lamina propria and between the muscle layers. Enterochromaffin cells 
were detected by serotonin and chromogranin staining in all the histologically 
"normal" and control appendices, 96% of the samples with follicular hyperplasia but 
in only 64% of the specimens with acute inflammation. The number of 
enterochromaffin cells per intact gland as well as the mean serotonin-containing cells 
per gland were significantly reduced in acutely inflamed specimens compared with 
the others. In a similar way, the number of chromogranin and synaptophysin 
immunoreactive cells were also significantly reduced in the acutely inflamed 
appendices compared with those of the other groups. Regarding the subepithelial 
neuroendocrine cells, they were stained by serotonin in 56% of acute appendicitis 
samples, 75% of follicular hyperplasia samples, 100% of histologically "normal" 
appendices and 91% of the control specimens. Immunostaining with synaptophysin 
and chromogranin did not demonstrate any significant difference between the four 
groups. Statistical analysis revealed that there was a strong correlation between the 
lack of neuroendocrine cells and acute inflammation.  
 
The findings of this study were in agreement with several studies that observed a 
reduced number of enterochromaffin cells in clinical or experimental models of 
colonic inflammation [157-162]. However, the results regarding the subepithelial 
neuroendocrine cells were in contradiction with those reported by Dhillon and Rhode 
[152] who observed that the serotonin immunoreactivity was significantly reduced in 
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the subepithelial neuroendocrine cells of histologically "normal" but painful 
appendices compared with the control group.  Nevertheless, the latter study did not 
investigate the serotonin content of inflamed appendices. Interestingly, in the group 
of follicular hyperplasia, Vasei et al. [133], observed a reduction in the number of 
enterochromaffin cells suggesting that this cell population is not only actively 
involved in the pathogenesis of acute right iliac fossa pain but it could also regulate 
the inflammatory process. Therefore, very early stages of inflammation like follicular 
hyperplasia could be transformed into acute inflammation due to sustained release 
of serotonin. 
  
In conclusion, several studies demonstrated evidence that the ENS plays a crucial role 
in the pathogenesis of appendicitis as well as in the symptomatology of patients with 
histologically "normal" appendices. Strong experimental evidence suggested that 
neuronal hypertrophy is likely to develop over a certain period of time due to 
repeated episodes of inflammation or chronic intraluminal obstruction. This was 
supported by the fact that patients with histologically "normal" appendices reported 
several episodes of right iliac fossa pain which eventually settled with 
appendicectomy. Moreover, the ENS was shown to be involved in crucial 
neuroimmune interactions as Substance P and VIP were able to induce neurogenic 
inflammation explaining some of the signs and symptoms of appendicitis without 
evidence on an inflammatory process on conventional histology.  The enteric nerve 
fibres were also shown to be in close proximity to mast as well as neuroendocrine 




2.3.4 Immune system and histologically "normal" appendicitis  
In 1996, Wang et al. [129] conducted the first study that demonstrated abnormal 
cytokine expression in histologically "normal" appendices obtained from patients 
with a clinical diagnosis of acute appendicitis. The study included 53 paediatric 
appendices, 31 of which were reported as histologically "normal" and employed in-
situ hybridisation to assess the expression of TNF-α and IL-2 mRNA. The luminal 
obstruction as a cause of increased cytokine expression was excluded by selecting 
specimens without any evidence of faecolith in the appendiceal lumen. It was 
reported that seven of the 31 histologically "normal" specimens expressed TNF-α and 
IL-2 in germinal centres, submucosa and lamina propria. Although, the cytokine 
expression was not as strong as in the specimens with acute inflammation, it was very 
similar to those. The appendices of the control group showed almost complete 
absence of TNF-α and IL-2 mRNA expression.  
 
In another study that tried to assess the inflammatory response in histologically 
"normal" appendices, Nemeth et al. [131] examined the expression of 
cyclooxygenase 1 and 2, prostaglandin E2, inducible nitric oxide synthase and major 
histocompatibility complex class II with immunohistochemistry using confocal laser 
microscopy. The study included 39 histologically "normal" appendices and 15 acutely 
inflamed appendices resected form children with a clinical diagnosis of acute 
appendicitis.  Gangrenous and perforated appendices were excluded from the study.  
The study demonstrated increased expression of cyclooxygenase 2 (COX-2) in the 
epithelial cells of more than half of the histologically "normal" appendices. The level 
of COX-2 expression in these patients was the same as that of samples with acute 
58 
 
inflammation, whereas, it was undetectable in the control samples. Prostaglandin E2, 
iNOS and MHC Class II expression levels were also found to be strongly expressed in 
more than half of the histologically "normal" appendices.  
 
The two studies provided evidence of an activated immune system at a stage where 
there were not any detectable inflammatory changes on conventional microscopy. 
The production of COX-2 is induced by cytokines such as IL-1 and TNF-α and it is 
responsible for the expression of prostaglandins, whereas, Prostaglandin E2 is 
considered as one of the most important proinflammatory prostanoid and a well-
known mediator of hyperalgesia [131, 163, 164]. The study by Wang et al. [129] 
highlighted that the presence of localised abdominal pain in patients with suspected 
appendicitis could be attributed to an abnormal cytokine expression and not to an 
underlying luminal obstruction which has been considered as one of the principal 
causes of appendicitis.  Even though an inflammatory process could be present at a 
molecular level without evident inflammatory infiltrates on routine H&E staining, the 
stage that the inflammatory process would reach and whether some other cytokines 
would be able to inhibit or amplify the inflammatory response remained unknown. 
In a novel study, Murphy et al. [165] attempted to characterise the inflammatory 
gene expression in acute appendicitis. The study involved 18 paediatric appendices 
resected following a clinical diagnosis of acute appendicitis. The appendix specimens 
were divided into three groups based on the severity of inflammation as histologically 
"normal", mild and severe appendicitis. The study included only two samples that 
were histologically "normal". It was reported that the gene expression profiles of 
samples with severe and mild appendicitis was very similar. Although, the vast 
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majority of genes that was differentially expressed in mild appendicitis was also 
expressed in the severe appendicitis group, few genes that were differentially 
expressed in the mild group, were not differentiability expressed in severe 
appendicitis. Therefore, the study demonstrated that a core set of inflammatory 
genes were activated in all samples regardless of the degree of inflammation 
suggesting that there is a uniform inflammatory response underlying the pathological 
basis of appendicitis. The mild group could represent an earlier stage of inflammatory 
process or a less severe inflammatory response. However, none of the samples in the 
severe and mild appendicitis groups had faecoliths. On the other hand, the 
histologically "normal" appendices were found to have faecoliths. The gene 
expression in one of the two histologically "normal" samples was identical to that of 
the control samples and therefore the specimen was considered as a true normal 
appendix. Nevertheless, the gene expression in the second histologically "normal" 
appendix demonstrated both upregulation and downregulation of several gene 
clusters. As a result, the authors assumed that the inflammatory response in that 
sample could represent a very early stage most likely due to luminal obstruction. 
Additionally, independent analysis, demonstrated very low expression of TNF, IL-12, 
IFN-γ, IL-4, IL-2 and IL15 in acute appendicitis samples without significant difference 
compared to control samples. The authors concluded that there was no evidence of 
Th1 or Th2 inflammatory response. As the expression of IL-17 was also very low there 
was not any evidence to suggest a Th17 inflammatory response either. Despite the 
fact that both IL-1 and TNF are strongly induced by bacterial LPS, only IL-1β was 
induced with TNF expression being undetectable in the acutely inflamed samples. 
The researchers concluded that despite the impressive histological appearance of 
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acute appendicitis the underlying inflammatory response is very focused, suggesting 
the selective activation of mediators of the innate inflammatory response.  
 
In conclusion, a small number of studies have provided evidence of upregulated 
expression of cytokines in patients who presented with right iliac fossa and their 
appendix was histologically "normal" on conventional microscopy. The abnormal 
expression of cytokines in this group of patients could indicate an activated immune 
system with an inflammatory response at very early stages with selective induction 
of specific inflammatory mediators. However, the inflammatory response could not 
be characterised as it was very focused and did not exhibit the features of any of the 
known inflammatory responses (Th1, Th2 or Th17). Therefore, more studies are 
needed to fully characterise the inflammatory profile of not only the histologically 
"normal" appendices but also that of the inflamed samples. Also, little is known about 
the immune response in complicated appendicitis as this group of patients is often 
excluded from the studies. Thus, the exploration of the potential differences or 
similarities in the immunopathogenesis of the complicated appendicitis compared 






Table 2.1 Consolidation of studies included in the literature review highlighting the investigated concept, study population, 
methodology and the studied markers.  
 





Method Studied markers 
Aubock and 
Ratzenhofer [142] 
1982 Neurogenic appendicopathy Adults & children 50 8 Electromicroscopy  ECC, nerve fibres 
Olsen and Holck [148] 1987 Neurogenic appendicopathy Adults & children 237 N/A IHC S-100 
Wolf et al. [149] 1981 Neurogenic appendicopathy Adults & children 127 4 H&E, clinical data Clinical data 
  Hofler et al. [150] 1983 Neurogenic appendicopathy Not stated 23 N/A IHC, ICC 
NSE, SP, somatostatin, CCK, glucagon, 13-
norleucine-motiline, 5-hydroxytryptamine, 
neurotensin, BPP<, VIP, ACTH, GFA 
Naik R [151] 1996 Neurogenic appendicopathy Not stated 150 150 IHC PTAH 
Dhillon and Rode [152] 1983 Neurogenic appendicopathy Not stated 50 24 IHC NSE, serotonin, SP, VIP 
Franke et al. [153] 2002 Neurogenic appendicopathy Adults & children 282 96 H&E, IHC S-100 
Grebeldinger et al. 
[154] 
2012 Neurogenic appendicopathy Children 209 50 H&E, IHC S-100 
Sesia et al. [155] 2013 Neurogenic appendicopathy Children 385 29 H&E, IHC S-100 
Di Sebastiano et al. 
[130] 
1999 Neuroimmune appendicitis  Adults 47 15 
IHC, computerised 
image analysis 
VIP, SP, GAP-43 
Bouchard et al. [134] 2001 Neuroimmune appendicitis Children 19 9 IHC VIP, SP, GAP-43 
Xiong et al. [132] 2000 ENS & mast cells  Children 40 10 
IHC, computerised 
image analysis 
S-100, CNPase, Synaptophysin, NSE, mast cell 
tryptase 
Amber et al. [135] 2010 ENS & mast cells Adults 50 25 
IHC, toluidine blue 
stain 
S-100, NSE, mast cells 
Nemeth et al. [127] 2003 Neuronal hypertrophy  Children 67 39 
IHC, computerised 
image analysis 
COX 1, COX-2, HLA II, iNOS 








Vasei et al. [133] 2008 ECCs & SNCs   Not stated 98 26 IHC Serotonin, chromogranin A, synaptophysin  
Murphy et al [165] 2008 Cytokine expression Children 22 2 Gene expression 




2.3.5 Clinical assessment and histologically "normal" appendicitis 
2.3.5.1 Overview 
The diagnosis of acute appendicitis is primarily clinical. Although, when the history 
and examination findings are typical it is easy to diagnose appendicitis, in some 
atypical cases the diagnosis can be very challenging. In the modern era, an increasing 
number of clinicians rely on additional testing and even on ultrasound, computed 
tomography or magnetic resonance imaging (MRI) to diagnose appendicitis and 
prevent delays in the management of the patient. A limited number of studies have 
described the presence of sign and symptoms as well as the levels of routine 
laboratory tests such as white cell count, neutrophil count, neutrophil to lymphocyte 
ratio and C-reactive protein (CRP) concentrations in patients with histologically 
"normal" appendices following a clinical diagnosis of acute appendicitis. However, 
the primary aim of most of those studies was to assess the trustworthiness of the 
clinical assessment in the diagnosis of acute appendicitis. Therefore, the research 
question was focused on the histologically inflamed samples and inevitably 
appendicectomies that resulted in histologically "normal" appendices were 
considered as "negative" or "unnecessary". 
 
2.3.5.2 Signs and symptoms  
Kalliakmanis et al. [166] designed a prospective study to assess the effectiveness of 
the initial diagnostic evaluation in patients with suspected appendicitis that was 
based on clinical findings. It was reported that 38.5% of patients with histologically 
"normal" appendices were found to exhibit signs of localised peritonism whereas 
44.7% and 71.5% of patients suffering from uncomplicated and complicated acute 
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appendicitis respectively exhibited peritonism in the right iliac fossa. In the same 
study, 11.5% of patients with histologically "normal" appendices reported to have 
nausea/vomiting whereas the reported incidence of nausea/vomiting in patients with 
uncomplicated and complicated acute appendicitis was 36.8% and 31.3% respectively. 
With regards to anorexia, it was reported that 35.9% of patients with histologically 
"normal" appendices suffered from anorexia while incidence of anorexia in patients 
with uncomplicated and complicated acute appendicitis was 36.8% and 31.3% 
respectively. Finally, the authors reported that 26.9% of the patients with no 
evidence of inflammation on histology were pyrexial in the preoperative period 
compared with 36.8% and 54.2% of the patients with uncomplicated and complicated 
acute appendicitis respectively. Interestingly, the researchers reported that the 
intraoperative diagnosis of the appendiceal inflammation differed significantly from 
the histopathological diagnosis. Patients who according to the surgeon had a 
macroscopically normal appendix or evidence of mild appendicitis were in a more 
severe setting than thought to be. In a similar way, samples with histologically 
advanced appendicitis were thought to have milder inflammation. Similar results 
were published in two other studies [167, 168]. However, the latter have not included 
patients with histologically "normal" appendices.  
 
2.3.5.3 Routine laboratory tests 
In a study published by Shafi et al. [169], the authors attempted to assess the 
diagnostic and predictive value of preoperative WCC, neutrophil to lymphocyte ratio 
and CRP concentrations in patients with a clinical diagnosis of acute appendicitis who 
underwent appendicectomy. A total of 110 patients were included in the study of 
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whom 18 had a histologically "normal" appendix. The authors reported that 8 of the 
18 patients with histologically "normal" appendices had abnormal WCC and 4 had 
abnormal CRP concentrations. Eleven of the 18 patients with histologically "normal" 
appendices were reported to have raised neutrophil count. Most of the patients with 
inflamed appendices (either uncomplicated or complicated appendicitis) had raised 
WCC, neutrophil count as well as CRP concentrations. However, the aim of the study 
was to assess the diagnostic and predictive value of routine laboratory tests and not 
the description of the levels between the different degrees of inflammation in the 
appendicitis spectrum and as a result statistical analysis to allow comparison of the 
results between the different groups of the study was not performed. Moreover, the 
study did not have a control group of normal appendices to allow comparison 
between the inflamed and the histologically "normal" samples.  
 
A similar study to that of Shafi et al [169] was published by Gurleyik et al. [170]. The 
aim of the authors was to determine the accuracy of serum CRP concentrations in the 
diagnosis of acute appendicitis. The study included 108 patients of whom 18 had a 
subsequent histologically "normal" appendix. The authors reported that 2 of the 18 
patients with histologically "normal" appendices demonstrated elevated 
concentrations of CRP. However, the CRP concentrations in those patients were not 
as high as in patients with inflamed appendices. On the other hand, the vast majority 
of patients with inflamed appendices on histopathologic examination demonstrated 
elevated CRP concentrations and those with complicated appendicitis were 




In a very recent prospective study, Khan et al. [171] examined the role of neutrophil 
to lymphocyte ratio in assessing the severity of appendicitis. The study included 453 
consecutive patients with a clinical diagnosis of acute appendicitis. However, 281 
underwent appendicectomy as the rest were managed conservatively. Out of the 281 
patients who had appendicectomy, 16 were excluded from the analysis as 
histopathological examination revealed a different pathology and 36 were found to 
have a histologically "normal" appendix. The CRP concentrations as well the 
neutrophil to lymphocyte ratio of those patients were elevated compared with 
normal values. Nevertheless, inflamed samples (either complicated or uncomplicated) 
demonstrated significantly elevated levels of CRP or neutrophil to lymphocyte ratio. 
However, as in the previously mentioned studies, the study by Khan et al. [171] this 
study did not aim to investigate symptomatic patients with histologically "normal" 
samples. Additionally, a large number of patients were treated conservatively as the 
clinical picture did not mandate appendicectomy. Thus, several patients from that 
group could have a histologically "normal" appendix altering the reported results 
significantly. Similar results were reported in a retrospective study but with a larger 
study population by Kahramanca et al. [172].  
 
Two more studies associated a lower neutrophil to lymphocyte ratio with less severe 
inflammation in samples demonstrating features of appendicitis [167, 168]. It was 
reported that neutrophil to lymphocyte ration was significantly lower in appendices 
exhibiting minimal feature of inflammation on histological examination whereas 
complicated appendicitis samples demonstrated a noticeably high neutrophil to 
lymphocyte ratio. However, none of the studies examined the neutrophil to 
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lymphocyte ratio in patients with histologically "normal" samples or normal 
appendiceal tissue as control samples.  
 
As a result, more studies are needed to focus primarily on the description of the signs 
and symptoms in combination with routine laboratory results of patients with a 
clinical diagnosis of acute appendicitis who were subsequently found to have 
histologically "normal" appendices. It would be useful in the understanding of the 
pathogenesis of appendicitis to compare the clinical data of these patients with 
patients with histologically proven appendicitis with varying degrees of inflammation.  
 
2.3.5.4 Presence of faecolith 
The presence of faecolith within the appendiceal lumen is considered as one of the 
principal causes of appendicitis [173]. It has also been assumed that complicated 
appendicitis has been associated with an obstructed lumen due to faecolith [174]. 
However, there have also been studies that questioned the theory of appendiceal 
faecoliths [175]. There is not enough experimental data to support or reject any of 
these theories and more importantly to associate the presence of faecolith with an 
altered inflammatory response in any of the different presentations of acute 
appendicitis. However, it has been shown that patients with faecoliths are less likely 
to respond to primary antibiotic therapy for acute appendicitis and usually need an 
appendicectomy [136]. 
 
Makaju et al. [176] investigated the theory that luminal obstruction due to a faecolith 
could be one of the cardinal causes of appendices and reported that in 518 
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appendices only 1.54% were found to feature faecoliths within their lumens. 
Histological examination demonstrated that early acute appendicitis was evident in 
34.75% of the cases, acute suppurative appendicitis in 48.26% whereas gangrenous 
appendicitis was evident in 19.99% of the samples. The authors concluded that their 
findings did not support the concept that luminal obstruction secondary to faecolith 
could cause appendicitis [176]. The findings of Chandrasegaram et al. [177] were in 
agreement with those reported by Makaju et al. [176] as they reported that among 
4670 appendices resected for faecoliths, worms, endometriosis or appendiceal 
tumours, 3.6% of the samples were found to have faecoliths and 39.5% were 
reported as histologically proven appendicitis. Therefore, their findings did not 
support the notion that luminal obstruction could be one of the causes of appendicitis.   
 
In an attempt to explore this theory further,  Singh and Mariadason [178] investigated 
the presence of faecolith in histologically "normal" and inflamed appendices from 
patients with a clinical diagnosis of acute appendicitis. It was reported that in 1014 
emergency appendicectomy specimens, 28.6% of the histologically "normal" 
appendices, 29.9% of the paediatric and 13.7% of the adult histologically proven 
appendicitis specimens were found to have faecoliths. Moreover, it was reported 
that faecoliths were found in 39.4% and 14.6% of complicated and uncomplicated 
appendicitis samples respectively. However, according to the authors the 
appendicectomies that resulted in a histologically "normal" sample were considered 
as negative appendicectomies. Therefore, the authors concluded that the prevalence 
of faecoliths was too low to consider the presence of a faecolith as the most common 
cause of appendicitis [178].  
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Ramdass et al. [179] also investigated the association between the presence of a 
faecolith and inflamed (complicated or uncomplicated) appendices as well as 
histologically "normal" appendices resected from symptomatic patients. They 
reported that there was an association between the presence of faecoliths and 
uncomplicated appendicitis or histologically "normal" appendices but there was no 
association between the presence of faecoliths and complicated appendicitis. 
Therefore, the fact that the histologically "normal" appendices were considered to 
be truly healthy (negative appendicectomy), taken together with absence of 
association between the presence of faecolith and complicated appendicitis, led 
Ramdass et al. [179] to support the theory that faecoliths were mainly incidental 
findings and not a true cause of appendicitis.  
 
In contrary to the two aforementioned studies, Alaedeen et al. [174] demonstrated 
that the presence of faecolith was associated with a higher perforation rate in 
children with acute appendicitis. A pre-operative CT scan was performed in 315 
patients and faecoliths were detected in 30% of them. Histologically "normal" 
appendices that resulted in a negative appendicectomy were found in 12.2% of the 
patients. Four patients with histologically "normal" appendices had a faecolith 
present on the CT scan (0.03%). The authors also reported that an appendicolith was 
present on CT scan, intraoperative inspection or pathologic review in 31% of the 
patients. The appendix was found to be perforated in 57% of patients who had 
faecoliths and in 36% of patients without faecoliths. Their findings were consistent 
with previous studies [180-182]. Interestingly, patients with faecoliths had higher CRP 
concentrations on admission compared with those without faecolith but there was 
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no difference in the white cell count between the two groups of patients. The clinical 
observations of Alaedeen et al. were also in agreement with previously published 
studies [183, 184].  Moreover, the presence of faecolith was associated with a 
significantly shorter time interval between the onset of symptoms and presentation 
with perforation compared with patients without a faecolith. Thus, the authors 
concluded that the presence of a faecolith in a patient with clinical features of acute 
appendicitis significantly increases the risk of earlier perforation. Alaedeen et al. also 
hypothesised that erosion of the faecolith through the appendiceal wall could be 
another mechanism of perforation leading to early rupture. Therefore, abdominal 
contamination in patients with faecoliths would be more rapid as well as more 
extensive compared with contamination that resulted from perforation of 
appendices without faecolith [174]. 
 
The role of faecoliths as a cause of abdominal pain in patients with histologically 
"normal" appendices was assessed in a study conducted by Grimes et al. [185]. The 
researchers reported that a faecolith was found in 13% of patients with histologically 
"normal" appendices. 33% of patients with faecolith and 29% of patients without 
faecoliths reported pain in the right iliac fossa without any difference in the pre-
operative duration of symptoms between the two groups. However, 52% of patients 
without faecolith reported to have recurrent episodes of pain after the operation 
while only 5% of patients with faecoliths experienced post-operative pain in the right 
iliac fossa. Therefore, the authors concluded that appendicular faecoliths could be 




Thus, it was apparent that the published data on the presence of a faecolith as a cause 
of appendicitis provided contradictory results. However, in several studies the 
histologically "normal" samples were considered as genuinely normal and the 
appendicectomy as negative. Therefore, more research is needed to examine how 
the presence of faecolith within the appendiceal lumen would affect the in-situ 
expression of several inflammatory markers as well as the magnitude of the 
inflammatory response before the increased intraluminal pressure due to faecolith 
can be considered as one of the causes of appendicitis. Furthermore, more studies 
are required to compare clinical parameters between patients with or without a 




2.4 Formulation of hypothesis and objectives 
2.4.1 Overview 
Appendicitis can present as an inflammatory spectrum. The conventional histology of 
the resected specimens can range from histologically "normal" when there is no 
microscopic evidence of inflammation, to acute inflammation with presence of 
neutrophils among other features of acute inflammation to gangrene and perforation 
that represent the most advanced stage of an inflammatory response. However, 
patients with histologically "normal" appendices surgically removed following a 
clinical diagnosis of appendicitis, may have subclinical inflammation that is not 
identified on conventional microscopy and resection of the appendix may prevent 
chronic or recurrent symptoms [127, 129, 131].  
 
2.4.2 Hypothesis 
This thesis tested the hypothesis that appendices which were resected from adult 
patients following a clinical diagnosis of acute appendicitis and reported as 
histologically "normal" on conventional histopathological examination, exhibited 









The objectives of this study were: 
• To describe the in-situ expression of TNF-α, IL-6, IL-2R and serotonin contents 
in samples of histologically "normal", acute uncomplicated and acute 
complicated appendicitis obtained from adult patients, with the use of 
immunohistochemistry. 
 
• To describe differences in the signs (peritonism, nausea/vomiting, 
temperature), symptoms (duration, severity and previous episodes of RIF 
pain),  laboratory investigations (WCC, NLR, CRP), intraoperative findings as 
well as other clinical parameters (presence of faecolith, pre- and post- 
operative stay) in patients with histologically "normal", acute uncomplicated 
and complicated appendicitis. 
 
• To describe how the presence of previous episodes of right iliac fossa pain, 
localised peritonism and faecolith within the appendix influenced the 
expression of the studied inflammatory markers and clinical parameters in 
patients with histologically "normal", acute uncomplicated and complicated 
appendicitis.  
 
• To explore whether the intraoperative appearance of histologically "normal" 
appendices reflected a difference in the expression of the studied 




2.4.4 Need for further research  
Following review of the available literature on appendicitis has become apparent that 
further research was needed as several aspects of its pathogenesis remain unclear. 
The vast majority of the previously published studies has focused on changes that 
occurred to the enteric nervous system of the resected appendices as a possible 
explanation of the signs and symptoms to suggest acute appendicitis in patients who 
were found to have histologically "normal" appendices. Some studies explored the 
concept of neurogenic appendicitis as they demonstrated either hyperplasia or 
hypertrophy of the nerve fibres in those patients with the use of 
immunohistochemistry whereas some earlier studies employed the role of 
microscopy (either conventional or electromicroscopy) to demonstrate close 
proximity of the nerve fibres to neuroendocrine cells. In order to further explore the 
pathogenesis of appendicitis and the symptomatology in patients with a 
subsequently histologically "normal" appendix, some authors investigated the 
interactions of the enteric nerve system with the immune system exploring the 
concept of neuroimmune appendicitis. Only three studies have focused entirely on 
the immune system of the appendix and the expression of inflammatory mediators 
that could explain the presentation of acute appendicitis in patients with 
histologically "normal" specimens [129, 131, 165]. However, since some of these 
studies were published, new evidence has emerged on the role of several cytokines 
and how they function depending on the type of inflammatory response. The 
function of TNF-α and IL-6 has been a characteristic example of this, as they could 
exhibit both inflammatory and anti-inflammatory actions. Therefore, the 
inflammatory response in acute appendicitis and more specifically in the 
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histologically "normal" appendices has not been adequately investigated and more 
studies are needed to explore the expression of inflammatory markers in the entire 
spectrum of appendicitis. 
 
To the best of our knowledge, most of the already published studies have been 
conducted on a paediatric population and only two studies used appendix samples 
from adults [130, 135]. Both studies explored the concept of neuroimmune 
appendicitis and not subclinical immunohistological expression of inflammatory 
markers. In addition, some of the earlier studies have used a mixed population of 
both adults and children which could result in inaccurate data due to the significant 
variation of patient age [142, 148, 149, 153]. Moreover, the pathogenesis of 
appendicitis in children could be significantly different from that in adults. This 
became apparent from the study published by Nemeth et al. [131] who proved that 
the nerve fibre size was significantly different between paediatric samples and those 
originated from adults. Thus, further research is needed to investigate the 
pathogenesis of appendicitis in adults as well as the possible causes of symptoms in 
patients with histologically "normal" appendices.  
 
Apart from the fact that most of the studies were conducted on children, the study 
population in most of them was relatively small given the prevalence of appendicitis 
in the general population. The study size in the published studies varied significantly  
from 19 [134] to 385 [155] patients. However, the number of patients with 
histologically "normal" appendices in the largest study that was published by Sesia et 
al. [155] was only 29. Most of the studies had a small number of histologically 
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"normal" appendices with only 3 to include more than 50 histologically "normal" 
samples [151, 153, 154]. In addition to small sample sizes, it was not possible to 
identify any study to examine specimens with evidence of gangrene or perforation in 
a separate group of samples from that with evidence of acute inflammation only. In 
most studies specimens with necrosis or perforation have either been excluded or 
included in the acute appendicitis group. The research team of the present study 
strongly believed that this group of patients was poorly investigated, and it could 
represent a different aspect of the disease and not only disease progression or 
different magnitude of the inflammatory response. As a result, not only bigger studies 
are needed but also studies to include samples from the entire spectrum of 
appendicitis which extends from histologically "normal" appendices, to acutely 
inflamed to samples with evidence of necrosis and/or perforation.  
 
Finally, a small number of studies have combined the experimental data with clinical 
data that originated from the same population. However, to the best of our 
knowledge, there was no published study to combine the experimental data with 
data derived from patient’s history and examination on the day of admission taken 
together with routine laboratory investigations as well as intraoperative findings. In 
the laparoscopic era, the diagnostic laparoscopy is frequently employed to help 
surgeons establish the correct diagnosis and initiate appropriate treatment. In the 
case of acute appendicitis, the surgeons are very often faced with appendices that 
appear grossly healthy and the dilemma of removing a macroscopically normal or a, 
as frequently described, "engorged" or "erythematous" appendix remains at 
surgeon’s discretion. To the best of our knowledge, the expression of cytokines 
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between histologically "normal" appendices that looked inflamed and those that 
looked macroscopically normal during laparoscopy has not been investigated. 
Moreover, only one study examined the expression of cytokines in appendices with 
and without the presence of faecolith [165]. However, the group of histologically 
"normal" appendices included only two samples and both of them were found to 
have faecoliths within their lumens. On the other hand, none of the acutely inflamed 
samples had faecoliths. Therefore, the researchers were not able to reach any 
conclusions on whether the presence of faecoliths affected the expression of 
cytokines or not. Obstruction of the appendiceal lumen is considered one of the 
principal causes of acute appendicitis, and the presence of a faecolith is one of the 
most common causes luminal obstruction. Therefore, there is need for more studies 
on how the expression of various inflammatory mediators is affected by the presence 
of faecoliths.  
 
The present study attempted to cover several gaps of the existing knowledge by 
examining the expression of key inflammatory markers in the entire spectrum of 
appendicitis ranging from histologically "normal" samples to acutely inflamed 
appendices without evidence of gangrene to complicated appendix specimens with 
evidence of gangrene or perforation in a large study with appendices derived from 
adult patients. It was also attempted to describe the experimental findings combined 
with clinical data from patients’ clinical picture, routine laboratory tests as well as 
intraoperative findings in the context of the latest evidence on the function of the 




2.4.5 Inflammatory markers examined in this thesis 
2.4.5.1 Overview 
This study has examined the expression of key inflammatory markers (serotonin, 
TNF-α, IL-6 and IL-2) in adult patients with clinical impression of appendicitis. These 
markers were specifically chosen due to their crucial role in the host immune 
response to antigenic stimuli as well as GI nociception. The expression of some of 
them has been previously assessed. However, most of the previous studies had a 
small sample size and were conducted on paediatric samples. In addition to this, new 
evidence has emerged for these markers since the previous studies were published 




Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter. 95% of 
the gastrointestinal serotonin can be found in the enterochromaffin cells (ECCs) with 
the rest contained within the ENS [186-188]. 5-HT synthesis from its precursor L-
tryptophan (L-TPH) is mediated by tryptophan hydroxylase (TPH) in the ECCS [189]. 
ECCs are located between epithelial cells of the GI mucosa where they can sense the 
intraluminal milieu as they are equipped with specialised microvilli projecting into the 
lumen as well as electron-dense secretory granules and transporters  that are located 
towards the apical parts of the cells [92, 190, 191].  Following ECCs stimulation, 
serotonin is predominantly released in the interstitial space as well as into the blood 
stream and the lumen, exhibiting various functions [92, 95, 192-194]. 5-HT can also 
78 
 
signal to CNS through activation of vagal afferent endings [92, 194] and its action is 
mediated through several receptors; 5-HT1 to 5-HT7 [195-200].  
 
Several studies have highlighted the significant role of serotonin and ECCs in GI 
inflammation. In an older study it was demonstrated that both the number of ECCs 
and the 5-HT availability were reduced in patients with ulcerative colitis or IBS [201]. 
A more recent study by Magro et al. [202] also demonstrated decreased levels of 
serotonin in inflamed and non-inflamed colonic tissue from patients with either 
ulcerative colitis or Crohn’s disease. However, Coates et al. [160, 201] showed a 
reduction in the number of serotonin producing ECCs in patients with severe 
ulcerative colitis but not in patients with mild ulcerative colitis. In a study that used 
computerised image analysis the area occupied by ECCs was increased in patients 
with IBD compared with the control group. The investigators attributed this increase 
to an increase in the number of ECCs as the mean individual cellular area of the 
endocrine cells types was the same in both the patient and control group [203]. 
Significant discrepancies in the number of ECCs as well as the level of 5-HT in 
intestinal tissue also described in experimental models of colitis [161, 204]. Moreover, 
Ghia et al. [205] investigated the role of endogenous 5-HT in intestinal inflammation 
using TPH deficient mice in a model of experimental colitis. It was reported that the 
reduced 5-HT synthesis resulted from the lack of TPH was not only associated with 
attenuation of the colonic inflammation but also with a reduction in expression of 
colonic IL-1β, IL-6 and TNF-α. Finally, in an in vitro study by Freire-Garabal et al. [206] 
the phagocytic activity of macrophages was significantly enhanced by serotonin. The 
findings of the aforementioned studies clearly show the crucial role of serotonin in 
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colonic inflammation as it is involved in the recruitment of inflammatory cells and 
cytokine expression.  
 
The in-situ levels of serotonin have not been previously described in the whole 
spectrum of appendicitis. The ECC cells are strategically located between epithelial 
cells and have the ability to sense the intraluminal pressure. Therefore, due to the 
fact that luminal obstruction by faecolith is considered as one of the principal causes 
of appendicitis, it would be interesting to compare the serotonin levels in patients 
with and without evidence of faecolith within the appendiceal lumen.  
 
2.4.5.3 Tumour necrosis factor alpha 
TNF-α is one of the most important inflammatory mediators as it can exhibit a wide 
variety of functions in immunity, cell proliferation, differentiation, apoptosis as well 
as tissue repair and angiogenesis [207-213]. Although, it is mainly produced by 
macrophages and T-lymphocytes, a wide range of cells such as mast cells, NK cells, 
neutrophils, epithelial cells, endothelial, smooth muscle cells, fibroblasts and 
osteoclasts can also produce TNF-α. [212, 213].  
 
Several studies have linked the expression of TNF-α in the intestinal mucosa with 
intestinal inflammation. TNF-α has been shown to activate intestinal microvascular 
endothelial cells and stimulate the expression of adhesion molecules as well as the 
production of TGF-β which is another potent pro-inflammatory cytokine [214]. 
Simpson et al [215] induced inflammatory bowel disease in mice, by transferring T 
cell-depleted wild-type bone marrow into syngeneic T cell-deficient (tge26) mice 
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(F1—tge26). This was accompanied by a prominent increase of TNF-α by colonic CD4+ 
and CD8+ TCRαβ T lymphocytes suggesting that the initiation of local inflammation 
in the colon of the transplanted tge26 mice was mediated by TNF-α. Neurath et al. 
[216] were among the first to describe the prominent overexpression of TNF-α in an 
animal model of colitis by showing that TNF-α transgenic mice developed fatal 
pancolitis following exposure to TNBS. Histological examination revealed substantial 
infiltrates of macrophages, granulocytes and T lymphocytes. The functional role of 
TNF-α in the experimental chronic colitis was established by demonstrating that TNF-
α knockout mice did not develop mucosal inflammation following administration of 
TNBS. Moreover, treatment with anti-TNF-α antibodies ameliorated both clinical and 
histological signs of colonic inflammation [217]. The first observation of 
overexpression of TNF-α in humans with inflammatory bowel disease was reported 
by MacDonald et al. [218] who demonstrated with the use of spot ELISA that all 
patients with Crohn’s disease, demonstrated increased levels of TNF-α.  
 
Although TNF-α has some well documented pro-inflammatory properties, there is 
strong evidence to suggest that TNF-α can also exhibit anti-inflammatory activities. 
With the use of an experimental model of colitis, Naito et al. [219] demonstrated that 
colonic inflammation was considerably exaggerated in genetically TNF-α deficient (-
/-) mice. Neutrophil infiltration was also shown to be markedly enhanced in the TNF-
α deficient mice and the survival rate of TNF-α deficient mice was significantly lower 
compared with TNF-α +/+ mice. These results suggested that TNF-α has an 
immunosuppressive role by downregulating the magnitude and the duration of the 
colonic inflammation. In a similar way, Kojouharoff et al. [220] demonstrated that 
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neutralisation of TNF-α led to exacerbation of acute colitis, demonstrating a 
protective role of TNF-α in the acute inflammation. However, in a model of chronic 
inflammation, neutralisation of TNF-α promoted epithelial damage and immune cell 
infiltrate indicating that TNF-α has the ability to perpetuate a chronic inflammatory 
status. TNF-α has also been implicated in the production of glucocorticoids by 
intestinal epithelial cells [221]. Extra-adrenal production of glucocorticoids by the 
intestinal epithelial cells has been shown to play a vital role in the maintenance of 
the colonic epithelial cell barrier by stimulating the production of adhesion molecules 
and hence, promoting tight junction formation between the epithelial cells. It is 
known that excessive apoptosis of epithelial cells in patients with inflammatory 
bowel disease leads to disruption of the epithelial barrier and impaired synthesis of 
glucocorticoids. This subsequently leads to entry of proinflammatory factors such as 
bacterial LPS into the colonic wall exacerbating the disease even further. On the other 
hand, systemic glucocorticoids have been shown to inhibit the pro-inflammatory 
action of TNF-α by downregulating the expression of the TNF-α gene [222]. 
 
To the best of our knowledge the expression of TNF-α has not been studied in 
samples with appendicitis that originated from adult patients. The previously 
published studies using paediatric appendices have provided conflicting results 
regarding the gene expression of TNF-α [129, 165]. However, both studies had a small 
number of samples. It would be interesting to document the number as well as the 
location of positively stained cells for TNF-α with the use of immunohistochemistry. 
Moreover, since the first study on the expression of TNF-α in appendicitis was 
published, new evidence has surfaced on the ability of TNF-α to function as pro- and 
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anti-inflammatory mediator. Therefore, this work sought to explore the differences 
in TNF-α expression in appendix specimens following a clinical diagnosis of acute 
appendicitis but with substantial differences in the clinical presentation, 
intraoperative findings, routine laboratory results and most importantly with 
different degrees of inflammatory response in the context of new evidence.  
 
2.4.5.4 Interleukin 6 
Interleukin 6 (IL-6) is another important inflammatory mediator that exhibits a 
plethora of functions and can act as both proinflammatory and anti-inflammatory 
cytokine [223]. IL-6 is mainly produced by macrophages, B- and T-lymphocytes, 
epithelial and endothelial cells as well as smooth muscle cells, fibroblasts and 
osteoblasts [224, 225]. 
 
IL-6 has been shown to exhibit pro-inflammatory actions with significant systemic 
effects. The first evidence to associate IL-6 with the expression of acute phase 
proteins originated from studies in human hepatocytes. It was demonstrated that IL-
6 was able to induce C-reactive protein and amyloid A synthesis [226]. Moreover, IL-
6 was able to induce expression of the full spectrum of acute phase proteins, whereas, 
IL-1 and TNF-α had only a moderate effect on acute phase proteins suggesting that 
IL-6 has a key pro-inflammatory action [224]. It has also been shown that IL-6 can act 
directly on B-lymphocytes by inducing production of immunoglobulins M, G and A. 
IL-6 has been demonstrated to play a crucial role in the activation and proliferation 




Apart from well described pro-inflammatory properties, IL-6 can also exhibit a wide 
variety of anti-inflammatory actions. It has been shown that absence of IL-6 resulted 
in a significantly higher circulating level of pro-inflammatory cytokines during 
endotoxemia such as MIP-2, IFN-γ and TNF-α. Each of these cytokines have been 
implicated in the elicitation of toxic syndromes in endotoxemia. Moreover, the anti-
inflammatory action of IL-6 has been further supported by the observation that IL-6 
-/- mice suffered from increased mortality when given a high dose of endotoxin. 
Moreover, it has been shown that administration of recombinant IL-6 was able to 
induce the expression of anti-inflammatory molecules IL-1 receptor antagonist and 
soluble TNF-α receptor and to inhibit TNF-α in experimental endotoxemia. It has also 
been shown that IL-6 was capable of inhibiting neutrophilia and stimulate the release 
of anti-inflammatory molecules such as anti-protease inhibitors [223].  This was 
further supported by the finding that IL-6 was able to restrict recruitment of 
neutrophils promoting their replacement by mononuclear cells steering the 
inflammatory response towards chronicity [227-229]. Therefore, it has been clearly 
documented that IL-6 is also a potent anti-inflammatory mediator. 
 
Although, IL-6 is one of the most potent pro-inflammatory mediators, its expression 
has never been studied in appendicitis. In this study there was an opportunity to 
compare the levels of expression of this key pro-inflammatory mediator in the whole 
spectrum of appendicitis from histologically "normal" appendices to specimens with 
areas of gangrene or perforation. However, as IL-6 has been shown to inhibit 
neutrophilia and direct the inflammatory process towards chronicity, it would be of 
paramount importance to assess IL-6 expression in patients with recurrent episodes 
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of right iliac fossa pain and histologically "normal" appendices and compare it with 
that in samples with evidence of acute inflammation without prior episodes of right 
iliac fossa pain that could suggest the presence of a chronic inflammatory response.  
 
2.4.5.5 Interleukin 2 
Among the different cytokines, IL-2 is one the most important ones in the generation 
and regulation of immune responses [230, 231]. IL-2 is mainly expressed by activated 
CD4+ and CD8+ T-lymphocytes. It is also produced by activated dendritic cells, natural 
killer as well as natural killer T-lymphocytes and its actions are mediated by the IL-2 
receptor (IL-2R)  [232-237].  
 
Among the most important pro-inflammatory action of IL-2 is its ability to promote 
proliferation of CD4+ and CD8+ T-lymphocytes as well as stimulate the expression of 
NK-derived cytokines such as TNF-α and IFN-γ. IL-2 has also been shown to upregulate 
expression of heavy and light chain genes in IgM producing B-lymphocytes. As in T-
lymphocytes, IL-2 further increases expression of IL-2R in B-lymphocytes, thus 
enhancing their responsiveness to IL-2 [238]. Finally, Dignass and Podolsky  [231] 
demonstrated that IL-2 could act as a link between the intestinal epithelial cells and 
the lamina propria and thus intergrade the epithelial surface to the intestinal immune 
system. It was shown that the rat intestinal epithelial cells exhibited IL-2 receptors in 
their surface responsible for epithelial cell proliferation and migration [231].    
 
IL-2 also plays an important role in downregulating immune responses. Previous 
studies have demonstrated that genetically modified mice with IL-2 gene knock-out 
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(IL-2 -/-) spontaneously developed bowel inflammation [239, 240]. Sadlack et al. [47] 
demonstrated that IL-2 -/- mice were normal at birth but they could die between 5-9 
weeks of an unrecognised disease which was charecterised by splenomegaly, 
lymphadenopathy and haemolytic anaemia. Nevertheless, the mice that survived 
beyond 9 weeks developed colonic inflammation that resembled human ulcerative 
colitis. Further characterisation of IL-2 gene knock out mice revealed that these mice 
could develop colitis characterised by increased IFN-γ, TNF-α and IL-1 in combination 
with decreased expression of IL-4 and IL-10 [241, 242]. However, between the age of 
10-18 weeks, the wild type demonstrated an increase in the endocrine cells 
myenteric nerves expressing VIP and Substance P, while no such increase was 
observed in healthy heterozygous or diseased IL-2 -/- mice. These results 
demonstrated the vital role of IL-2 in the interactions between the neuroendocrine 
and immune system of the GI tract. In a recent study, Nikiforou et al. [243] showed 
that intravenous administration of IL-2 can protect the fetal gut against inflammation 
and mucosal injury in the course of chorioamnionitis. The protective effect of IL-2 
administration could be explained by different ways. IL-2 could protect foetal 
intestine against inflammation by preventing IL-17 induction as IL-17 mRNA levels 
were found to be reduced 2 days after IL-2 treatment. IL-17 is known to promote 
neutrophil recruitment and colonic inflammation [244-246]. Another possible 
explanation could be the inhibition of IL-6, as IL-6 has been implicated in the epithelial 
tight junctional loss and mucosal injury [247]. It could also be the direct action of IL-
2 on the epithelial cells as IL-2 preserved the epithelial integrity by promoting 
epithelial cell restitution and cell proliferation [231]. Therefore, it was clear that IL-2 
played a crucial role in the regulation of immune responses.  
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Despite the significant amount of knowledge on the actions of IL-2 in colonic 
inflammation, its role in appendicitis has not been studied enough as only one study 
has assessed its expression in a paediatric population [129]. As mentioned earlier, IL-
2 is expressed by activated CD4+ and CD8+ T-lymphocytes and therefore increased 
expression of IL-2 would indicate an activated immune system. This thesis attempted 
to assess whether the immune system of patients with histologically "normal" 
appendices was activated or not. Thus, the in-situ level of IL-2 would indicate whether 
the histologically "normal" samples were truly normal or not. Moreover, increased 
expression of IL-2 could indirectly imply that the expression of IL-17 could be low and 
therefore the inflammatory response of appendicitis would not exhibit features of 
Th17 immune response. Finally, since the publication of Wang et al. [129], new 
evidence has highlight the role of IL-2 as an anti-inflammatory cytokine and this work  









CHAPTER 3: Materials and methods 
3.1 Overview 
In-situ expression of two cytokines (IL-6, TNF-α), a cytokine receptor (IL-2R) and one 
neuropeptide (serotonin) was studied using immunohistochemistry on paraffin-
embedded samples that were retrospectively collected from the archive of the 
Department of Histopathology at Queen’s Medical Centre, Nottingham University 
Hospitals NHS Trust in Nottingham, UK. Clinical data relevant to the underlying 
pathology and associated to the reason for admission to hospital were collected from 
the patient notes as well as the electronic patient database of Nottingham University 
Hospitals NHS Trust.  
 
The study was given approval by Health Research Authority. Reference Number: 




3.2 Specimens and clinical data 
3.2.1 Inclusion criteria 
The appendix specimens included in this study were obtained from patients who 
underwent emergency appendicectomy between September 2013 and May 2011 in 
a consecutive order until the required number of patients for each group was 
achieved. Queen’s Medical Centre is the tertiary hospital of the region of East 
Midlands. The samples derived from adult patients of all ages, genders, ethnicities 
and socio-economic groups following a clinical impression of acute appendicitis. As a 
result, the study population was a true representation of the adult population of City 
of Nottingham and subsequently of the challenges and dilemmas that general 
surgeons face on a day to day basis. The control group was consisted of specimens 
from patients who underwent elective abdominal surgery and the appendix was 
removed as part of the resected colon. 
 
The appendix specimens obtained at surgery were fixed in formalin and divided into 
three sections according to the protocol of the Department of Histopathology (2 
longitudinal sections with one originating from the tip and the other from the 
resection margin and one transverse section form the middle of the appendix). 
Following retrieval of the slides from the archive of the Department of 
Histopathology, they were re-examined by a senior Histopathology consultant (Dr. A. 
M. Zaitoun) and were given a diagnosis which was based on the severity of 
inflammation (histologically "normal", uncomplicated acutely inflamed, complicated 
acutely inflamed). Dr A. M. Zaitoun was blinded to the initial diagnosis as stated on 
the official Histology report following the routine histopathological examination of 
89 
 
the sample post-operatively. In order for the specimens to be included in the study, 
the diagnosis made by Dr A. M. Zaitoun had to match with the initial diagnosis on the 
Histology report. The appendix specimens for the control group were also re-
examined by Dr A. M. Zaitoun and the diagnosis of being normal had to match the 
initial diagnosis on the Histology report for them to be included in the study. 
Therefore, each sample that has been included in the study was examined by two 
Histopathology consultants who independently agreed on the underlying pathology.  
 
3.2.2 Exclusion criteria 
Several factors were considered for the exclusion criteria and were divided into 
patient factors and specimen factors. With regards to patient factors, appendix 
specimens obtained following interval appendicectomy were excluded from the 
study as patients were not admitted as an emergency and therefore there was not a 
diagnosis of acute appendicitis at the time the appendix was obtained. Samples that 
demonstrated features of sub-serosal inflammation with a healthy mucosa were not 
included in the study as this finding could indicate the presence of an inflammatory 
process arising elsewhere in the abdomen. Characteristic example of this, is pelvic 
inflammatory disease or other pelvic pathology in patients who presented with right 
iliac fossa pain, underwent a diagnostic laparoscopy and the decision was made for 
the appendix to be removed. Patients who were admitted months or even years after 
the appendicectomy and were diagnosed with inflammatory bowel disease were also 
excluded from the study as the right iliac fossa pain and the subsequent diagnosis of 
acute appendicitis could potentially indicate the first presentation of inflammatory 
bowel disease. Finally, as mentioned in the inclusion criteria section, patients whose 
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diagnosis by a second Histopathology consultant did not match the initial diagnosis 
on the Histology report post-operatively were excluded from the study.  
 
As far as the control group was concerned, patients that were identified to suffer 
from inflammatory bowel disease following review of the clinical data were excluded 
from the study as that could affect the expression of the examined inflammatory 
markers within the appendix. Moreover, patients with obstructing tumours 
anywhere in the colon were also excluded as it was thought that increased 
intraluminal pressure could also affect the expression of different inflammatory 
markers even though there was no microscopic evidence of inflammation on 
conventional histology. Patients with caecal tumours as indicated on the histology 
report were excluded from the study due to the close proximity of the tumour to 
appendix and the possible effect that this proximity could have on the expression of 
the studied markers.   
 
Specimens with extensive necrosis were excluded from the study as that would 
compromise the quality of immunohistochemistry and would not allow examination 
of several different microscopy fields. Appendix samples with significant amount of 
calcification or evidence of poor tissue fixation were also excluded as that would 
affect the quality as well as the thickness of the sections and as consequence the 




3.2.3 Pathological characteristics and clinical data 
A computerised search was conducted in the database of the Department of 
Histopathology at Nottingham University Hospitals NHS Trust to retrospectively 
identify consecutive histology reports involving appendix specimens. The histology 
reports as well as patient notes were reviewed in order to make sure that the 
appendicectomy was performed following a clinical diagnosis of acute appendicitis. 
This was followed by retrieval of consecutive histology slides that were re-examined 
by a senior Histopathology consultant (Dr. A. M. Zaitoun) and allocated into four 
groups. Group I included patients with histologically confirmed uncomplicated acute 
appendicitis (n=120). The H&E stained sections of this group could demonstrate signs 
of acute inflammation such as vasodilation, oedema, infiltration of the different 
layers of the appendix with polymorphonuclear leucocytes, ulcers of the epithelium 
as well as local abscesses and fibrinous exudates on the serosa of the appendix. 
Group II included patients with histologically confirmed complicated appendicitis 
(n=118). The appendix specimens of this group demonstrated features of acute 
inflammation with additional evidence of gangrene and/or perforation on 
conventional microscopy. Group III included patients that histological examination of 
their appendix did not show any of the signs of acute inflammation (n=104). In the 
specimens of this group the epithelial layer was intact and the histological 
architecture of the mucosa, submucosa and muscularis propria had normal 
appearance. The control group (Group IV) was consisted of appendices removed as 
part of the resected colon for pathology other than appendicitis (n=106). The 
specimens of this group had no evidence of inflammation with an intact epithelial 
layer and the histological architecture of all the layers was normal.  
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Clinical data on patient’s history and examination findings was retrospectively 
collected from the surgical clerking proforma of Nottingham University Hospitals NHS 
Trust as it was documented on the day of admission. Several members of the surgical 
team were able to document patient consultations and examinations that took place. 
The on-call surgical team staffing the Surgical Admission at the Queen’s Medical 
Centre consisted of a Foundation Year 1 doctor, one Core Surgical Trainee/Senior 
House Officer, two Higher Specialty Trainees/Registrars and a Surgical Consultant. 
The level of training and experience of the different members of the surgical team 
varied significantly with the Foundation Year 1 doctor being the least experienced 
and the surgical consultant the most experienced member of the team. The data for 
this work derived from entries that were made by the most senior members of the 
team on the admission proforma. This data involved the duration of symptoms that 
made the patient to seek medical advice as it was stated by the patient on admission 
to the Surgical Admission Unit. Data regarding the presence of previous episodes of 
right iliac fossa pain from patient’s history as it was recorded on the surgical clerking 
proforma was also collected. The presence or absence of nausea and/or vomiting was 
recorded regardless the frequency of vomiting. The presence or absence of localised 
peritonism was also recorded with localised peritonism defined as the presence of 
abdominal guarding or rebound tenderness over the McBurney’s point.  With the 
data derived from patient notes, the length of pre- and post-operative stay for 
patients with acute uncomplicated appendicitis, complicated appendicitis and 




Data on the severity of right iliac fossa pain was collected from the admission 
documentation that the nursing staff had to complete as soon as the patient arrived 
on the Surgical Admission Unit. Each patient was asked to rate his or her pain on a 
scale from 0 to 10. Zero represented the absence of pain and 10 was the worst pain 
that the patient had ever felt.  
 
With regards to the intraoperative impression of the operating surgeon whether the 
subsequently histologically "normal" appendices looked inflamed or not, data was 
collected from the operative record as it was documented by the surgical consultant 
or registrar who performed the appendicectomy. Apart from clear documentation 
that the appendix looked inflamed, expressions such as injected appendix, engorged 
appendix and hyper-vascular appendix were also classified as inflamed appendix.  
 
Data was collected on the presence of faecolith for the groups of patients with acute 
appendicitis, complicated appendicitis and histologically "normal" appendices. The 
reports of the imaging tests that patients underwent on admission (abdominal USS 
or CT scan) were reviewed for the presence of faecolith within the appendix. The 
operative record was also reviewed for evidence of faecal material when the 
appendix was divided as well as the histology report for evidence of faecal material 
within the appendicular lumen during preparation of the specimens for histological 
examination. By collecting data on the presence of faecolith from all the available 
modalities that could identify faecoliths the chances of missing appendix specimens 




Regarding the results of routine laboratory investigations that are commonly used to 
guide the surgical team, data on white cell count, neutrophil count, neutrophil to 
lymphocyte ratio and C-reactive protein concentrations was collected. All these 
markers are used as indicators of the severity of the inflammatory process. The 
collected data on these markers was originated from the first blood sample that was 
obtained from the patient on the day of admission. All the blood samples were 
processed by the Biochemistry laboratory at the Queen’s Medical Centre and the 
results were uploaded to the hospital’s electronic database called Notis. Data on 
these markers for the patients of the control group were not collected as most of 
these patients had their last blood test several days or weeks prior to the elective 
abdominal surgery during the pre-operative assessment and not on the day the 
appendix was obtained. 
 
Finally, data was obtained on the body temperature of the patients with acute 
uncomplicated appendicitis, acute complicated appendicitis and histologically 
"normal" appendices. First body temperature was defined as the measurement that 
was recorded by either the General Practitioner who referred the patient to the 
Surgical Admission Unit or the team in Accident and Emergency where the patient 
presented with abdominal pain. The first recorded body temperature was considered 
to be an important indicator of the inflammatory process as it could influence the 
decision of the General Practitioner or Accident and Emergency team to refer the 
patient to the surgical team. The highest body temperature in the pre-operative 
period was also recorded while the patient was under the care of the surgical team. 
This measurement was considered to be a marker of severity of the inflammatory 
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factor and an important factor that could possibly influence the decision made by the 
surgical team to proceed with appendicectomy. 
 
The allocation of specimens into 4 groups allowed for the expression of the selected 
markers to be studied in the entire spectrum of appendicitis, from histologically 
"normal" appendices obtained from symptomatic patients, to acutely inflamed 
samples, to complicated appendicitis with evidence of gangrene or perforation. It is 
widely acceptable that the group of patients with gangrenous or perforated 
appendicitis has not been adequately studied. This could be due to the technical 
difficulties in using tissues with necrosis or because gangrenous appendicitis has 
always been considered as progression of the inflammatory status and therefore did 
not attract much interest. In some of the previously published studies, samples with 
evidence of necrosis were examined in the same group with appendices that 
exhibited features of acute inflammation only. Thus, the published data might not be 
representative of the underlying pathology. The allocation of the specimens into four 
groups samples also facilitated the comparison of the different clinical parameters 
between patients with different aspects of the appendicitis disease. To the best of 
our knowledge there has not been a previously published study to investigate the 
expression of cytokines within the appendix tissue in the entire spectrum of 
appendicitis along with data from clinical findings, routine laboratory investigations 






Immunohistochemistry (IHC) is a robust tool for gaining more information on tissue 
specimens compared with the conventional histological examination. IHC can be used 
not only to study the expression of cellular markers defining cellular/tissue 
phenotypes but also the location of proteins/molecules in tissue samples. The added 
information can be used for diagnostic, prognostic and predictive purposes related 
to a disease status and normal biology. Therefore, the application of enzyme-labelled 
antibodies to study formalin-fixed tissue samples provides an additional parameter 
in the assessment of inflammation biology. 
 
Immunohistochemistry was chosen as a method to assess the in-situ expression   of 
the studied inflammatory markers due to its inherent advantages. As it examines 
protein expression, IHC can provide information on the final product of gene 
expression. Increased gene expression does not always translate to increased protein 
levels as the RNA interference system is able to silence gene expression at the mRNA 
level. Immunohistochemistry has also the advantage of demonstrating the location 
of the protein within the tissue architecture, it is easily reproducible and more 
economical compared to gene analysis especially in studies with a large sample size. 
Immunohistochemistry has been used successfully not only for research purposes but 
also for diagnostic, prognostic as well as predictive purposes in patients with 
malignancies. Several studies on colorectal cancer have compared 
immunohistochemistry with PCR and have shown that the coincidence rate of the 
two methods for detecting microsatellite states was 91.92% [248-251].  
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3.3.2 Antibody class and structure 
Antibodies entail a group of proteins called immunoglobulins (Igs) which are 
produced by B lymphocytes following stimulation by antigens and which react 
specifically with those antigens. They are formed in the blood as well as the 
peripheral tissues of normal individuals.  Ig comprises five classes (IgG, IgA, IgM, IgD 
and IgE). Each antibody has two identical heavy chains and light chains. The antigenic 
and structural properties of the heavy chains vary significantly and define the class of 
Ig. The most frequently used antibody in IHC is the IgG. IgG consists of two 
monovalent antigen-binding fragments (Fab) and one crystalline fragment (Fc). 
Additionally, IgG particles can be split into variables and constant domains.  The 
variable domains of heavy and light chains create the antigen-binding site (paratope) 
which specifically recognises the antigenic determinant (epitope) of an antigen [252]. 
Monoclonal antibodies are produced by a single B cell clone and form a homogenous 
population of Ig that can target a single epitope. Every monoclonal antibody has 
unique specificity and affinity. On the other hand, polyclonal antibodies are 
heterogenous as they consist of a mixture of antibodies directed against several 
epitopes of the same antigen. Polyclonal antibodies are harvested from the blood of 
animal which have been immunised with a specific antigen. On one hand, their ability 
to target several epitopes on an antigen makes them more reliable compared with 
the monoclonal antibodies when they are used on routinely processed samples. On 
the other hand, being able to recognise multiple epitopes, increases the chance for 
cross reactivity with other antigens or proteins. Moreover, a lot to lot inconsistency 




3.3.3 Antibody affinity and titre 
Functional affinity of an antibody is defined as the total time required to saturate all 
available antibody binding sites with antigens (equilibrium). Therefore, antibodies 
with low affinity will require longer time to reach the maximal staining intensity.  On 
the other hand, intrinsic affinity of an antibody refers to the concentration of an 
antigen to saturate the antibody. Therefore, an antibody with higher intrinsic affinity 
will need lower concentration of an antigen to reach equilibrium. Affinity can also 
refer to the binding strength between the antigen and the antibody (immune 
complex). In IHC, the antigen-antibody binding is reversible and may dissociate during 
the phase of washing. The dissociation of an immune complex can be reduced by 
lowering the temperature. 
 
The ideal antibody titre is the highest dilution which can achieve a maximum of 
specific staining intensity with the least non-specific background staining under the 
predetermined conditions. The ideal dilution is also determined by antibody affinity. 
In a given dilution and incubation period, a low affinity antibody will result in weaker 
staining intensity compared with an antibody with high affinity.  
 
3.3.4 Incubation period 
The incubation time, temperature as well as antibody titre and affinity are 
interdependent factors as a change in one will influence the others. Incubation time 
can vary from 10 minutes to 24 hours. In general, the use of higher antibody titre will 
result in less incubation time. The most widely used incubation time is 10-30 minutes 
as it is adequate for antibodies with high affinity and concentration to be saturated 
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with their antigens. However, a 24-hour incubation time offers economic benefits as 
the amount of the antibody needed is significantly reduced.  
 
IHC is most commonly performed at room temperature (25 °C). The equilibrium of 
antigen-antibody can be reached faster at 37 °C. However, while increasing 
temperature allows the use of a shortened incubation time, increased background 
staining may appear. A temperature of 4 °C is commonly used for 24-hour or 
overnight incubation. A humidity room is necessary to prevent drying/evaporation of 
the tissue sections [254]. 
 
3.3.5 De-masking of antigens 
The 3-dimensional structure of proteins within the tissue is altered during formalin 
fixation of the specimen. Therefore, antigenic epitopes can be masked or even 
destroyed resulting in inability to react with antibodies. De-masking of antigen or 
epitope retrieval is the process that can reverse this by the protein cross-links, which 
were formed during the fixation, in order to expose the antigen epitopes. Antigen de-
masking can be done by heating the sample for a certain period of time [heat-induced 
epitope retrieval (HIER)] or using enzymatic digestion. Despite the fact that many 
epitope retrievals have been described, the most commonly used is heating the 
specimens in a microwave oven with citrate buffer pH 6.0. Nonetheless, the optimal 




3.3.6 Immunoenzymatic staining with enzyme substrate reactions 
In immunoenzymatic staining methods, such as IHC, colourless substrates are 
converted into coloured end products with the use of enzymes. Several factors such 
as incubation time, temperature, pH, concentration and light can affect the catalytic 
reaction of those enzymes. Among the most commonly used enzymes are the 
Horseradish peroxidase (HRP) and the calf intestine alkaline phosphatase (AP). 
Substrates become coloured following oxidation by HRP. The colour of the end-
product depends on the chromogen used. Diaminobenzidine (DAB) has been used in 
this study, as it is one of the most commonly used in IHC and the end-product is 
brown in colour. It is highly stable in alcohol solvents used in IHC. Haematoxylin and 
non-aqueous DPX (dibutyl phthalate) mounting medium can also be used with DAB. 
Moreover, it was endeavoured to control all the factors that can affect the catalytic 
reactions during each IHC run. The incubation time of each substrates was strictly 
kept with the use of a timer. The concentration and the pH of each substrate was 
either prepared according to the information sheet supplied by the manufacturer or 
as it was already supplied by the manufacture (e.g. Novolink™ polymer detection 
system, Leica® RE7280-K). The experiments were conducted in a certified laboratory 
of the University of Nottingham that provided stable conditions such as temperature 
and light [254].  
 
3.3.7 Secondary antibody: Labelling reagents and amplifications 
Several amplification methods have been described in order for even small amounts 
of antigen to be detected by a high sensitivity test. The intensity of the staining can 
be significantly increased by using a conjugated/labelled secondary antibody. 
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Therefore, even a faint but specific signal can be amplified without compromising the 
specificity [256]. Streptavidin and avidin molecules have four binding sites with 
strong affinities for the vitamin biotin. HRP is easily conjugated to biotin. Therefore, 
a single antibody can be associated with several peroxidase molecules and a larger 
enzyme to primary antibody ratio can increase the sensitivity of the of the antigen 
detection [257]. However, the existence of endogenous biotin in the tissue can lead 
background staining and blocking the endogenous biotin is not very effective. The 
polymer based IHC technique that has been used in this study does not depend on 
endogenous biotin as it uses a polymer dextran backbone in which several secondary 
antibodies and peroxidase enzymes can be conjugated. The secondary antibody 
attached to this polymer comprises of both anti-rabbit and anti-mouse Ig molecules. 
Hence, it can be used to detect primary antibodies of either rabbit or mouse origin 
[258].   
 
3.3.8 IHC standardisation 
Although, IHC has been shown to be a very effective technique in demonstrating 
related biomarkers in diagnosis and classification of tumours, concerns have been 
expressed regarding the validation of the reagents, the reproducibility of the staining 
methods and the interpretation of the results. Despite the fact that several attempts 
have been made to standardise IHC techniques, standardisation remains largely a 
critical issue. Several intrinsic factors such as variable conditions in tissue processing 
and fixation that can affect the preservation of antigens remain uncontrolled [259]. 
Fixation of the tissue prevents proteins in the specimen from degradation and 
modification as well as preserves the location of the antigens whether they are found 
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in the nucleus, in the cytoplasm or in the membrane. On the other hand, the use of 
formalin has a negative impact on the antigenicity of the tissue. Moreover, as necrotic 
degradation of the tissue starts immediately following devascularisation of the tissue, 
the time to fixation is vital. Inequivalent IHC staining can be obtained among 
formalin-fixed paraffin-embedded (FFPE) tissue samples with different periods of 
time between tissue fixation and staining [260]. The utilisation of validated reagents, 
optimised conditions and protocols, positive and negative controls is vital to ensure 
the reproducibility of a test with high sensitivity and specificity.   
 
3.3.8.1 Primary antibody validation and optimisation  
The selection primary antibodies with the required specificity in detecting the target 
antigen is based on the data supplied by the manufacturers. Even though these 
antibodies have been tested for specificity by reliable manufacturers, it is of 
paramount importance to confirm functional specificity by using appropriate positive 
and negative control specimens. The optimal staining intensity in combination with 
the lowest level of non-specific background staining can be achieved by adjusting the 
concentration of the primary antibody for each staining condition with the use of a 
particular secondary labelling system. The optimal working concentration can be 
found by experimenting with serial titrations. The concentration of primary 
monoclonal antibody can be accurately determined as μg/ml but it can only be 
estimated for polyclonal antibodies. Therefore, a dilution fraction e.g. 1:50 or 1:100 




3.3.8.2 Positive and negative controls 
Both positive and negative controls are tissue samples that have been fixed and 
processed in the same way to the test specimens. Positive controls are known to have 
the target antigen and should demonstrate a range of staining intensity. This will help 
greatly in selecting the optimal working dilution. Positive control samples that 
contain high levels of the target antigen can lead to the selection of a working dilution 
that will fail to detect low levels of target antigen in the test specimens. The use of 
negative controls that are identified by the absence of staining incorporates two 
concepts [261, 262].  
 
3.3.8.3 False positive and negative errors 
The presence of endogenous peroxidase activity has been demonstrated in red blood 
cells (haemoglobin), muscle fibres (myoglobin), inflammatory cells such as 
granulocytes and monocytes (cytochrome) as well as liver and kidney (catalases). It 
can give rise to false positive staining when HRP-based detection methods are used 
and therefore, suppression of its activity is essential prior to the addition of primary 
antibody during the during the staining process.  This can be achieved by incubation 
of the tissue sample in 3% H2O2 for 5-10 minutes. 
 
Both primary antibodies and detection systems are protein-based reagents that can 
react with non-specific binding sites in the tissue sample. This will result in false 
positive as well as background staining. The use of a protein blocking reagent is 
essential in order to reduce non-specific protein-protein interactions between IHC 
reagents and tissues.  
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False negative staining can arise following inappropriate tissue handling, fixation, 
processing or antigen retrieval due to loss of antigenicity in the specimen. Moreover, 
false negative staining can ensue when steps of the staining protocol are omitted 
accidentally [263]. 
 
3.3.8.4 Computer-aided scoring 
The assessment of the immunostaining has been conducted mainly by human visual 
scoring.  The scoring parameters are generally predetermined by quantitative or 
semi-quantitative cut-off values, resulting in categorical values for statistical analysis. 
The IHC assessment can be very time-consuming when carried out by human 
interpretation. Moreover, pathological examination of tissue samples remains a 
subjective process as the intensity of the observed staining and the subsequent 
scoring are prone to visual bias. A solution to these issues is the utilisation of 
computer-assisted scoring with scanning devices and image analysis software. The 
computer-assisted scoring is not subjected to confounding factors such as fatigue and 
ambient light, and also minimises the issue of inter-observer discrepancies [264]. It 
has been demonstrated that computer-aided scoring is a reliable and more time-
effective alternative to human visual scoring. However, it does not provide an 
analytical advantage [265-267]. 
 
The main disadvantages of the computer-assisted scoring consist of the inability to 
classify tissue type and distinguish membrane, cytoplasmic and nuclear staining as 
well as the inability to differentiate tumour from non-tumour tissue or necrotic from 
non-necrotic tissue. Moreover, it has been shown that more time is needed for 
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subsequent analysis using automated IHC scoring [265]. Therefore, the use of manual 
IHC assessment, as described in the section 3.4.4 Assessment of 
immunohistochemical, staining has been selected as the preferred method of scoring 







3.4 Methods  
3.4.1 Overview 
The in-situ expression of inflammatory markers IL-6, TNF-α, IL-2R and serotonin was 
studied using immunohistochemistry on formalin-fixed, paraffin-embedded samples.  
The archived tissue blocks were melted, and two tissue specimens were re-
embedded into a new tissue blocks (Figure 3.1) using the Thermo Scientific® 
HistoStar™ embedding module (Figure 3.2). All specimens were sectioned using the 
LEICA® RM2125 Microtome (Figure 3.3) and mounted on Surgipath™ X-tra™ Adhesive 
Leica® slides. Subsequently, the sections were immunostained according to an 
established protocol (Appendix-1 IHC protocol) using 4 antibodies to determine 
expression of inflammatory markers.  The stained slides were scored on a Zeiss® 
Axioskop 2 microscope (Figure 3.4). Photographs were taken using a Nikon® Eclipse 
80i microscope with a Nikon® DS-L3 digital camera system (Figure 3.5). 
 
 





Figure 3.2: Thermo Scientific® HistoStar™ embedding module. 
 
 





Figure 3.4: Zeiss® Axioskop 2 microscope 
  
 
Figure 3.5: Nikon® Eclipse 80i microscope with a Nikon® DS-L3 digital camera system 
 
3.4.2 Primary Antibodies 
Four antibodies were used to detect the expression of the chosen inflammatory 
markers (Table 3.1). They have been validated and guaranteed for IHC of formalin-
fixed and paraffin-embedded samples by their commercial suppliers. The optimal 
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dilution/concentration, incubation time and antigen retrieval of each antibody were 
optimised for the study’s samples. The optimisation process started with the 
recommended conditions on the antibody datasheets provided by the suppliers. The 
conditions that were used in previously published studies were also taken into 
account. The conditions were adjusted accordingly for the optimal staining intensity 
and clear staining background to be achieved. Positive staining controls were used as 
recommended by the antibody supplier. Positive control sections were included in 
every IHC run and stained along with the rest of the slides (Table 3.2). Negative 
controls were included in each IHC run and demonstrated by omitting the primary 
antibody.  
 
Beta-2 immunoglobulin was used as a primary antibody to stain one section in each 
IHC run. However, it was not used to assess the expression of an inflammatory marker 
as part of the experimental work of this study. Incubation with beta-2 
immunoglobulin resulted in an immunostaining of distinctive intensity. The use of 
beta-2 immunoglobulin allowed the detection of variations in the immunostaining 
between different IHC runs that would indicate inconsistencies in either the 
technique or the application of the different substrates of the Novolink™ polymer 
detection system, Leica® RE7280-K. When the expected intensity, as indicated by the 
beta-2 immunoglobulin, was not achieved, all the slides of that particular IHC run 
were discarded and the run was repeated. The use of this method ensured that the 





Table 3.1: Primary antibodies used in this study.  
Cellular marker Primary antibody Clones Cellular location 
Supplier 
(Product No) 
Serotonin Mouse monoclonal 5HT-H209 Cytoplasm 
Dako 
(M0758) 
TNF-α Mouse monoclonal 2C8 Cytoplasm 
LSBio 
(LS-B7268) 
IL-6 Mouse monoclonal 10C10 Cytoplasm 
Leica 
(NCL-L-IL6) 



















HIER with citrate 
buffer 
1:100 30 minutes at RT 
Anti-TNF-α Inflamed colon 
HIER with citrate 
buffer 
7.5 μl/ml 1 hour at RT 
Anti-IL-6 Normal colon 
HIER with citrate 
buffer 
1:50 1 hour at RT 
Anti-IL-2R Tonsil 
HIER with citrate 
buffer 




HIER with citrate 
buffer 
1:2000 






3.4.3 Immunohistochemical staining procedure 
Immunohistochemistry was performed on 5 μm tissue sections. The slides were 
heated on a 60 °C hotplate (Figure 3.6) for 10 minutes and then loaded to Leica® 
Autostainer XL (Figure 3.7) for dewaxing and rehydration with xylene and graded 
alcohol. The slides were subsequently boiled at 98 °C in 0.01 M citrate buffer of pH 
6.0 for 20 minutes in a microwave oven [1000-Watt Whirlpool® Jet Stream 359 6th 
sense (Figure 3.8)] to achieve heat induced epitope retrieval (HIER). After cooling 
down for 5 minutes under running water, the slides were loaded onto the Shandon 
Sequenza® coverplates (Figures 3.9 and 3.10). Serial blocking was performed with 
peroxidase (3-4% hydrogen peroxidase) and protein [0.4% Casein in phosphate-
buffered saline (PBS)] for 5 minutes each.  The slides were incubated with the primary 
antibody against the specific cellular protein for the required period time and 
temperature as determined by optimisation. The Novolink™ polymer detection 
system, Leica® RE7280-K with HRP-linker antibody conjugates and DAB chromogen 
was applied for enzyme-substrate labelling. Each substrate was applied for 5 minutes.  
In a similar way, each section was incubated with DAB for 5 minutes. Following 
incubation with each of the substrates of the Novolink™ polymer detection system, 
including DAB, the slides were washed with H2O twice. Each wash lasted 5 minutes. 
Following the final wash, haematoxylin was applied for 6 minutes to achieve 
counterstaing of the sections. A timer was used to ensure accurate time keeping. The 
Leica® Autostainer XL was used for dehydration of the slides. Finally, the slides were 
mounted in non-aqueous dibutyl phthalate with xylene (DPX) mounting medium 







































3.4.4 Assessment of immunohistochemical staining 
Manual IHC assessment was used in this study as some of the inflammatory markers 
were detected in the membrane and some other in the cytoplasm of the cells and 
computer-aided scoring would not provide accurate data. This work examined the 
expression of four inflammatory mediators. The quantitative/semi-quantitative 
evaluations were done in stained full sections of surgical specimen. The scoring 
methods that were used to establish the expression/presence of each biological 
marker in the tissues have been described in previously published studies on the 
corresponding biological markers. In two of them (TNF-α and IL-2R) the 
immunostaining was quantified by painstakingly counting the positively stained cells. 
The quantification of TNF-α was performed simultaneously by the author of this 
thesis and a senior histopathology consultant, Dr A. M. Zaitoun. The in-situ levels of 
serotonin were also simultaneously semi-quantified by the author of this thesis and 
Dr A. M. Zaitoun using the H-scoring system. Both researchers had to agree on the 
score given to each slide. The expression of IL-6 was semi-quantified by the author of 
this thesis using the H-scoring system. 25% of the slides stained for IL-6 and IL-2R 
were independently assessed by Dr A. M. Zaitoun. As the differences in the scores 
between the two researchers were not significant, the scores obtained by the author 
of this thesis were used in the final analysis. Moreover, during the scoring process, 
both the clinical and histopathological characteristics of each slide were masked from 




3.4.4.1 Semi quantification of serotonin positive cells 
Ten non-overlapping fields were selected and examined at ×200 magnification by two 
observers simultaneously. Positive staining was observed in the cytoplasm of the 
enterochromaffin and subepithelial neuroendocrine cells of the mucosa. The amount 
of serotonin in the specimen was semi-quantified using a modified H-scoring system. 
The total number of immunostained cells of each field was counted and multiplied 
by a number representing the intensity (1 for weak, 2 for moderate and 3 for strong). 
Both observers had to agree on the score that was given to each field. The average 
of the scored fields for each cell population was calculated and formed the 
immunohistochemical score of the specimen for the particular cell population. 
Samples with less than three of ×200 magnification fields were excluded from the 
analysis. 
 
3.4.4.2 Quantification of TNF-α positive cells 
Ten non-overlapping fields were selected in the mucosa of each section and 
examined at high-power magnification (×400) by two observers simultaneously. 
Positive staining for TNF-α was observed as dark-brown cytoplasm of mononuclear 
cells. The positively stained cells of each high-power field were counted, and the 
average of the scored fields was calculated and formed the immunohistochemical 
score of the specimen. Specimens with less than four high-power fields were 




3.4.4.3 Semi-quantification of IL-6 positive cells 
Ten non-overlapping fields were selected in the mucosa and examined at high-power 
magnification (×400). Positive staining was observed in the cytoplasm of epithelial 
and inflammatory cells. The expression of IL-6 was semi-quantified using the H-
scoring system. The average of the scored fields was calculated and formed the 
immunohistochemical score of the specimen. Samples with less than four high-power 
fields were excluded from the analysis. 25% of the slides were independently 
assessed by Dr A. M. Zaitoun. As the differences in the scores between the two 
researchers were not significant, the scores obtained by the author of this thesis were 
used in the analysis. 
 
3.4.4.4 Quantification of IL-2R positive cells 
Ten non-overlapping fields were selected in the mucosa and submucosa and 
examined at high-power magnification (×400). Positive staining was observed in the 
membrane of lymphocytes. The positively stained cells of each high-power field were 
counted, and the average number of positively stained cells was calculated for the 
mucosa and submucosa of each section. In the submucosa, the germinal centres were 
avoided due to the extremely high number of positive cells. Specimens with less than 
three high-power fields were excluded from the analysis. 25% of the slides were 
independently assessed by Dr A. M. Zaitoun. As the differences in the scores between 
the two researchers were not significant, the scores obtained by the author of this 




3.4.5 Statistical analysis 
Statistical analysis was performed using the IBM SPSS statistics software, version 22 
(SPSS Inc, Chicago, IL, USA). Where data did not follow a normal distribution (Shapiro-
Wilk test, p<0.05), non-parametric tests [Mann-Whitney U test (between two groups) 
and Kruskal-Wallis H test (between three or more groups)] were used to compare the 
differences between the groups based on histopathological parameters. Cross 
tabulation and the Pearson’s chi-square test were used for categorical variables. The 
results were considered as statistically significant when the probability value (p value) 
was less than 0.05 (p<0.05, 2 tailed). In order to avoid Type I error, Bonferroni 
correction was applied when multiple comparisons were performed. Bonferroni 
correction is calculated by dividing the p value by the number of comparisons. 
Tukey’s boxplots (box and whisker plots) were created on GraphPad Prism version 





3.5 Challenges and technical difficulties 
During the project several challenges had to be overcome. Difficulties were 
encountered in all stages, from acquiring significant number of slides while ensuring 
that inclusion and exclusion criteria were met, to technical difficulties with the 
immunostaining, as well as funding issues.  
 
The first challenge that the research team had to overcome was the amount of time 
that was needed to acquire the required number of slides from the archive of the 
Department of Histopathology at the Queen’s Medical Centre. According to the 
design of the study, each group should include at least 100 patients and given the 
size of the centre the study was conducted in, this task seemed to be a reasonably 
easy to accomplish. No issues were encountered in acquiring the required number of 
slides for the acute uncomplicated appendicitis group. However, several difficulties 
were encountered during the collection of the slides for the other groups. Although, 
every effort was made to include consecutive samples, some of the specimens were 
already taken for other projects. This issue was especially apparent in the collection 
of appendix specimens for the control group.  Many of the slides containing normal 
appendices, which were resected as part of elective colectomy, were missing from 
the archive as they were used by other researchers for projects dealing with bowel 
cancer. Regarding the group of histologically "normal" appendices, it was challenging 
to acquire the desired number of 100 samples as some of the samples retrieved from 
the archive had to be excluded from the study. Although the histopathology report 
on the electronic database stated that the appendix was normal due to absence of 
feature of inflammation, a careful review of several sections by a second 
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histopathologist revealed some evidence of inflammation in some areas of the 
appendix. Therefore, these slides were excluded as according to inclusion criteria the 
initial diagnosis that was stated on the histopathology report had to match with the 
second review by Dr A. M. Zaitoun who is a senior histopathology consultant. It was 
also very challenging to identify slides with evidence of necrosis or perforation that 
would be suitable for the study. Slides with extensive necrosis had to be excluded as 
they have not had enough areas to score the immunostaining. Moreover, significant 
amount of calcification would affect the thickness of the slides as well as the 
immunostaining and the samples had to be excluded. As a consequence, a big 
number of slides that were initially retrieved from the archive were excluded which 
resulted in further electronic searches in the database and several visits to the archive 
to collect more samples.  Thus, the collection of the required number of slides 
according to inclusion and exclusion criteria, while maintaining the quality standards 
of the project as high as possible, required significant amount of time that was not 
anticipated at the initial stages of the study.  
 
Another aspect of the study that proved to be very challenging was the retrieval of a 
big number of patient notes from the case note library of the hospital. The patient 
notes had to be requested in small batches according the prescribed protocol of 
Nottingham University Hospitals NHS Trust. The research team encountered 
significant delays in retrieving some of the notes, as the use of the case notes for 
clinical reasons took priority over the use for research purposes.  Moreover, the 
extraction of significant amount of data from a large number of patient notes was 
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very time consuming. Therefore, substantial amount of time was needed to collect 
the required clinical data for the current study. 
 
During this project considerable challenges in several aspects of the laboratory work 
had to be overcome. First and foremost, several hours of training by certified 
technicians of the immunohistochemistry laboratory of the University of Nottingham 
were needed, in order for the author of this thesis to be able to successfully perform 
all the technical aspects in preparation of the experimental work such as melting and 
re-embedding tissue blocks as well as sectioning tissue blocks. Moreover, several 
training immunohistochemistry runs were performed under the close supervision of 
experienced technicians in order to achieve consistency. The results were assessed 
by Dr A. M. Zaitoun and only when the required experience was achieved the 
experimental work was performed by the author of this thesis.  
 
Another difficulty that was encountered during the laboratory work was the 
consistency in the intensity of the immunostaining between different 
immunohistochemistry runs. To overcome this challenge, immunostaining with β2 
immunoglobulin was used as described in the chapter 3.4.2 Primary antibodies. 
When the intensity of the β2 immunoglobulin immunostaining between different 
immunohistochemistry runs for the same inflammatory marker was not the same, 
the slides were discarded, and the immunostaining was performed again. Once the 
slides were re-stained, the intensity was examined by Dr A. M. Zaitoun to ensure that 
consistency was achieved. Following a satisfactory review by Dr A. M. Zaitoun the 
slides were scored.  
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Moreover, as it will become apparent later in this thesis, some of the results, such as 
the significantly low expression of TNF-α and IL-6 of the acute uncomplicated 
appendicitis samples, were not anticipated. In order to validate the observations and 
assess the reproducibility of the results, the immunohistochemistry runs with each 
specific antibody were repeated and the slides scored again by two researchers. The 
differences between the initial and the repeat immunohistochemistry runs were not 
significantly different and therefore, the scores of the initial immunohistochemistry 
runs were kept for the analysis.  
 
Finally, financial difficulties were encountered during this project as the funding 
available to the research team was very limited due to unforeseen circumstances. 
With the limited budget available, some of the technical aspects of the experimental 
work such as the re-embedding and sectioning of blocks could not be performed by 
University of Nottingham or NHS technicians as the quoted cost was not possible to 
be covered. Should the research team was able to afford this, the experimental work 
would have been completed a lot sooner. Moreover, the limited funding prevented 
the research team from exploring the use of other techniques such as gene analysis 
and qPCR to measure mRNA expression. Although these techniques, would provide 
additional data to help the understanding of the pathogenesis as well as the immune 
response in the different aspects of appendicitis, are very costly and in the present 
study, given the number of patients included, the cost would rise to levels well above 




CHAPTER 4: Results 
4.1 Demographics  
As it has been described in CHAPTER 3: Materials and methods, the samples that were 
collected from the archive of the Department of Histopathology at Nottingham 
University Hospitals NHS Trust, were allocated into four different groups following 
conventional histopathological examination. Group I included 120 appendix 
specimens exhibiting features of uncomplicated acute appendicitis (median age 30.0, 
IQ range 22.0-45.0). Group II included 118 appendix specimens with features of 
complicated acute appendicitis (median age 34.0, IQ range 21.0-49.2), whereas group 
III included 104 appendix specimens with no features of inflammation on 
conventional microscopy (histologically "normal") specimens (median age 22.0, IQ 
range 18.0-29.0). The control group (Group IV) was consisted of appendices removed 
as part of the resected colon (n=106) for pathology other than appendicitis as 
described in the inclusion and exclusion criteria section (median age 70.5, IQ range 
61.0-79.0). The uncomplicated acute appendicitis group included 65 (54%) male and 
54 (45%) female patients. The complicated acute appendicitis group included 72 (61%) 
male and 46 (39%) female patients. The group of histologically "normal" specimens 
included 44 (43%) male and 60 (54%) female patients. The control group included 46 







Table 4.1: Summary of the population and the demographics of the patients between the 4 groups of the study. Group I-patients 
with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically 
"normal" appendices, Group IV-patients of the control group. N represents the number of patients in each group. Data is 
presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range.  
 
 Gender Age 
Groups N Male Female Median 25th 75th IQ range 
I 120 65 54 30.0 22.0 45.0 23.0 
II 118 72 46 34.0 21.0 49.2 28.2 
III 104 44 60 22.0 18.0 29.0 11.0 
IV 106 46 57 70.5 61.0 79.0 18.0 
 
 
Graph 4.1: Summary of data on the gender of patients between the 4 groups of the study. Group I-patients with uncomplicated 
appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" appendices, Group 































4.2 Experimental data 
4.2.1 Serotonin content 
Immunohistochemistry performed with anti-serotonin antibody demonstrated 
enterochromaffin cells within the crypts of the epithelium. Immunostaining also 
revealed subepithelial neuroendocrine cells in the lamina propria. Subepithelial 
neuroendocrine cells appeared either as solitary cells or small clusters close to the 
crypts. 
 
4.2.1.1 Serotonin contents of enterochromaffin cells 
Serotonin contents of enterochromaffin cells ware assessed on a total of 437 
specimens as 11 samples did not have at least 3 fields with ×200 magnification and 
therefore excluded from the study. Enterochromaffin cells of both uncomplicated 
acute (median 3.0, IQ range 0-30.0, p<0.001) and complicated acute (median 0, IQ 
range 0-8.5, p<0.001) appendicitis specimens were markedly depleted of serotonin 
compared with the control group (median 43.5, IQ range 9.5-115.8). The amount of 
serotonin contained by enterochromaffin cells of histologically "normal" appendices 
(median 49.7, IQ range 16.7-107.5) did not differ significantly compared with the 
control group (median 43.5, IQ range 9.5-115.8, p=0.60). Both group I (median 3.0, 
IQ range 0-30.0, p<0.001) and II (median 0, IQ range 0-8.5, p<0.001) contained 
significantly less serotonin compared with group III (median 49.7, IQ range 16.7-
107.5). Moreover, enterochromaffin cells of complicated acute appendicitis (median 
0, IQ range 0-8.5) samples were significantly depleted compared with acute 
uncomplicated appendicitis (median 3.0, IQ range 0-30.0, p=0.001) samples (Table 
4.2, graph 4.2, figures 4.1-4.12). 
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Table 4.2: Summary of the analysis of serotonin contents of enterochromaffin cells between the 4 groups of specimens. Group 
I-uncomplicated appendicitis specimens; Group II-complicated appendicitis specimens; Group III-histologically "normal" 
appendices; Group IV-control specimens. N represents the number of specimens that were included in the analysis. Data is 
presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05. 
 
Group N Median 25th 75th IQ range p value 
I 115 3.0 0.0 30.0 30.0 
<0.001 
II 113 0.0 0.0 8.5 8.5 
III 104 49.7 16.7 107.5 90.8 




























































Graph 4.2: Tukey’s boxplots displaying data of serotonin contents of enterochromaffin cells between the 4 groups of specimens. 
Group I-uncomplicated appendicitis specimens, median 3.0, 25th percentile (Q1) 0.0, 75th percentile (Q3) 30.0, interquartile (IQ) 
range 30.0; Group II-complicated appendicitis specimens, median 0.0, 25th percentile (Q1) 0.0, 75th percentile (Q3) 8.5, 
interquartile (IQ) range 8.5; Group III-histologically "normal" specimens, median 49.7, 25th percentile (Q1) 16.7, 75th percentile 
(Q3) 107.5, interquartile (IQ) range 90.8; Group IV-control specimens, median 43.5, 25th percentile (Q1) 9.5, 75th percentile (Q3) 
115.8, interquartile (IQ) range 90.8. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference 
between the upper (Q1) and lower (Q2) hinge (box), upper fence= 1.5 × IQ range, lower fence= Q1-1.5 × IQ range. Values plotted 




Figure 4.1: Serotonin contents (very low/negative) of enterochromaffin cells in a patient with acute uncomplicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 
30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The absence of positive brown cytoplasmic-stained cells indicates that the sample was severely depleted of serotonin. The H-
score for this sample was 0.  
 
  
Figure 4.2: Serotonin contents (moderate) of enterochromaffin cells in a patient with acute uncomplicated appendicitis, using 
IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 
(20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 
mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-










Figure 4.3: Serotonin contents (very high) of enterochromaffin cells in a patient with acute uncomplicated appendicitis, using 
IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 
(20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 
mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-
score for this sample was 262.5. 
 
   
Figure 4.4: Serotonin contents (negative) of enterochromaffin cells in a patient with acute complicated appendicitis, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The absence of positive brown cytoplasmic-stained cells indicates that the sample was severely depleted of serotonin. The H-











Figure 4.5: Serotonin contents (moderate to high) of enterochromaffin cells in a patient with acute complicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 
30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-
score for this sample was 4.  
 
  
Figure 4.6: Serotonin contents (very high) of enterochromaffin cells in a patient with acute complicated appendicitis, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-












Figure 4.7: Serotonin contents (low) of enterochromaffin cells in a patient with a histologically "normal" appendix, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-
score for this sample was 16.5. 
 
  
Figure 4.8: Serotonin contents (moderate) of enterochromaffin cells in a patient with a histologically "normal" appendix, using 
IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 
(20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 
mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-












Figure 4.9: Serotonin contents (high) of enterochromaffin cells in a patient with a histologically "normal" appendix, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. 
The positive brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-
score for this sample was 342.5. 
 
  
Figure 4.10: Serotonin contents (low) of enterochromaffin cells in a patient from the control group, using IHC staining, at ×200 
(A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The modified H-score [number of positive cells (brown cytoplasmic-stained cells) × 
intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. The positive brown 
cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-score for this sample 












Figure 4.11: Serotonin contents (moderate) of enterochromaffin cells in a patient from the control group, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown cytoplasmic-
stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. The positive 
brown cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-score for this 
sample was 124.  
 
  
Figure 4.12: Serotonin contents (high) of enterochromaffin cells in a patient from the control group, using IHC staining, at ×200 
(A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The modified H-score [number of positive cells (brown cytoplasmic-stained cells) × 
intensity of staining (1 to 3)] was used to assess the serotonin contents of enterochromaffin cells. The positive brown 
cytoplasmic staining indicates enterochromaffin cells within the crypts of the epithelium (arrows). The H-score for this sample 










4.2.1.2 Serotonin contents of subepithelial neuroendocrine cells 
Serotonin contents of subepithelial neuroendocrine cells were assessed on a total of 
446 specimens as 2 samples did not have at least 3 fields with ×200 magnification and 
therefore excluded from the study. Subepithelial neuroendocrine cells of 
complicated appendicitis (median 0, IQ range 0-0) samples were significantly 
depleted of serotonin compared with the control group (median 0, IQ range 0-3.0, 
p<0.001). The amount of serotonin contained by subepithelial neuroendocrine cells 
of acute uncomplicated appendicitis (median 0, IQ range 0-2.0, p=0.39) samples and 
histologically "normal" appendices (median 1.0, IQ range 0-5.7, p=0.15) did not differ 
significantly compared with the control group (median 0, IQ range 0-3.0). 
Subepithelial neuroendocrine cells of complicated acute appendicitis (median 0, IQ 
range 0-0) contained significantly less serotonin compared with acute uncomplicated 
appendicitis (median 0, IQ range 0-2.0, p=0.004) samples and histologically "normal" 
appendices (median 1.0, IQ range 0-5.7, p<0.001). However, subepithelial 
neuroendocrine cells of acute uncomplicated appendicitis (median 0, IQ range 0-2.0) 
samples contained significantly more serotonin compared with the histologically 










Table 4.3: Summary of the analysis of serotonin contents of subepithelial neuroendocrine cells between the 4 groups of 
specimens. Group I-specimens with uncomplicated appendicitis, Group II-specimens with complicated appendicitis, Group III-
histologically "normal" appendices, Group IV-control specimens. N represents the number of specimens that were included in 
the analysis. Data is presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically 
significant difference between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as 
statistically significant when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 120 0.0 0.0 2.0 2.0 
<0.001 
II 117 0.0 0.0 0.0 0.0 
III 104 1.0 0.0 5.7 5.7 





























































Graph 4.3: Tukey’s boxplots displaying data of serotonin contents of subepithelial neuroendocrine cells between the 4 groups 
of specimens. Group I-uncomplicated appendicitis specimens, median 0.0, 25th percentile (Q1) 0.0, 75th percentile (Q3) 2.0, 
interquartile (IQ) range 2.0; Group II-complicated appendicitis specimens, median 0.0, 25th percentile (Q1) 0.0, 75th percentile 
(Q3) 0.0, interquartile (IQ) range 0.0; Group III-histologically "normal" specimens, median 1.0, 25th percentile (Q1) 0.0, 75th 
percentile (Q3) 5.7, interquartile (IQ) range 5.7; Group IV-control specimens, median 0.0, 25th percentile (Q1) 0.0, 75th percentile 
(Q3) 3.0, interquartile (IQ) range 3.0. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference 
between the upper (Q1) and lower (Q2) hinge (box), upper fence= 1.5 × IQ range, lower fence= Q1-1.5 × IQ range. Values plotted 




Figure 4.13: Serotonin contents (very low/negative) of subepithelial neuroendocrine cells in a patient with acute uncomplicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 
1:100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The modified H-score [number of 
positive cells (brown cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of 
subepithelial neuroendocrine cells. The absence of positive brown cytoplasmic-stained cells indicates that the sample was 
severely depleted of serotonin. The H-score for this sample was 0.  
 
  
Figure 4.14: Serotonin contents (moderate) of subepithelial neuroendocrine cells in a patient with acute uncomplicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 
1:100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The modified H-score [number of 
positive cells (brown cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of 
subepithelial neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black 












Figure 4.15: Serotonin contents (high) of subepithelial neuroendocrine cells in a patient with acute uncomplicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 
30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of subepithelial 
neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black arrows) and 
enterochromaffin cells (blue arrows). The H-score for this sample was 12. 
 
  
Figure 4.16: Serotonin contents (very low/negative) of subepithelial neuroendocrine cells in a patient with acute complicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 
1:100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The modified H-score [number of 
positive cells (brown cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of 
subepithelial neuroendocrine cells. The absence of positive brown cytoplasmic-stained cells indicates that the sample was 












Figure 4.17: Serotonin contents (low/moderate) of subepithelial neuroendocrine cells in a patient with acute complicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 
1:100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The modified H-score [number of 
positive cells (brown cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of 
subepithelial neuroendocrine cells. The absence of positive brown cytoplasmic-stained cells indicates that the sample was 
severely depleted of serotonin. The H-score for this sample was 0. 
 
  
Figure 4.18: Serotonin contents (high) of subepithelial neuroendocrine cells in a patient with acute complicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 
30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of subepithelial 
neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black arrows) and 









Figure 4.19: Serotonin contents (very low/negative) of subepithelial neuroendocrine cells in a patient with a histologically 
"normal" appendix, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed 
using citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at 
a 1:100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The modified H-score [number of 
positive cells (brown cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of 
subepithelial neuroendocrine cells. The absence of positive brown cytoplasmic-stained cells indicates that the sample was 
severely depleted of serotonin. The H-score for this sample was 0. 
 
  
Figure 4.20: Serotonin contents (moderate to high) of subepithelial neuroendocrine cells in a patient with a histologically 
"normal" appendix, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed 
using citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at 
a 1:100 dilution for 30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The modified H-score [number of 
positive cells (brown cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of 
subepithelial neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black 











Figure 4.21: Serotonin contents (high) of subepithelial neuroendocrine cells in a patient with a histologically "normal" appendix, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 
30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of subepithelial 
neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black arrows) and 
enterochromaffin cells (blue arrows). The H-score for this sample was 14. 
 
  
Figure 4.22: Serotonin contents (very low/negative) of subepithelial neuroendocrine cells in a patient from the control group, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 
30 mins at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise 
the staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of subepithelial 
neuroendocrine cells. The absence of positive brown cytoplasmic-stained cells indicates that the sample was severely depleted 








Figure 4.23: Serotonin contents (moderate) of subepithelial neuroendocrine cells in a patient from the control group, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of subepithelial 
neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black arrows) and 
enterochromaffin cells (blue arrows). The H-score for this sample was 2. 
 
  
Figure 4.24: Serotonin contents (high) of subepithelial neuroendocrine cells in a patient from the control group, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to serotonin (Dako, M0758) at a 1:100 dilution for 30 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The modified H-score [number of positive cells (brown 
cytoplasmic-stained cells) × intensity of staining (1 to 3)] was used to assess the serotonin contents of subepithelial 
neuroendocrine cells. The positive brown cytoplasmic staining indicates subepithelial neuroendocrine cells (black arrows) and 











4.2.2 Expression of TNF-α 
Immunohistochemistry performed with anti-TNF-α antibody demonstrated 
monocytes in the mucosa of the samples. TNF-α expression was assessed on a total 
of 417 specimens as 31 samples did not have at least four high-power fields and 
therefore excluded from the study. Both groups of acute uncomplicated (median 5.9, 
IQ range 3.1-9.8, p<0.001) and complicated (median 6.8, IQ range 3.6-12.1, p<0.001) 
appendicitis demonstrated significantly increased expression of TNF-α compared 
with the control group (median 3.0, IQ range 1.4-4.7). The expression of TNF-α in the 
histologically "normal" appendices (median 9.8, IQ range 6.2-15.2) was also 
significantly increased compared with the control group (median 3.0, IQ range 1.4-
4.7, p<0.001). Moreover, the TNF-α expression of the acute uncomplicated 
appendicitis (median 5.9, IQ range 3.1-9.8) samples was significantly reduced 
compared with the histologically "normal" (median 9.8, IQ range 6.2-15.2, p<0.001) 
samples as was the complicated appendicitis (median 6.8, IQ range 3.6-12.1) 
compared with the histologically "normal" appendices (median 9.8, IQ range 6.2-15.2, 
p=0.004). However, TNF-α expression between group I (median 5.9, IQ range 3.1-9.8) 
and group II (median 6.8, IQ range 3.6-12.1, p=0.17) did not vary significantly (Table 









Table 4.4: Summary of the analysis of TNF-α expression between the 4 groups of specimens. Group I-specimens with 
uncomplicated appendicitis, Group II-specimens with complicated appendicitis, Group III-histologically "normal" appendices, 
Group IV-control specimens. N represents the number of specimens that were included in the analysis. Data is presented with 
median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 4 groups 
was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value 
(p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 109 5.9 3.2 9.9 6.6 
<0.001 
II 102 6.8 3.6 12.1 8.4 
III 102 9.8 6.2 15.2 9.0 









































































Graph 4.4: Tukey’s boxplots displaying data of TNF-α expression between the 4 groups of specimens. Group I-uncomplicated 
appendicitis specimens, median 5.9, 25th percentile (Q1) 3.2, 75th percentile (Q3) 9.9, interquartile (IQ) range 6.6; Group II-
complicated appendicitis specimens, median 6.8, 25th percentile (Q1) 3.6, 75th percentile (Q3) 12.1, interquartile (IQ) range 8.4; 
Group III-histologically "normal" specimens, median 9.8, 25th percentile (Q1) 6.2, 75th percentile (Q3) 15.2, interquartile (IQ) 
range 9.0; Group IV-control specimens, median 3.0, 25th percentile (Q1) 1.4, 75th percentile (Q3) 4.7, interquartile (IQ) range 3.3. 
Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the upper (Q1) and lower (Q2) 





Figure 4.25: Expression of TNF-α (low) in monocytes of a patient with acute uncomplicated appendicitis, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
(arrows), regardless of the intensity, was quantified. The score for this sample was 3.1. 
 
  
Figure 4.26: Expression of TNF-α (moderate) in monocytes of a patient with acute uncomplicated appendicitis, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 









Figure 4.27: Expression of TNF-α (high) in monocytes of a patient with acute uncomplicated appendicitis, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
(arrows), regardless of the intensity, was quantified. The score for this sample was 12.7. 
 
  
Figure 4.28: Expression of TNF-α (low) in monocytes of a patient with acute complicated appendicitis, using IHC staining, at ×200 
(A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 















Figure 4.29: Expression of TNF-α (moderate) in monocytes of a patient with acute complicated appendicitis, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
(arrows), regardless of the intensity, was quantified. The score for this sample was 7.5. 
 
  
Figure 4.30: Expression of TNF-α (high) in monocytes of a patient with acute complicated appendicitis, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 









Figure 4.31: Expression of TNF-α (low) in monocytes of a patient with a histologically "normal" appendix, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
(arrows), regardless of the intensity, was quantified. The score for this sample was 7.4. 
 
  
Figure 4.32: Expression of TNF-α (moderate) in monocytes of a patient with a histologically "normal" appendix, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
















Figure 4.33: Expression of TNF-α (high) in monocytes of a patient with a histologically "normal" appendix, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at 
RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
(arrows), regardless of the intensity, was quantified. The score for this sample was 24. 
 
  
Figure 4.34: Expression of TNF-α (low) in monocytes of a patient from the control group, using IHC staining, at ×200 (A) and 
×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections were 
then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa (arrows), 









Figure 4.35: Expression of TNF-α (moderate) in monocytes of a patient from the control group, using IHC staining, at ×200 (A) 
and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa 
(arrows), regardless of the intensity, was quantified. The score for this sample was 3.2. 
 
  
Figure 4.36: Expression of TNF-α (high) in monocytes of a patient from the control group, using IHC staining, at ×200 (A) and 
×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections were 
then incubated with monoclonal antibody to TNF-α (LSBio, LS-B7268) at a 7.5 μl/ml concentration for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The average number of brown cytoplasmic-stained cells in the mucosa (arrows), 















4.2.3 Expression of IL-6 
Immunohistochemistry performed with anti-IL-6 antibody revealed epithelial and 
inflammatory cells in the mucosa of the specimens. Regarding the inflammatory cells, 
staining was observed in both mononuclear and polymorphonuclear cells. 
 
4.2.3.1 Expression of IL-6 in epithelial cells 
The expression of IL-6 in epithelial cells was assessed on a total of 423 specimens as 
25 samples did not have at least four high-power fields and therefore excluded from 
the study. Epithelial cells of specimens with complicated appendicitis (median 44.0, 
IQ range 8.0-97.0) demonstrated significantly increased expression of IL-6 compared 
with the control appendices (median 9.5, IQ range 1.0-60.25, p<0.001). The 
histologically "normal" appendices (median 71.0, IQ range 18.5-130.0) also showed 
significantly increased IL-6 expression compared with the control group (median 9.5, 
IQ range 1.0-60.25, p<0.001). However, IL-6 expression of acute uncomplicated 
appendicitis (median 9.0, IQ range 1.0-53.5) samples did not significantly differ from 
the control group (median 9.5, IQ range 1.0-60.2, p=0.89). Epithelial IL-6 expression 
was significantly higher in both group II (median 44.0, IQ range 8.0-97.0, p<0.001) 
and III (median 71.0, IQ range 18.5-130.0, p<0.001) compared with group I (median 
9.0, IQ range 1.0-53.5). Moreover, histologically "normal" appendices (median 71.0, 
IQ range 18.5-130.0) showed significantly elevated levels of epithelial IL-6 expression 
compared with complicated appendicitis (median 44.0, IQ range 8.0-97.0, p=0.04) 





Table 4.5: Summary of the analysis of IL-6 expression in epithelial cells between the 4 groups of specimens. Group I-specimens 
with uncomplicated appendicitis, Group II-specimens with complicated appendicitis, Group III-histologically "normal" 
appendices, Group IV-control specimens. N represents the number of specimens that were included in the analysis. Data is 
presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 109 9.0 1.0 53.5 52.5 
 
<0.001 
II 107 44.0 8.0 97.0 89.0 
III 103 71.0 18.5 130.0 111.5 




























































Graph 4.5: Tukey’s boxplots displaying data of IL-6 expression in epithelial cells between the 4 groups of specimens. Group I-
uncomplicated appendicitis specimens, median 9.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 53.5, interquartile (IQ) range 
52.5; Group II-complicated appendicitis specimens, median 44.0, 25th percentile (Q1) 8.0, 75th percentile (Q3) 97.0, interquartile 
(IQ) range 89.0; Group III-histologically "normal" specimens, median 71.0, 25th percentile (Q1) 18.5, 75th percentile (Q3) 130.0, 
interquartile (IQ) range 111.5; Group IV-control specimens, median 9.5, 25th percentile (Q1) 1.0, 75th percentile (Q3) 60.2, 
interquartile (IQ) range 59.2. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the 





Figure 4.37: Expression of IL-6 (very low/negative) in epithelial cells of a patient with acute uncomplicated appendicitis, using 
IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 
(20 mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained 
epithelial cells) × intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The absence of brown 




Figure 4.38: Expression of IL-6 (moderate) in epithelial cells of a patient with acute uncomplicated appendicitis, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) 
× intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic 









Figure 4.39: Expression of IL-6 (high) in epithelial cells of a patient with acute uncomplicated appendicitis, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium.  The positive brown cytoplasmic staining indicates 
epithelial cells within the glands of the mucosa (arrows). The H-score for this sample was 67. 
 
  
Figure 4.40: Expression of IL-6 (low) in epithelial cells of a patient with acute complicated appendicitis, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic staining indicates 









Figure 4.41: Expression of IL-6 (moderate to high) in epithelial cells of a patient with acute complicated appendicitis, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) 
× intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic 
staining indicates epithelial cells within the glands of the mucosa (arrows). The H-score for this sample was 72.5. 
 
  
Figure 4.42: Expression of IL-6 (high) in epithelial cells of a patient with acute complicated appendicitis, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic staining indicates 













Figure 4.43: Expression of IL-6 (low) in epithelial cells of a patient with a histologically "normal" appendix, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic staining indicates 
epithelial cells within the glands of the mucosa (arrows). The H-score for this sample was 22.5. 
 
  
Figure 4.44: Expression of IL-6 (moderate) in epithelial cells of a patient with a histologically "normal" appendix, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) 
× intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic 










Figure 4.45: Expression of IL-6 (high) in epithelial cells of a patient with a histologically "normal" appendix, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic staining indicates 
epithelial cells within the glands of the mucosa (arrows). The H-score for this sample was 195. 
 
  
Figure 4.46: Expression of IL-6 (very low/negative) in epithelial cells of a patient from the control group, using IHC staining, at 
×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The absence of brown cytoplasmic staining 









Figure 4.47: Expression of IL-6 (moderate) in epithelial cells of a patient from the control group, using IHC staining, at ×200 (A) 
and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric HRP-
linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity 
of staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic staining indicates 
epithelial cells within the glands of the mucosa (arrows). The H-score for this sample was 16.5. 
 
  
Figure 4.48: Expression of IL-6 (high) in epithelial cells of a patient from the control group, using IHC staining, at ×200 (A) and 
×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections were 
then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric HRP-linker 
antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections were 
counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained epithelial cells) × intensity of 
staining (1 to 3)] was used to assess the expression of IL-6 in the epithelium. The positive brown cytoplasmic staining indicates 








4.2.3.2 Expression of IL-6 in inflammatory cells 
The expression of IL-6 in inflammatory cells was assessed on a total of 423 specimens 
as 25 samples did not have at least four high-power fields and therefore excluded 
from the study. Complicated appendicitis (median 22.5. IQ range 10.6-46.0) group 
demonstrated significantly increased expression of IL-6 secreted by inflammatory 
cells compared with the control group (median 8.3, IQ range 4.4-23.6, p<0.001). 
Histologically "normal" appendices (median 21.0, IQ range 10.0-42.2) also 
demonstrated significantly elevated expression of IL-6 compare with the control 
group (median 8.3, IQ range 4.4-23.6, p<0.001). However, IL-6 expression of acute 
uncomplicated appendicitis (median 8.0, IQ range 3.0-17.5) samples did not 
significantly differ from the control group (median 8.3, IQ range 4.4-23.6, p=0.07). 
Groups II (median 22.5. IQ range 10.6-46.0, p<0.001) and III (median 21.0, IQ range 
10.0-42.2, p<0.001) demonstrated significantly increased inflammatory cell IL-6 
expression compared with group I (median 8.0, IQ range 3.0-17.5). Moreover, the 
inflammatory cell expression of IL-6 did not differ significantly between the groups of 
histologically "normal" (median 21.0, IQ range 10.0-42.2) and complicated 










Table 4.6: Summary of the analysis of IL-6 expression in inflammatory cells between the 4 groups of specimens. Group I-
specimens with uncomplicated appendicitis, Group II-specimens with complicated appendicitis, Group III-histologically "normal" 
appendices, Group IV-control specimens. N represents the number of specimens that were included in the analysis. Data is 
presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 109 8.0 3.0 17.5 14.5 
<0.001 
II 107 22.5 10.6 46.0 35.3 
III 103 21.0 10.0 42.2 32.2 






























































Graph 4.6: Tukey’s boxplots displaying data of IL-6 expression in inflammatory cells between the 4 groups of specimens. Group 
I-uncomplicated appendicitis specimens, median 8.0, 25th percentile (Q1) 3.0, 75th percentile (Q3) 17.5, interquartile (IQ) range 
14.5; Group II-complicated appendicitis specimens, median 22.5, 25th percentile (Q1) 10.6, 75th percentile (Q3) 46.0, 
interquartile (IQ) range 35.3; Group III-histologically "normal" specimens, median 21.0, 25th percentile (Q1) 10.0, 75th percentile 
(Q3) 42.2, interquartile (IQ) range 32.2; Group IV-control specimens, median 8.3, 25th percentile (Q1) 4.4, 75th percentile (Q3) 
23.6, interquartile (IQ) range 19.2. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 




   
Figure 4.49: Expression of IL-6 (low) in inflammatory cells of a patient with acute uncomplicated appendicitis, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 
staining indicates inflammatory cells within the mucosa (arrows). The H-score for this sample was 1.2. 
 
  
Figure 4.50: Expression of IL-6 (moderate) in inflammatory cells of a patient with acute uncomplicated appendicitis, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory 
cells) × intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown 








Figure 4.51: Expression of IL-6 (high) in inflammatory cells of a patient with acute uncomplicated appendicitis, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 
staining indicates inflammatory cells within the mucosa (arrows). The H-score for this sample was 27.5. 
 
  
Figure 4.52: Expression of IL-6 (low) in inflammatory cells of a patient with acute complicated appendicitis, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 









Figure 4.53: Expression of IL-6 (moderate) in inflammatory cells of a patient with acute complicated appendicitis, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory 
cells) × intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown 
cytoplasmic staining indicates inflammatory cells within the mucosa (arrows). The H-score for this sample was 29. 
 
  
Figure 4.54: Expression of IL-6 (high) in inflammatory cells of a patient with acute complicated appendicitis, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 









Figure 4.55: Expression of IL-6 (low to moderate) in inflammatory cells of a patient with a histologically "normal" appendix, using 
IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 
(20 mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins 
at RT. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the 
staining. The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained 
inflammatory cells) × intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The 




Figure 4.56: Expression of IL-6 (moderate) in inflammatory cells of a patient with a histologically "normal" appendix, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory 
cells) × intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown 









Figure 4.57: Expression of IL-6 (high) in inflammatory cells of a patient with a histologically "normal" appendix, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric 
HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 
staining indicates inflammatory cells within the mucosa (arrows). The H-score for this sample was 114. 
 
  
Figure 4.58: Expression of IL-6 (low) in inflammatory cells of a patient from the control group, using IHC staining, at ×200 (A) 
and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric HRP-
linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 









Figure 4.59: Expression of IL-6 (moderate) in inflammatory cells of a patient from the control group, using IHC staining, at ×200 
(A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric HRP-
linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 
staining indicates inflammatory cells within the mucosa (arrows). The H-score for this sample was 10.4. 
 
  
Figure 4.60: Expression of IL-6 (high) in inflammatory cells of a patient from the control group, using IHC staining, at ×200 (A) 
and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The sections 
were then incubated with monoclonal antibody to IL-6 (Leica, NCL-L-IL6) at a 1:50 dilution for 60 mins at RT. Polymeric HRP-
linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. The sections 
were counterstained with haematoxylin. The H-score [% of positive cells (brown cytoplasmic-stained inflammatory cells) × 
intensity of staining (1 to 3)] was used to assess the expression of IL-6 in the inflammatory cells. The positive brown cytoplasmic 













4.2.4 Expression of IL-2R 
Immunohistochemistry performed with anti-IL-2R revealed lymphocytes in the 
mucosa and submucosa of the samples. In the germinal centres IL-2R expression was 
extremely intense making it impossible to be quantified. Therefore, quantification of 
IL-2R expression in the submucosa was performed between the germinal centres. 
 
4.2.4.1 Expression of IL-2R in mucosa 
The expression of IL-2R in mucosa was assessed on a total of 417 specimens as 31 
samples did not have at least three high-power fields and therefore excluded from 
the study. Mucosal IL-2R expression was significantly increased in both groups of 
acute uncomplicated (median 47.4, IQ 34.8-69.0, p<0.001) and complicated (median 
37.8, IQ range 25.4-60.4, p<0.001) appendicitis compared with the control group 
(median 15,4, IQ range 7.9-24.8), as was IL-2R expression in the histologically 
"normal" appendices (median 27.0, IQ range 20.2-42.4) compared with the control 
specimens (median 15,4, IQ range 7.9-24.8, p<0.001). Both group I (median 47.4, IQ 
34.8-69.0, p<0.001) and II (median 37.8, IQ range 25.4-60.4, p<0.001) demonstrated 
significantly increased IL-2R expression compared with group III (median 27.0, IQ 
range 20.2-42.4). Moreover, IL-2R expression was significantly higher in the acute 
uncomplicated appendicitis (median 47.4, IQ 34.8-69.0) samples compared with the 
complicated appendicitis (median 37.8, IQ range 25.4-60.4, p=0.001) samples (Table 






Table 4.7: Summary of the analysis of IL-2R expression in mucosa between the 4 groups of specimens. Group I-specimens with 
uncomplicated appendicitis, Group II-specimens with complicated appendicitis, Group III-histologically "normal" appendices, 
Group IV-control specimens. N represents the number of specimens that were included in the analysis. Data is presented with 
median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 4 groups 
was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value 
(p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 109 47.4 34.8 69.0 34.2 
<0.001 
II 103 37.8 25.4 60.4 35.0 
III 103 27.0 20.2 42.4 22.2 









































































Graph 4.7: Tukey’s boxplots displaying data of IL-2R expression in the mucosa between the 4 groups of specimens. Group I-
uncomplicated appendicitis specimens, median 47.4, 25th percentile (Q1) 34.8, 75th percentile (Q3) 69.0, interquartile (IQ) range 
34.2; Group II-complicated appendicitis specimens, median 37.8, 25th percentile (Q1) 25.4, 75th percentile (Q3) 60.4, 
interquartile (IQ) range 35.0; Group III-histologically "normal" specimens, median 27.0, 25th percentile (Q1) 20.2, 75th percentile 
(Q3) 42.4, interquartile (IQ) range 22.2; Group IV-control specimens, median 15.4, 25th percentile (Q1) 7.9, 75th percentile (Q3) 
24.8, interquartile (IQ) range 16.8. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 





Figure 4.61: Expression of IL-2R (low) in inflammatory cells of the mucosa in a patient with acute uncomplicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the mucosa (arrows), regardless of the intensity, was counted. The score for this sample was 29.8. 
 
  
Figure 4.62: Expression of IL-2R (moderate) in inflammatory cells of the mucosa in a patient with acute uncomplicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 
1:400 dilution for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-









Figure 4.63: Expression of IL-2R (high) in inflammatory cells of the mucosa in a patient with acute uncomplicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the mucosa (arrows), regardless of the intensity, was counted. The score for this sample was 76.8. 
 
  
Figure 4.64: Expression of IL-2R (low) in inflammatory cells of the mucosa in a patient with acute complicated appendicitis, using 
IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 
(20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for 
overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 









Figure 4.65: Expression of IL-2R (moderate) in inflammatory cells of the mucosa in a patient with acute complicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the mucosa (arrows), regardless of the intensity, was counted. The score for this sample was 38.6. 
 
  
Figure 4.66: Expression of IL-2R (high) in inflammatory cells of the mucosa in a patient with acute complicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 









Figure 4.67: Expression of IL-2R (low) in inflammatory cells of the mucosa in a patient with a histologically "normal" appendix, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the mucosa (arrows), regardless of the intensity, was counted. The score for this sample was 14.8. 
 
  
Figure 4.68: Expression of IL-2R (moderate) in inflammatory cells of the mucosa in a patient with a histologically "normal" 
appendix, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 
1:400 dilution for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-









Figure 4.69: Expression of IL-2R (high) in inflammatory cells of the mucosa in a patient with a histologically "normal" appendix, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the mucosa (arrows), regardless of the intensity, was counted. The score for this sample was 52. 
  
  
Figure 4.70: Expression of IL-2R (low) in inflammatory cells of the mucosa in a patient from the control group, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for overnight at 4 °C. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in the mucosa, regardless 









Figure 4.71: Expression of IL-2R (moderate) in inflammatory cells of the mucosa in a patient from the control group, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for 
overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the mucosa (arrows), regardless of the intensity, was counted. The score for this sample was 15.8. 
 
  
Figure 4.72: Expression of IL-2R (high) in inflammatory cells of the mucosa in a patient from the control group, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for overnight at 4 °C. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in the mucosa, regardless 














4.2.4.2 Expression of IL-2R in submucosa 
The expression of IL-2R in submucosa was assessed on 445 specimens as 3 samples 
did not have at least three high-power fields and therefore excluded from the study. 
Both groups of acute uncomplicated (median 67.8, IQ range 50.5-87.6, p<0.001) and 
complicated (median 47.9, IQ range 30.9-69.4, p<0.001) appendicitis demonstrated 
significantly increased IL-2R expression in the submucosa compared with the control 
group (median 2.8, IQ range 1.2-5.7). The histologically "normal" appendices (median 
18.4, IQ range 10.1-34.7) also expressed significantly increased IL-2R expression 
compared with the control group (median 2.8, IQ range 1.2-5.7, p<0.001). Moreover, 
both group I (median 67.8, IQ range 50.5-87.6, p<0.001) and group II (median 47.9, 
IQ range 30.9-69.4, p<0.001) showed significantly increased expression of IL-2R in the 
submucosa compared with group III (median 18.4, IQ range 10.1-34.7). In a similar 
pattern to mucosal expression, IL-2R expression of the acute uncomplicated 
appendicitis group (median 67.8, IQ range 50.5-87.6) was found to be significantly 
increased compared with the complicated appendicitis (median 47.9, IQ range 30.9-











Table 4.8: Summary of the analysis of IL-2R expression in submucosa between the 4 groups of specimens. Group I-specimens 
with uncomplicated appendicitis, Group II-specimens with complicated appendicitis, Group III-histologically "normal" 
appendices, Group IV-control specimens. N represents the number of specimens that were included in the analysis. Data is 
presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 120 67.8 50.5 87.6 37.0 
<0.001 
II 118 47.9 30.9 69.4 38.5 
III 104 18.4 10.1 34.7 24.6 









































































Graph 4.8: Tukey’s boxplots displaying data of IL-2R expression in the submucosa between the 4 groups of specimens. Group I-
uncomplicated appendicitis specimens, median 67.8, 25th percentile (Q1) 50.5, 75th percentile (Q3) 87.6, interquartile (IQ) range 
37.0; Group II-complicated appendicitis specimens, median 47.9, 25th percentile (Q1) 30.9, 75th percentile (Q3) 69.4, 
interquartile (IQ) range 38.5; Group III-histologically "normal" specimens, median 18.4, 25th percentile (Q1) 10.1, 75th percentile 
(Q3) 34.7, interquartile (IQ) range 24.6; Group IV-control specimens, median 2.8, 25th percentile (Q1) 1.2, 75th percentile (Q3) 
5.7, interquartile (IQ) range 4.5. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 





Figure 4.73: Expression of IL-2R (low) in inflammatory cells of the submucosa in a patient with acute uncomplicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the submucosa (arrows), regardless of the intensity, was counted. The score for this sample was 39.6. 
 
  
Figure 4.74: Expression of IL-2R (moderate) in inflammatory cells of the submucosa in a patient with acute uncomplicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 
1:400 dilution for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-









Figure 4.75: Expression of IL-2R (high) in inflammatory cells of the submucosa in a patient with acute uncomplicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the submucosa (arrows), regardless of the intensity, was counted. The score for this sample was 101.8. 
 
  
Figure 4.76: Expression of IL-2R (low) in inflammatory cells of the submucosa in a patient with acute complicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 









Figure 4.77: Expression of IL-2R (moderate) in inflammatory cells of the submucosa in a patient with acute complicated 
appendicitis, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 
1:400 dilution for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-
stained cells in the submucosa (arrows), regardless of the intensity, was counted. The score for this sample was 47.4. 
 
  
Figure 4.78: Expression of IL-2R (high) in inflammatory cells of the submucosa in a patient with acute complicated appendicitis, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 









Figure 4.79: Expression of IL-2R (low) in inflammatory cells of the submucosa in a patient with a histologically "normal" appendix, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the submucosa (arrows), regardless of the intensity, was counted. The score for this sample was 7. 
 
  
Figure 4.80: Expression of IL-2R (moderate) in inflammatory cells of the submucosa in a patient with a histologically "normal" 
appendix, using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using 
citrate buffer, pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 
1:400 dilution for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen 
was used to visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-









Figure 4.81: Expression of IL-2R (high) in inflammatory cells of the submucosa in a patient with a histologically "normal" appendix, 
using IHC staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, 
pH 6 (20 mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution 
for overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the submucosa (arrows), regardless of the intensity, was counted. The score for this sample was 47.2. 
 
  
Figure 4.82: Expression of IL-2R (low) in inflammatory cells of the submucosa in a patient of the control group, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for overnight at 4 °C. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in the submucosa (arrows), 









Figure 4.83: Expression of IL-2R (moderate) in inflammatory cells of the submucosa in a patient of the control group, using IHC 
staining, at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 
mins). The sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for 
overnight at 4 °C. Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to 
visualise the staining. The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in 
the submucosa (arrows), regardless of the intensity, was counted. The score for this sample was 3.2. 
 
  
Figure 4.84: Expression of IL-2R (high) in inflammatory cells of the submucosa in a patient of the control group, using IHC staining, 
at ×200 (A) and ×400 (B) magnification. Heat-mediated antigen retrieval was performed using citrate buffer, pH 6 (20 mins). The 
sections were then incubated with monoclonal antibody to IL-2R (Leica, NCL-CD25-305) at a 1:400 dilution for overnight at 4 °C. 
Polymeric HRP-linker antibody conjugate was used as secondary antibody. DAB chromogen was used to visualise the staining. 
The sections were counterstained with haematoxylin. The number of brown membrane-stained cells in the submucosa (arrows), 













4.3 Clinical data 
4.3.1 White cell count  
The white cell count (WCC) was assessed on 436 patients as data was not available 
on 12 patients. Both groups of patients with acute uncomplicated (median 13.6, IQ 
range 11.4-16.0, p<0.001) and complicated (median 15.2, IQ range 12.4-18.5, 
p<0.001) appendicitis demonstrated significantly increased WCC compared with the 
control group (median 8.3, IQ range 6.8-10.9). Patients with histologically "normal" 
appendices (median 10.0, IQ range 7.3-12.6) also demonstrated significantly 
increased WCC compared with the control group (median 8.3, IQ range 6.8-10.9, 
p=0.02). Moreover, both group I (median 13.6, IQ range 11.4-16.0, p<0.001) and 
group II (median 15.2, IQ range 12.4-18.5, p<0.001) showed significantly increased 
WCC compared with group III (median 10.0, IQ range 7.3-12.6). Patients with 
complicated (median 15.2, IQ range 12.4-18.5) appendicitis demonstrated a 
significantly higher WCC compared with patients with acute uncomplicated (median 












Table 4.9: Summary of the analysis of the WCC between the 4 groups of patients. Group I-patients with uncomplicated 
appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" appendices, Group 
IV-patients of the control group. N represents the number of patients that were included in the analysis. Data is presented with 
median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 4 groups 
was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value 
(p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 119 13.6 11.4 16.0 4.6 
<0.001     
II 118 15.2 12.4 18.5 6.0 
III 104 10.0 7.3 12.6 5.6 




































































Graph 4.9: Tukey’s boxplots displaying data of the WCC between the 4 groups of specimens. Group I-uncomplicated appendicitis 
specimens, median 13.6, 25th percentile (Q1) 11.4, 75th percentile (Q3) 16.0, interquartile (IQ) range 4.6; Group II-complicated 
appendicitis specimens, median 15.2, 25th percentile (Q1) 12.4, 75th percentile (Q3) 18.5, interquartile (IQ) range 6.0; Group III-
histologically "normal" specimens, median 10.0, 25th percentile (Q1) 7.3, 75th percentile (Q3) 12.6, interquartile (IQ) range 5.6; 
Group IV-control specimens, median 8.3, 25th percentile (Q1) 6.8, 75th percentile (Q3) 10.9, interquartile (IQ) range 4.1. Median: 
line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the upper (Q1) and lower (Q2) hinge (box), 




4.3.2 Neutrophil count 
The neutrophil count was assessed on 436 patients as data was not available on 12 
patients. Both groups of patients with acute uncomplicated (median 11.0, IQ range 
8.6-13.2, p<0.001) and complicated (median 12.6, IQ range 10.1-15.5, p<0.001) 
appendicitis demonstrated significantly increased neutrophil count compared with 
the control group (median 5.7, IQ range 4.2-9.3). Patients with histologically "normal" 
appendices (median 6.2, IQ range 3.9-8.1) did not demonstrate significant difference 
in the neutrophil count compared with the control group (median 5.7, IQ range 4.2-
9.3, p=0.50). Both group I (median 11.0, IQ range 8.6-13.2, p<0.001) and group II 
(median 12.6, IQ range 10.1-15.5, p<0.001) showed significantly increased neutrophil 
count compared with group III (median 6.2, IQ range 3.9-8.1). Moreover, patients 
with complicated (median 12.6, IQ range 10.1-15.5) appendicitis demonstrated a 
higher neutrophil count compared with patients with acute uncomplicated (median 












Table 4.10: Summary of the analysis of the neutrophil count between the 4 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices, Group IV-patients of the control group. N represents the number of patients that were included in the analysis. 
Data is presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 119 11.0 8.6 13.2 4.6 
<0.001 
II 118 12.6 10.1 15.5 5.4 
III 104 6.2 3.9 8.1 5.4 
















































































Graph 4.10: Tukey’s boxplots displaying data of the neutrophil count between the 4 groups of specimens. Group I-
uncomplicated appendicitis specimens, median 11.0, 25th percentile (Q1) 8.6, 75th percentile (Q3) 13.2, interquartile (IQ) range 
4.6; Group II-complicated appendicitis specimens, median 12.6, 25th percentile (Q1) 10.1, 75th percentile (Q3) 15.5, interquartile 
(IQ) range 5.4; Group III-histologically "normal" specimens, median 6.2, 25th percentile (Q1) 3.9, 75th percentile (Q3) 8.1, 
interquartile (IQ) range 5.4; Group IV-control specimens, median 5.7, 25th percentile (Q1) 4.2, 75th percentile (Q3) 9.3, 
interquartile (IQ) range 3.9. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the 




4.3.3 Lymphocyte count 
The lymphocyte count was assessed on 435 patients as data was not available on 13 
patients. Patients with acute uncomplicated (median 1.6, IQ range 1.2-2.0) 
appendicitis did not demonstrate significant difference in the lymphocyte count 
compared with the control group (median 1.5, IQ range 1.1-1.9, p=0.44). Patients 
with complicated (median 1.2, IQ range 0.9-1.8) appendicitis demonstrated 
significantly reduced lymphocyte count compared with the control group (median 1.5, 
IQ range 1.1-1.9, p=0.01). Patients with histologically "normal" appendices (median 
2.1, IQ range 1.3-2.8) demonstrated significantly increased lymphocyte count 
compared with the control group (median 1.5, IQ range 1.1-1.9, p<0.001) as well as 
with group I (median 1.6, IQ range 1.2-2.0, p<0.001) and group II (median 1.2, IQ 
range 0.9-1.8, p<0.001). Moreover, patients with acute uncomplicated (median 1.6, 
IQ range 1.2-2.0) appendicitis demonstrated significantly higher lymphocyte count 
compared with patients complicated (median 1.2, IQ range 0.9-1.8, p=0.002) 












Table 4.11: Summary of the analysis of the lymphocyte count between the 4 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices, Group IV-patients of the control group. N represents the number of patients that were included in the analysis. 
Data is presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 119 1.6 1.2 2.0 0.8 
<0.001 
II 118 1.2 0.9 1.8 0.9 
III 103 2.1 1.3 2.8 1.5 

















































































Graph 4.11: Tukey’s boxplots displaying data of the lymphocyte count between the 4 groups of specimens. Group I-
uncomplicated appendicitis specimens, median 1.6, 25th percentile (Q1) 1.2, 75th percentile (Q3) 2.0, interquartile (IQ) range 0.8; 
Group II-complicated appendicitis specimens, median 1.2, 25th percentile (Q1) 0.9, 75th percentile (Q3) 1.8, interquartile (IQ) 
range 0.9; Group III-histologically "normal" specimens, median 2.1, 25th percentile (Q1) 1.3, 75th percentile (Q3) 2.8, interquartile 
(IQ) range 1.5; Group IV-control specimens, median 1.5, 25th percentile (Q1) 1.1, 75th percentile (Q3) 1.9, interquartile (IQ) range 
0.8. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the upper (Q1) and lower 
(Q2) hinge (box), upper fence= 1.5 × IQ range, lower fence= Q1 - 1.5 × IQ range. Values plotted with ▪ represent outliers. 
187 
 
4.3.4 Neutrophil to lymphocyte ratio  
The neutrophil to lymphocyte (NLR) ratio was assessed on 435 patients as data was 
not available on 13 patients. Both groups of patients with acute uncomplicated 
(median 7.1, IQ range 4.6-10.6, p<0.001) and complicated (median 9.5, IQ range 6.5-
15.2, p<0.001) appendicitis demonstrated significantly increased neutrophil to 
lymphocytes ratio compared with the control group (median 3.7, IQ range 2.3-7.1). 
Patients with histologically "normal" appendices (median 2.8, IQ range 1.6-6.0) 
demonstrated a significantly reduced neutrophil to lymphocyte ratio compared with 
the control group (median 3.7, IQ range 2.3-7.1, p=0.02). Moreover, patients with 
histologically "normal" (median 2.7, IQ range 1.6-6.0) appendicitis demonstrated 
significantly reduced neutrophil to lymphocyte ratio compared with group I (median 
7.1, IQ range 4.6-10.6, p<0.001) and group II (median 9.5, IQ range 6.5-15.2, p<0.001). 
Patients with acute uncomplicated (median 7.1, IQ range 4.6-10.6, p<0.05) 
appendicitis demonstrated a reduced neutrophil to lymphocyte count compared with 
patients with complicated (median 9.5, IQ range 6.5-15.2, p<0.001) appendicitis 











Table 4.12: Summary of the analysis of the neutrophil to lymphocyte ratio between the 4 groups of patients. Group I-patients 
with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically 
"normal" appendices, Group IV-patients of the control group. N represents the number of patients that were included in the 
analysis. Data is presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant 
difference between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically 
significant when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 119 7.1 4.6 10.6 6.0 
<0.001 
II 118 9.5 6.5 15.2 8.7 
III 103 2.8 1.6 6.0 4.4 


























































Graph 4.12: Tukey’s boxplots displaying data of the neutrophil to lymphocyte ratio (NLR) between the 4 groups of specimens. 
Group I-uncomplicated appendicitis specimens, median 7.1, 25th percentile (Q1) 4.6, 75th percentile (Q3) 10.6, interquartile (IQ) 
range 6.0; Group II-complicated appendicitis specimens, median 9.5, 25th percentile (Q1) 6.5, 75th percentile (Q3) 15.2, 
interquartile (IQ) range 8.7; Group III-histologically "normal" specimens, median 2.8, 25th percentile (Q1) 1.6, 75th percentile 
(Q3) 6.0, interquartile (IQ) range 4.4; Group IV-control specimens, median 3.7, 25th percentile (Q1) 2.3, 75th percentile (Q3) 7.1, 
interquartile (IQ) range 4.7. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the 




4.3.5 C-reactive protein concentrations 
The C-reactive protein (CRP) concentrations were assessed on 283 patients as data 
was not available on 165 patients. Patients with complicated (median 77.0, IQ range 
24.0-170.0) appendicitis demonstrated significantly increased CRP concentrations 
compared with the control group (median 18.0, IQ range 5.0-71.0, p=0.001). Patients 
with acute uncomplicated (median 39.0, IQ range 10.0-90.0) appendicitis did not 
demonstrate a difference in the CRP concentrations compared with the control 
(median 18.0, IQ range 5.0-71.0, p=0.10) group. Patients with histologically "normal" 
appendices (median 5.0, IQ range 5.0-23.7) demonstrated significantly reduced CRP 
concentrations compared with the control group (median 18.0, IQ range 5.0-71.0, 
p=0.004). Moreover, both group I (median 39.0, IQ range 10.0-90.0, p<0.001) and 
group II (median 77.0, IQ range 24.0-170.0, p<0.001) showed significantly increased 
CRP concentrations compared with group III (median 5.0, IQ range 5.0-23.7). Patients 
with complicated (median 77.0, IQ range 24.0-170.0) appendicitis demonstrated 
significantly higher CRP concentrations compared with patients with acute 











Table 4.13: Summary of the analysis of the CRP concentrations between the 4 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices, Group IV-patients of the control group. N represents the number of patients that were included in the analysis. 
Data is presented with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference 
between the 4 groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant 
when the probability value (p value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range P value 
I 93 39.0 10.0 90.0 80.0 
<0.001 
II 79 77.0 24.0 170.0 146.0 
III 80 5.0 5.0 23.7 18.7 






























































Graph 4.13: Tukey’s boxplots displaying data of the CRP concentrations between the 4 groups of specimens. Group I-
uncomplicated appendicitis specimens, median 39.0, 25th percentile (Q1) 10.0, 75th percentile (Q3) 90.0.0, interquartile (IQ) 
range 80.0; Group II-complicated appendicitis specimens, median 77.0, 25th percentile (Q1) 24.0, 75th percentile (Q3) 170.0, 
interquartile (IQ) range 146.0; Group III-histologically "normal" specimens, median 5.0, 25th percentile (Q1) 5.0, 75th percentile 
(Q3) 23.7, interquartile (IQ) range 18.7; Group IV-control specimens, median 18.0, 25th percentile (Q1) 5.0, 75th percentile (Q3) 
71.0, interquartile (IQ) range 66.0. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 




4.3.6 Duration of symptoms 
The duration of symptoms suggesting acute appendicitis was assessed in the groups 
of acute appendicitis, complicated appendicitis and histologically "normal" samples 
by reviewing the clinical notes on the day of admission to hospital. The duration of 
symptoms was assessed on 313 patients as data was not available on 30 patients. 
Patients with histologically "normal" (median 2.0, IQ range 1.0-3.0) appendices did 
not demonstrate significant difference in the duration of symptoms suggesting 
appendicitis compared with the uncomplicated acute (median 2.0, IQ range 1.0-2.0, 
p=0.11) appendicitis or complicated appendicitis (median 2.0, IQ range 1.0-3.0, 
p=0.18) samples. Moreover, patients with acute (median 2.0, IQ range 1.0-2.0) 
appendicitis did not demonstrate significantly different duration of symptoms 
compared with patients with complicated (median 2.0, IQ range 1.0-3.0, p=0.87) 














Table 4.14: Summary of the analysis of the duration of symptoms between the 3 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices. N represents the number of patients that were included in the analysis. Data is presented with median, 25th 
percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 3 groups was 
calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value (p 
value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 111 2.0 1.0 2.0 1.0 
0.62 II 108 2.0 1.0 3.0 2.0 



























































Graph 4.14: Tukey’s boxplots displaying data of the duration of symptoms between the 3 groups of patients. Group I-patients 
with uncomplicated appendicitis, median 2.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 2.0, interquartile (IQ) range 1.0; 
Group II-patients with complicated appendicitis, median 2.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 3.0, interquartile (IQ) 
range 2.0; Group III-patients with histologically "normal" appendices, median 2.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 
3.0, interquartile (IQ) range 2.0. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 




4.3.7 Severity of pain 
The severity of pain was assessed in the groups of acute appendicitis, complicated 
appendicitis and histologically "normal" samples by reviewing the clinical notes on 
the day of admission to hospital. The patient was asked to rate the pain on a scale of 
0 to 10 with 0 being no pain and 10 being the worst pain ever experienced.  The 
severity of pain was assessed on 301 patients as data was not available on 41 patients. 
Patients with histologically "normal" (median 8.0, IQ range 5.0-9.0) appendices did 
not demonstrate significant difference in the severity of pain compared with the 
acute (median 8.0, IQ range 4.2-8.7, p=0.68) or complicated (median 8.0, IQ range 
7.0-10.0, p=0.07) appendicitis patients. Moreover, patients with acute (median 8.0, 
IQ range 4.2-8.7) appendicitis demonstrated significantly reduced severity of pain 
compared with patients with complicated (median 8.0, IQ range 7.0-10.0, p=0.01) 














Table 4.15: Summary of the analysis of the severity of pain between the 3 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices. N represents the number of patients that were included in the analysis. Data is presented with median, 25th 
percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 3 groups was 
calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value (p 
value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 108 8.0 4.2 8.7 4.5 
0.04 II 105 8.0 7.0 10.0 3.0 



























































Graph 4.15: Tukey’s boxplots displaying data of the severity of pain between the 3 groups of patients. Group I-patients 
uncomplicated appendicitis, median 8.0, 25th percentile (Q1) 4.2, 75th percentile (Q3) 8.7, interquartile (IQ) range 4.5; Group II-
patients with complicated appendicitis, median 8.0, 25th percentile (Q1) 7.0, 75th percentile (Q3) 10.0, interquartile (IQ) range 
3.0; Group III-patients with histologically "normal" appendices, median 8.0, 25th percentile (Q1) 5.0, 75th percentile (Q3) 9.0, 
interquartile (IQ) range 4.0. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between the 





4.3.8 Nausea and/or vomiting 
The symptoms of nausea and/or vomiting were assessed in the groups of acute 
appendicitis, complicated appendicitis and histologically "normal" samples by 
reviewing the clinical notes on the day of admission to hospital. The symptoms of 
nausea and/or vomiting were assessed on 313 patients as data was not available on 
29 patients. In the acute appendicitis group, 78 (71%) patients complained of nausea 
and/or vomiting. In the complicated appendicitis group, 81 (75%) patients 
complained of nausea and/or vomiting, whereas, in the group of patients with 
histologically normal appendices 63 (66%) patients complained of nausea and/or 

















Table 4.16: Summary of the presence of nausea/vomiting between the 3 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices. Statistically significant difference between the 3 groups was calculated using the Pearson’s Chi-Square test. The 
results were considered as statistically significant when the probability value (p value) was less than 0.05. 
 
Presence of nausea or vomiting  
Groups 
Number of patients 
assessed 
Number of patients 
with nausea or vomiting 
% Pearson’s Chi-Square 
I 110 78 71% 
p=0.397 
II 108 81 75% 
III 95 63 66% 
Total 313 222  
 
 






































4.3.9 Body temperature on admission 
The body temperature on admission was assessed in the groups of acute appendicitis, 
complicated appendicitis and histologically "normal" by reviewing the first recorded 
temperature on admission to the Accident and Emergency department or the letter 
from the General Practitioner who referred the patient to the Surgical Admission Unit. 
Therefore, the body temperature was not affected by antipyretic medication such as 
paracetamol. The body temperature on admission was assessed on 312 patients as 
data was not available on 30 patients. Patients with histologically "normal" (median 
37.1, IQ range 36.6-37.5) appendices did not demonstrate significant difference in 
the first recorded body temperature compared with the uncomplicated acute 
(median 37.2, IQ range 36.8-37.7, p=0.16) appendicitis patients.  Patients with 
complicated (median 37.4, IQ range 37.0-38.0) appendicitis demonstrated 
significantly increased body temperature on admission compared with patients with 
histologically "normal" appendices (median 37.1, IQ range 36.6-37.5, p=0.002) as well 
as with the acute (median 37.2, IQ range 36.8-37.7, p=0.047) appendicitis patients. 











Table 4.17: Summary of the analysis of body temperature on admission between the 3 groups of patients. Group I-patients with 
uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" 
appendices. N represents the number of patients that were included in the analysis. Data is presented with median, 25th 
percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 3 groups was 
calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value (p 
value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 110 37.2 36.8 37.7 0.9 
0.005 II 108 37.4 37.0 38.0 1.0 






























































Graph 4.17: Tukey’s boxplots displaying data of body temperature on admission between the 3 groups of patients. Group I-
patients uncomplicated appendicitis, median 37.2, 25th percentile (Q1) 36.8, 75th percentile (Q3) 37.7, interquartile (IQ) range 
0.9; Group II-patients with complicated appendicitis, median 37.4, 25th percentile (Q1) 37.0, 75th percentile (Q3) 38.0, 
interquartile (IQ) range 1.0; Group III-patients with histologically "normal" appendices, median 37.1, 25th percentile (Q1) 36.6, 
75th percentile (Q3) 37.5, interquartile (IQ) range 0.9. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: 
difference between the upper (Q1) and lower (Q2) hinge (box), upper fence= 1.5 × IQ range, lower fence= Q1 - 1.5 × IQ range. 




4.3.10 Highest body temperature pre-operatively  
The highest body temperature during admission was assessed in the groups of acute 
appendicitis, complicated appendicitis and histologically "normal" by recording the 
highest temperature in the pre-operative period. The highest body temperature was 
assessed on 311 patients as data was not available on 31 patients. The highest 
recorded temperature pre-operatively in patients with histologically "normal" 
(median 37.4, IQ range 37.1-37.8) appendices was significantly lower compared with 
acute (median 37.6, IQ range 37.2-38.1, p=0.02) appendicitis as well as with 
complicated (median 38.0, IQ range 37.5-38.7, p<0.001) appendicitis patients. The 
highest recorded temperature pre-operatively in patients with complicated (median 
38.0, IQ range 37.5-38.7) appendicitis was significantly higher compared with 
patients with acute (median 37.6, IQ range 37.2-38.1, p<0.001) appendicitis (Table 














Table 4.18: Summary of the analysis on the highest body temperature pre-operatively between the 3 groups of patients. Group 
I-patients with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with 
histologically "normal" appendices. N represents the number of patients that were included in the analysis. Data is presented 
with median, 25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 3 
groups was calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the 
probability value (p value) was less than 0.05. 
 
Groups N Median 25th 75th IQ range p value 
I 119 37.6 37.2 38.1 0.9 
<0.001 II 108 38.0 37.5 38.7 1.2 






























































Graph 4.18 Tukey’s boxplots displaying data on the highest body temperature pre-operatively between the 3 groups of patients. 
Group I-patients uncomplicated appendicitis, median 37.6, 25th percentile (Q1) 37.2, 75th percentile (Q3) 38.1, interquartile (IQ) 
range 0.9; Group II-patients with complicated appendicitis, median 38.0, 25th percentile (Q1) 37.5, 75th percentile (Q3) 38.7, 
interquartile (IQ) range 1.2; Group III-patients with histologically "normal" appendices, median 37.4, 25th percentile (Q1) 37.1, 
75th percentile (Q3) 37.8, interquartile (IQ) range 0.7. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: 
difference between the upper (Q1) and lower (Q2) hinge (box), upper fence= 1.5 × IQ range, lower fence= Q1 - 1.5 × IQ range. 




4.3.11 Previous episodes of right iliac fossa pain 
The presence of previous episodes of right iliac fossa pain was assessed in acute 
appendicitis, complicated appendicitis and histologically "normal" appendices by 
reviewing the clinical notes on the day of admission to hospital. Therefore, the 
presence of previous episodes of right iliac fossa pain was assessed on 317 patients 
as data was not available on 25 patients. In the acute appendicitis group, 16 (14%) 
patients were found to have previous episodes of right iliac fossa pain.  In the 
complicated appendicitis group, 4 (4%) patients reported to have previous episodes 
of right iliac fossa pain. Moreover, in the histologically "normal" samples 22 (23%) 
patients were found to have previous episodes of right iliac fossa pain. The observed 
differences between the three groups were statistically significant (Table 4.19, graph 
4.19). 
 
The expression of the studied inflammatory markers (TNF-α, IL-6, IL-2R and serotonin) 
as well as the levels of various clinical parameters (WCC, NLR, CRP, severity of pain, 
duration of symptoms, body temperature on admission and highest body 
temperature) were assessed between patients with and without previous episodes 
of right iliac fossa pain in the groups of acute uncomplicated appendicitis, acute 
complicated appendicitis and in patients with histologically "normal" appendices. The 
observed differences between patients with and without previous episodes of right 
iliac fossa pain were not statistically significant in any of the studied parameters. Due 
to multiple statistical testing, a Bonferroni-adjusted p value (0.0035) was applied to 




Table 4.19: Summary of the presence of previous episodes of right iliac fossa pain between the 3 groups of patients. Group I-
patients with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically 
"normal" appendices. Statistically significant difference between the 3 groups was calculated using the Pearson’s Chi-Square 
test. The results were considered as statistically significant when the probability value (p value) was less than 0.05. 
  
Previous episodes of right iliac fossa pain 
Groups 
Number of patients 
assessed 
Number of patients 
with previous episodes of 
RIF pain 
% Pearson’s Chi-Square 
I 112 16 14% 
p<0.001 
II 109 4 4% 
III 96 22 23% 
Total 317 69  
 
 































Table 4.20: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with acute uncomplicated appendicitis due to previous episodes of right iliac fossa pain. Due to multiple 
statistical testing, a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the observed 
difference in the CRP concentrations (*) was not statistically significant.   
 
Previous episodes of RIF pain in uncomplicated appendicitis and other variables 
Variable 
With previous RIF pain 
median (25th -75th) 
Without previous RIF pain 
median (25th -75th) 
p value 
TNF-α 6.0 (2.6-10.4) 5.9 (3.4-9.6) 0.86 
IL-6 
Epithelial 19.0 (1.5-63.7) 8.0 (1.1-52.0) 0.63 
Inflammatory 4.8 (1.9-16.6) 8.3 (3.4-17.7) 0.37 
IL-2R 
Mucosa 44.2 (25.1-84.2) 45.7 (36.0-68.2) 0.60 
Submucosa 61.4 47.5-81.1) 67.8 (50.5-88.5) 0.63 
Serotonin 
ECCs 6.5 (0-45.3) 3.0 (0-27.0) 0.46 
SNCs 0 (0-4.6) 0 (0-2.0) 0.49 
WCC 12.5 (11.0-14.9) 13.7 (11.5-16.2) 0.26 
NLR 7.7 (3.2-10.6) 7.1 (4.6-10.7) 0.66 
CRP 14.5 (5.0-63.0) 40.0 (19.5-95.0) 0.03* 
Severity of pain 8.0 (6.0-10.0) 8.0 (4.0-8.0) 0.25 
Duration of symptoms 2.0 (1.0-3.7) 2.0 (1.0-2.0) 0.08 
Temperature on admission 37.4 (36.8-37.8) 37.1 (36.7-37.6) 0.38 












Table 4.21: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with acute complicated appendicitis due to previous episodes of right iliac fossa pain. Due to multiple 
statistical testing, a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the observed 
differences in the severity of pain and duration of symptoms (*) were not statistically significant. In this group of patients several 
values of CRP concentrations (**) were not available and as result, statistical analysis could not be performed. 
 
Previous episodes of RIF pain in complicated appendicitis and other variables 
Variable 
With previous RIF pain 
median (25th -75th) 
Without previous RIF pain 
median (25th -75th) 
p value 
TNF-α 4.2 (4.1- -) 7.0 (3.5-11.8) 0.57 
IL-6 
Epithelial 50.0 (45.0- -) 51.0 (8.5-103.0) 0.46 
Inflammatory 19.3 (18.0- -) 24.7 (10.0-49.5) 0.70 
IL-2R 
Mucosa 46.2 (44.4- -) 36.5 (25.3-60.4) 0.49 
Submucosa 58.7 (32.1-78.5) 48.4 (30.3-68.5) 0.66 
Serotonin 
ECCs 25.5 (0- -) 0 (0-9.3) 0.22 
SNCs 1.0 (0- -) 0 (0-0) 0.18 
WCC 15.2 (12.7-20.8) 15.2 (12.3-18.5) 0.74 
NLR 6.3 (37-12.9) 10.1 (6.5-15.5) 0.22 
CRP** N/A N/A N/A 
Severity of pain 4.2 (4.0-6.5) 7.0 (4.0-8.0) 0.14 
Duration of symptoms 1.0 (1.0-1.0) 1.0 (2.0-3.0) 0.03* 
Temperature on admission 36.7 (36.2-37.1) 37.4 (37.0-38.0) 0.02* 











Table 4.22: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with histologically "normal" appendices due to previous episodes of right iliac fossa pain. Due to multiple 
statistical testing, a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the observed 
difference in the CRP concentrations (*) was not statistically significant.   
 
Previous episodes of RIF pain in histologically "normal" appendices and other variables 
Variable 
With previous RIF pain 
median (25th -75th) 
Without previous RIF pain 
median (25th -75th) 
p value 
TNF-α 11.4 (7.0-16.1) 9.6 (5.8-15.2) 0.29 
IL-6 
Epithelial 69.0 (7.6-172.5) 74.5 (24.0-130.5) 0.88 
Inflammatory 27.0 (6.1-52.7) 20.5 (11.3-41.2) 0.93 
IL-2R 
Mucosa 27.2 (22.3-43.2) 28.3 (19.5-43.6) 0.85 
Submucosa 16.8 (7.6-31.8) 21.6 (10.4-36.9) 0.40 
Serotonin 
ECCs 33.3 (14.5-113.5) 43.4 (16.3-95.5) 0.96 
SNCs 2.0 (0-6.8) 1.0 (0-4.0) 0.36 
WCC 9.5 (6.3-10.5) 10.2 (7.4-13.3) 0.97 
NLR 1.9 (1.2-4.7) 3.3 (1.7-6.3) 0.73 
CRP 5.0 (5.0-8.7) 7.0 (5.0-48.5) 0.03* 
Severity of pain 8.0 (5.5-10.0) 8.0 (5.0-9.0) 0.51 
Duration of symptoms 2.0 (1.0-3.5) 2.0 (1.0-3.0) 0.62 
Temperature on admission 37.1 (36.6-37.4) 37.1 (36.6-37.6) 0.84 












4.3.12 Localised peritonism  
The presence of localised peritonism in the right iliac fossa was assessed in the groups 
of acute appendicitis, complicated appendicitis and histologically "normal" samples 
by reviewing the clinical notes on the day of admission to hospital. Documentation of 
presence of guarding and/or rebound tenderness by surgical registrars or consultants 
was considered as localised peritonism. The sign of peritonism was assessed on 314 
patients as data was not available on 28 patients. In the acute appendicitis group, 81 
(73%) patients were found to have localised peritonism. In the complicated 
appendicitis group, 79 (73%) patients were found to have peritonism in the right iliac 
fossa. Moreover, in the group of patients with histologically normal appendices, 53 
(56%) patients were found to have localised peritonism on examination. The 
observed differences between the three groups were statistically significant (Table 
4.23, graph 4.20).  
 
The expression of the studied inflammatory markers (TNF-α, IL-6, IL-2R and serotonin) 
as well as the levels of various clinical parameters (WCC, NLR, CRP, severity of pain, 
duration of symptoms, body temperature on admission and highest body 
temperature) were assessed between patients with and without localised peritonism 
in the groups of acute uncomplicated appendicitis, acute complicated appendicitis 
and in patients with histologically "normal" appendices. The observed differences 
between patients with and without the localised peritonism were not statistically 
different in any of the studied parameters. Due to multiple statistical testing, a 




Table 4.23: Summary of the presence of localised peritonism in the right iliac fossa between the 3 groups of patients. Group I-
patients with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically 
"normal" appendices. Statistically significant difference between the 3 groups was calculated using the Pearson’s Chi-Square 
test. The results were considered as statistically significant when the probability value (p value) was less than 0.05.  
 
Presence of localised peritonism 
Groups 
Number of patients 
assessed 
Number of patients 
with localised peritonism 
% Pearson’s Chi-Square 
I 111 81 73% 
p=0.01 
II 108 79 73% 
III 95 53 56% 
Total 314 213  
 
 



































Table 4.24: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with uncomplicated appendicitis due to the presence of localised peritonism in the right iliac fossa. Due 
to multiple statistical testing, a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the 
observed difference in the duration of symptoms (*) was not statistically significant.   
 
Presence of localised peritonism in uncomplicated appendicitis and other variables 
Variable 
With localised peritonism 
median (25th -75th) 
Without localised peritonism 
median (25th -75th) 
p value 
TNF-α 6.0 (3.1-9.9) 5.9 (3.4-8.8) 0.78 
IL-6 
Epithelial 9.0 (1.0-71.5) 7.0 (3.0-51.0) 0.82 
Inflammatory 6.8 (3.0-16.7) 11.6 (1.8-19.0) 0.74 
IL-2R 
Mucosa 47.4 (38.3-67.4) 40.8 (30.8-70.6) 0.26 
Submucosa 67.8 (50.2-89.5) 65.7 (51.4-79.9) 0.60 
Serotonin 
ECCs 4.0 (0-36.0) 2.0 (0-9.0) 0.15 
SNCs 0 (0-2.5) 0 (0-2.0) 0.54 
WCC 13.6 (11.4-16.3) 13.7 (12.2-15.2) 0.99 
NLR 7.4 (4.5-10.7) 6.1 (4.7-9.3) 0.29 
CRP 37.5 (16.0-88.5) 33.0 (5.0-72.2) 0.46 
Severity of pain 8.0 (5.0-9.0) 7.0 (4.0-8.0) 0.20 
Duration of symptoms 2.0 (1.0-3.0) 1.0 (1.0-2.0) 0.02* 
Temperature on admission 37.3 (36.8-37.7) 37.0 (36.7-37.6) 0.13 












Table 4.25: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with complicated appendicitis due to the presence of localised peritonism in the right iliac fossa. The 
observed differences were not statistically significant.  
 
Presence of localised peritonism in complicated appendicitis and other variables 
Variable 
With localised peritonism 
median (25th -75th) 
Without localised peritonism 
median (25th -75th) 
p value 
TNF-α 7.5 (4.2-11.3) 5.9 (3.4-13.6) 0.99 
IL-6 
Epithelial 50.0 (8.7-111.2) 61.0 (8.6-92.0) 0.90 
Inflammatory 24.0 (10.9-50.6) 22.4 (8.6-51.6) 0.84 
IL-2R 
Mucosa 38.4 (25.0-60.7) 35.0 (29.9-44.5) 0.52 
Submucosa 46.6 (29.8-67.0) 55.6 (34.0-77.9) 0.23 
Serotonin 
ECCs 0 (0-12.0) 0 (0-1.5) 0.23 
SNCs 0 (0-0) 0 (0-1.0) 0.74 
WCC 15.1 (11.9-18.0) 15.4 (12.6-19.1) 0.39 
NLR 10.6 (6.4-14.7) 8.5 (6.2-17.9) 0.54 
CRP 85 (21.0-195.0) 73.0 (47.0-162.0) 0.98 
Severity of pain 8.0 (7.0-10.0) 8.0 (7.0-9.0) 0.42 
Duration of symptoms 2.0 (1.0-3.0) 2.0 (1.0-2.0) 0.14 
Temperature on admission 37.4 (37.0-38.0) 37.3 (37.0-37.7) 0.61 













Table 4.26: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with histologically "normal" appendices due to the presence of localised peritonism in the right iliac 
fossa. The observed differences were not statistically significant. 
 
Presence of localised peritonism in histologically "normal" appendices and other variables 
Variable 
With localised peritonism 
median (25th -75th) 
Without localised peritonism 
median (25th -75th) 
p value 
TNF-α 9.7 (6.8-15.3) 9.7 (5.5-14.6) 0.56 
IL-6 
Epithelial 81.0 (19.7-131.0) 70.0 (20.2-142.5) 0.97 
Inflammatory 20.0 (10.2-40.1) 27.0 (11.0-44.3) 0.50 
IL-2R 
Mucosa 30.0 (22.8-45.5) 24.3 (1831-39.9) 0.98 
Submucosa 22.8 (10.2-37.7) 17.0 (7.6-34.5) 0.26 
Serotonin 
ECCs 33.6 (13.1-86.9) 45.5 (1937-115.0) 0.47 
SNCs 1.0 (0-5.4) 1.0 (0-5.2) 0.87 
WCC 10.0 (7.5-12.6) 10.1 (7.2-13.1) 0.82 
NLR 2.9 (1.9-5.8) 2.9 (1.4-8.6) 0.90 
CRP 5.0 (5.0-25.0) 6.0 (5.0-43.7) 0.64 
Severity of pain 8.0 (6.0-10.0) 8.0 (4.0-8.5) 0.20 
Duration of symptoms 2.0 (1.0-3.0) 2.0 (1.0-3.0) 0.50 
Temperature on admission 37.1 (36.6-37.6) 37.1 (36.5-37.5) 0.85 
















4.3.13 Presence of faecolith 
The presence of faecolith was assessed in the acute uncomplicated appendicitis, 
complicated appendicitis and histologically "normal" appendices by reviewing the 
imaging results (USS or CT), the operative record and the histopathology report. 
Therefore, the presence of faecolith was assessed on 317 patients as data was not 
available on 25 patients. In the acute uncomplicated appendicitis group, 12 (10%) 
patients were found to have a faecolith within the lumen of the appendix.  In the 
complicated appendicitis group, 30 (25%) patients were found to have a faecolith 
with the lumen of the appendix. Moreover, 27 (26%) patients were found to have a 
faecolith in the histologically "normal" samples. The observed differences between 
the three groups were statistically significant (Table 4.27, graph 4.21). 
 
The expression of the studied inflammatory markers (TNF-α, IL-6, IL-2R and serotonin) 
as well as the levels of various clinical parameters (WCC, NLR, CRP, severity of pain, 
duration of symptoms, body temperature on admission and highest body 
temperature) were assessed between patients with and without faecolith in the 
groups of acute uncomplicated appendicitis, acute complicated appendicitis and in 
patients with histologically "normal" appendices. The observed differences between 
patients with and without faecolith were not statistically different in any of the 
studied parameters. Due to multiple statistical testing, a new Bonferroni-adjusted p 





Table 4.27: Summary of the presence of faecolith between the 3 groups of patients. Group I-patients with uncomplicated 
appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically "normal" appendices. 
Statistically significant difference between the 3 groups was calculated using the Pearson’s Chi-Square test. The results were 
considered as statistically significant when the probability value (p value) was less than 0.05. 
 
Presence of faecolith 
Groups 
Number of patients 
assessed 
Number of patients 
with faecolith 
% Pearson’s Chi-Square 
I 112 12 10% 
p=0.003 
II 109 30 25% 
III 96 27 26% 
Total 317 69  
 
 

































Table 4.28: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with acute uncomplicated appendicitis due to the presence of faecolith. The observed differences were 
not statistically significant. 
   
Presence of faecolith in uncomplicated appendicitis and other variables 
Variable 
With faecolith 
median (25th -75th) 
Without faecolith 
median (25th -75th) 
p value 
TNF-α 6.8 (3.6-12.2) 5.9 (3.3-9.6) 0.46 
IL-6 
Epithelial 31.5 (731-123.0) 8.0 (1.0-52.0) 0.13 
Inflammatory 8.0 (1.8-26.9) 7.3 (3.0-17.0) 0.85 
IL-2R 
Mucosa 54.5 (32.2-86.5) 45.8 (35.2-68.2) 0.68 
Submucosa 68.4 (41.1-89.5) 67.9 (52.6-87.9) 0.78 
Serotonin 
ECCs 1.0 (0-29.5) 3.0 (0-30.0) 0.57 
SNCs 0 (0-1.5) 0 (0-2.2) 0.36 
WCC 13.6 (11.9-17.7) 13.6 (11.2-16.0) 0.72 
NLR 7.7 (4.8-12.4) 7.1 (4.6-10.6) 0.66 
CRP 58.0 (13.5-120.2) 39.0 (11.5-87.0) 0.54 
Severity of pain 7.5 (4.0-10.0) 8.0 (5.0-8.0) 0.91 
Duration of symptoms 1.0 (1.0-3.5) 2.0 (1.0-2.0) 0.47 
Temperature on admission 37.3 (36.7-37.6) 37.2 (36.8-37.7) 0.97 













Table 4.29: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with acute complicated appendicitis due to the presence of faecolith. Due to multiple statistical testing, 
a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the observed difference in the CRP 
concentrations (*) was not statistically significant.   
 
Presence of faecolith in complicated appendicitis and other variables 
Variable 
With faecolith 
median (25th -75th) 
Without faecolith 
median (25th -75th) 
p value 
TNF-α 7.0 (3.2-11.3) 6.6 (3.7-12.5) 0.39 
IL-6 
Epithelial 65.0 (20.0-135.0) 27.5 (5.7-94.2) 0.64 
Inflammatory 31.1 (18.0-61.1) 20.0 (9.5-39.6) 0.91 
IL-2R 
Mucosa 35.6 (18.4-60.3) 38.4 (26.9-58.4) 0.51 
Submucosa 52.4 (30.5-70.2) 47.0 (31.1-69.5) 0.52 
Serotonin 
ECCs 0 (0-8.7) 0 (0-8.5) 0.74 
SNCs 0 (0-0) 0 (0-0) 0.63 
WCC 14.9 (9.9-18.5) 15.4 (13.1-1834) 0.20 
NLR 9.7 (5.2-16.4) 9.2 (6.4-14.7) 0.79 
CRP 147.0 (72.0-229) 65.5 (20.0-161.5) 0.02* 
Severity of pain 8.0 (7.2-9.0) 8.0 (7.0-10.0) 0.90 
Duration of symptoms 2.0 (1.0-3.0) 2.0 (1.0-2.0) 0.19 
Temperature on admission 37.4 (37.0-38.3) 37.4 (37.0-37.9) 0.43 












Table 4.30: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with histologically "normal" appendices due to the presence of faecolith. Due to multiple statistical 
testing, a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the observed difference in the 
epithelial expression of IL-6 (*) was not statistically significant.   
 
Presence of faecolith in histologically "normal" appendices and other variables 
Variable 
With faecolith 
median (25th -75th) 
Without faecolith 
median (25th -75th) 
p value 
TNF-α 11.2 (6.7-16.1) 9.7 (6.9-14.4) 0.50 
IL-6 
Epithelial 29.5 (11.0-87.0) 82.5 (30.0-150.0) 0.04* 
Inflammatory 20.0 (5.8-42.0) 21.5 (11.5-43.4) 0.33 
IL-2R 
Mucosa 26.4 (19.6-44.4) 27.2 (20.4-39.9) 0.87 
Submucosa 13.6 (7.0-27.0) 21.6 (12.0-39.6) 0.05 
Serotonin 
ECCs 25.0 (13.2-96.0) 53.5 (19.1-112.3) 0.27 
SNCs 1.0 (0-3.0) 2.0 (0-0.6) 0.13 
WCC 9.5 (7.3-11.3) 10.1 (7.0-13.0) 0.89 
NLR 3.3 (1.65-7.1) 2.6 (1.5-5.8) 0.40 
CRP 5.0 (5.0-36.0) 5.0 (5.0-24.0) 0.98 
Severity of pain 8.0 (4.5-10.0) 8.0 (5.0-9.0) 0.72 
Duration of symptoms 2.0 (1.0-3.0) 2.0 (1.0-3.0) 0.68 
Temperature on admission 37.1 (36.7-37.5) 37.1 (36.5-37.5) 0.76 












4.3.14 Intraoperative diagnosis 
The intraoperative impression of the operating surgeons, whether the appendix 
appeared to be inflamed or not, was assessed in the histologically "normal" 
specimens. Expressions such as injected appendix, slightly engorged appendix, hyper-
vascular appendix were classified as inflamed appendix. The intraoperative diagnosis 
was available on 96 patients as data was not available on 8 patients. In 49 (51%) of 
96 patients who subsequently had a histologically "normal" appendix, the operating 
surgeons described the appendix as inflamed (Graph 4.22). 
 
The expression of the studied inflammatory markers (TNF-α, IL-6, IL-2R and serotonin) 
as well as the levels of various clinical parameters (WCC, NLR, CRP, severity of pain, 
duration of symptoms, body temperature on admission and highest body 
temperature) were assessed between patients whose appendix appeared normal 
and those whose appendix appeared inflamed in the groups of acute uncomplicated 
appendicitis, acute complicated appendicitis and in patients with histologically 
"normal" appendices. The observed differences between patients whose appendix 
appeared normal and those whose appendix appeared inflamed were not statistically 
different in any of the studied parameters. Due to multiple statistical testing, a 







Graph 4.22: Intraoperative impression of the histologically "normal" appendices.  
 
Table 4.31: Summary of the differences in the expression of the studied inflammatory markers and the levels of clinical 
parameters in patients with histologically "normal" appendices according to the intraoperative diagnosis. Due to multiple 
statistical testing, a Bonferroni-adjusted p value (0.0035) was applied to control for Type I error. Therefore, the observed 
difference in the highest body temperature pre-operatively (*) was not statistically significant.   
 
Intraoperative diagnosis in histologically "normal" appendices and other variables 
Variable 
Appeared normal 
median (25th -75th) 
Appeared inflamed 
median (25th -75th) 
p value 
TNF-α 8.4 (6.1-12.8) 11 (6.3-16.1) 0.06 
IL-6 
Epithelial 71 (21.0-140.0) 78.0 (18.2-120.0) 0.77 
Inflammatory 21.0 (8.6-43.0) 22.0 (10.7-42.1) 0.94 
IL-2R 
Mucosa 26.2 (1934-39.0) 30.0 (21.4-46.3) 0.20 
Submucosa 21.6 (12.0-30.8) 17.6 (7.4-39.7) 0.80 
Serotonin 
ECCs 61.5 (17.5-116.0) 33.0 (12.1-86.9) 0.97 
SNCs 1.0 (0-6.0) 1.0 (0-4.0) 0.63 
WCC 10.1 (6.9-13.5) 10.0 (7.4-12.3) 0.82 
NLR 4.0 (1.6-6.9) 2.6 (1.5-5.3) 0.15 
CRP 5.0 (5.0-37.0) 5.0 5.0-29.2) 0.76 
Severity of pain 8.0 (6.5-10.0) 8.0 (4.0-8.0) 0.12 
Duration of symptoms 2.0 (1.0-3.0) 2.0 (1.0-3.0) 0.14 
Temperature on admission 36.6 (36.2-37.2) 36.5 (36.2-37.1) 0.36 





















4.3.15 Pre-operative length of stay in hospital 
The number of days of pre-operative stay in hospital was assessed in the groups of 
acute appendicitis, complicated appendicitis and histologically "normal" on a total of 
316 patients as data was not available on 26 patients. The number of days of pre-
operative stay in patients with histologically "normal" (median 1.0, IQ range 1.0-2.0) 
appendices was significantly increased compared with the acute (median 1.0, IQ 
range 0-1.0, p=0.006) appendicitis as well as with the complicated (median 1.0, IQ 
range 0-1.0, p=0.01) appendicitis patients. The number of days of pre-operative stay 
in patients with acute (median 1.0, IQ range 0-1.0) appendicitis did not vary 
significantly compared with complicated (median 1.0, IQ range 0-1.0, p=0.79) 















Table 4.32: Summary of the analysis of the preoperative length of stay in hospital between the 3 groups of patients. Group I-
patients with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically 
"normal" appendices. N represents the number of patients that were included in the analysis. Data is presented with median, 
25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 3 groups was 
calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value (p 
value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 112 1.0 0 1.0 1.0 
0.01 II 108 1.0 0 1.0 1.0 


























































Graph 4.23: Tukey’s boxplots displaying data of the pre-operative length of stay between the 3 groups of patients. Group I-
patients uncomplicated appendicitis, median 1.0, 25th percentile (Q1) 0, 75th percentile (Q3) 1.0, interquartile (IQ) range 1.0; 
Group II-patients with complicated appendicitis, median 1.0, 25th percentile (Q1) 0.0, 75th percentile (Q3) 1.0, interquartile (IQ) 
range 1.0; Group III-patients with histologically "normal" appendices, median 1.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 
2.0, interquartile (IQ) range 1.0. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 





4.3.16 Post-operative length of stay in hospital 
The number of days of post-operative stay was assessed in the groups of acute 
appendicitis, complicated appendicitis and histologically "normal" on a total of 312 
patients as data was not available on 30 patients. The number of days of post-
operative stay in patients with histologically "normal" (median 1.0, IQ range 1.0-2.0) 
appendices was significantly lower compared with the complicated (median 2.0, IQ 
range 1.0-5.0, p<0.001) appendicitis but did not differ significantly compared with the 
acute (median 1.0, IQ range 1.0-3.0, p=0.06) appendicitis patients. The number of 
days of post-operative stay in patients with complicated (median 2.0, IQ range 1.0-
5.0) appendicitis was significantly increased compared with the acute (median 1.0, IQ 
















Table 4.33: Summary of the analysis of the postoperative length of stay in hospital between the 3 groups of patients. Group I-
patients with uncomplicated appendicitis, Group II-patients with complicated appendicitis, Group III-patients with histologically 
"normal" appendices. N represents the number of patients that were included in the analysis. Data is presented with median, 
25th percentile, 75th percentile and the interquartile (IQ) range. Statistically significant difference between the 3 groups was 
calculated using the Kruskal-Wallis H test. The results were considered as statistically significant when the probability value (p 
value) was less than 0.05.  
 
Groups N Median 25th 75th IQ range p value 
I 111 1.0 1.0 3.0 2.0 
<0.001 II 105 2.0 1.0 5.0 4.0 



























































Graph 4.24: Tukey’s boxplots displaying data of the post-operative length of stay between the 3 groups of patients. Group I-
patients uncomplicated appendicitis, median 1.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 3.0, interquartile (IQ) range 2.0; 
Group II-patients with complicated appendicitis, median 2.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 5.0, interquartile (IQ) 
range 4.0; Group III-patients with histologically "normal" appendices, median 1.0, 25th percentile (Q1) 1.0, 75th percentile (Q3) 
2.0, interquartile (IQ) range 1.0. Median: line through the box, Q1: upper hinge, Q2: lower hinge, IQ range: difference between 




CHAPTER 5: Discussion 
This study showed that different levels of expression of immune markers were well 
described with immunohistochemistry techniques in formalin-fixed and paraffin 
embedded appendix specimens. The pathology of the specimens varied significantly 
from complicated appendicitis (perforation or gangrene) to histologically "normal" 
samples resected from patients with suspected appendicitis in order to cover the 
entire inflammatory spectrum of the disease. The studied markers were chosen due 
to their key role in the inflammatory process as well as intestinal nociception. Their 
expression was assessed in the context of new evidence on their actions that has 
recently emerged.  Our experimental findings were supported by clinical data on the 
same patients. This study provided clear evidence that there were profound 
differences in the clinical presentation of patients with different aspects of the 
disease.  
 
The use of immunohistochemistry was decided as it is a robust tool for gaining more 
information on tissue specimens compared with the conventional histological 
examination. Immunohistochemistry examines protein expression and therefore 
provides information on the final product of a certain gene. A higher gene expression 
in a given situation does not always imply that the final protein will also be highly 
expressed. This is due to the RNA interference system that is able to silence gene 
expression at the mRNA level. Immunohistochemistry also has the advantage of 
demonstrating the location of the protein within the tissue architecture and it is more 
economical and convenient for clinical purposes compared with PCR [248-251]. 
Therefore, one could advocate that the use of immunohistochemistry was an 
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excellent and valid tool of examining the expression of inflammatory markers within 
the appendiceal tissue as provided information on protein expression combined with 
the location of the protein and it was easily reproducible and economical compared 
to gene analysis especially in a study with a large sample size such as this.   
 
Despite the fact that acute appendicitis is the commonest surgical emergency, its 
diagnosis continues to be very challenging as, on one hand, it remains primarily 
clinical and, on the other, many patients present with atypical clinical picture. In 
addition to the diagnostic dilemma, the significant increase in morbidity and even 
mortality due to delay in treatment has led surgeons to perform early 
appendicectomy in patients with possible appendicitis. Although the introduction of 
this practice has resulted in a decrease of complications due to delays in the 
management of the patient, it did increase the number of histologically "normal" 
appendices removed from patients with a clinical picture of acute appendicitis. In the 
laparoscopic era, diagnostic laparoscopy has been employed to reduce the so called 
by clinicians "negative or unnecessary" appendicectomy.  However, surgeons are 
often puzzled by the conflicting finding of a macroscopically normal appendix in a 
patient with strong clinical suspicion of appendicitis. Therefore, the dilemma of 
removing normal looking appendices from patients with right iliac fossa pain remains 
and the decision rests with the surgeon’s discretion in the absence of formal guidance 
or policy. In addition to the aforementioned clinical dilemma, the observation that 
appendicectomy relieves symptoms in most patients who subsequently found to 
have a histologically "normal" appendix may suggest the existence of an unknown 
pathology. This study has investigated the discrepancy between the clinical and 
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histological diagnosis and has shown that not only the degree of inflammatory 
response can vary significantly but also the histologically "normal" appendices 
removed from patients with right iliac fossa pain exhibit abnormal levels of cytokine 
expression. 
 
The crucial role of serotonin in the pathogenesis of intestinal inflammation is widely 
acceptable [133, 161, 202, 205, 270, 271]. In this study, the serotonin contents of 
neuroendocrine cells were examined in appendices obtained from patients with 
clinical diagnosis of acute appendicitis. Immunostaining for serotonin revealed 
enterochromaffin cells in the crypts of the epithelium and subepithelial 
neuroendocrine cells in the lamina propria located close to the crypts in all four 
groups of the study. This study demonstrated that histologically proven inflamed 
appendices were noticeably depleted of serotonin in both the epithelium 
(enterochromaffin cells) and lamina propria (subepithelial neuroendocrine cells) 
when compared with histologically "normal" and control samples. Serotonin 
contents of the histologically "normal" appendices did not differ significantly from 
the control group. Our results were in agreement with the results reported by Vasei 
et al. [133] who also found that inflamed appendices were severely depleted of 
serotonin and histologically "normal" appendices from symptomatic appendices did 
not exhibit significant changes compared with the control group. However, our 
results and those reported by Vasei et al. [133] were in contrast with the results 
published by Dhillon et al. [152] who reported reduction in the serotonin 
immunostaining in subepithelial neuroendocrine cells and enterochromaffin cells of 
histologically "normal" appendices removed from symptomatic patients. Vasei et al. 
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[133], also investigated the serotonin contents of appendices with follicular 
hyperplasia and reported to be reduced compared with the control group. According 
to the authors, in the early stages of the inflammatory process such as follicular 
hyperplasia, serotonin excretion from neuroendocrine cells increases and might lead 
to histologically proven acute appendicitis.  
 
In addition to the aforementioned findings, this study investigated the serotonin 
contents of specimens with complicated appendicitis (perforation or gangrene) 
which represents the most advanced stage of the inflammatory process. Interestingly, 
significantly less serotonin was observed in the neuroendocrine cells of appendices 
with perforation or gangrene compared with the uncomplicated samples. Given the 
fact that serotonin can act as a potent vasoconstrictor through 5-HT1 and 5-HT2β 
receptors [272], the finding of significantly reduced contents of serotonin in the 
neuroendocrine cells of patient with complicated acute appendicitis could imply that 
serotonin released by the ECC and SNCs in the interstitial tissue, could play an active 
role in the pathogenesis of ischaemia and subsequent necrosis or perforation of the 
appendiceal wall.   
 
It is supported that enterochromaffin cells are able to sense the increased 
intraluminal pressure due to accumulated mucosal secretions following obstruction 
and respond by releasing serotonin [188, 273]. Serotonin is also a potent intestinal 
secretory mediator which further aggravates intraluminal secretions worsening the 
already increased intraluminal pressure [188]. However, according to the data 
presented in this thesis, 25% of the patients with complicated acute appendicitis 
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were found to have evidence of a faecolith within their appendix but the serotonin 
contents of neuroendocrine cells were not different between appendices with 
faecoliths and those without faecoliths. In a similar way, in the group of patients with 
acute uncomplicated appendicitis there was not any difference in the serotonin 
contents of appendices with and without the presence of faecolith within their lumen 
despite the fact that only 10% of patients with uncomplicated appendicitis had 
evidence of faecolith in their appendices. To the best of our knowledge there is not 
any previously published study to examine the serotonin contents in appendices with 
and without faecoliths in both complicated and uncomplicated appendicitis. The 
findings of this study could not support the theory according to which 
neuroendocrine cells respond to increased intraluminal pressure by releasing 
serotonin as the presence of faecolith within the appendiceal lumen did not change 
the observed levels of serotonin contained by the neuroendocrine cells.  
 
Moreover, the reported interactions of serotonin with other inflammatory markers 
such as IL-1β, IL-6 and TNF-α, could also indicate that serotonin plays a central role in 
the pathogenesis of appendicitis. In the present study it was observed that the group 
of patients with complicated appendicitis who demonstrated to have 
neuroendocrine cells severely depleted of serotonin compared to patients with 
uncomplicated appendicitis were also found to have significantly increased epithelial 
IL-6 expression. However, the TNF-α expression between the two groups of patients 
did not differ significantly. Moreover, serotonin is known to enhance the phagocytic 
activity of macrophages as well as promote recruitment of inflammatory cells. This 
could potentially be reflected in the observation of significantly increased white cell 
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and neutrophil count in the blood of patients with complicated appendicitis 
compared with those with uncomplicated appendicitis. This work also demonstrated 
that patients with complicated appendicitis had significantly increased body 
temperature pre-operatively as well as increased white cell count and CRP. These 
findings could potentially be attributed to the enhanced expression of IL-6 due to 
increased interstitial serotonin, as IL-6 is a well-known pyrogen and is also able to 
promote the expression of acute phase proteins as well as proliferation of 
inflammatory cells [274-277]. On the other hand, in either group of complicated or 
uncomplicated acute appendicitis the serotonin contents of neuroendocrine cells did 
not seem to be directly linked to the presence of localised peritonism or previous 
episodes of right iliac fossa pain. Given the observed difference in serotonin contents 
between patients with complicated and uncomplicated appendicitis, as well as its 
ability to enhance the recruitment of inflammatory cells and the expression of potent 
pro-inflammatory mediators in combination with effective vasoconstriction [188, 
273], it could be hypothesised that neuroendocrine cells and serotonin could be able 
to divert an insult to the appendiceal mucosa to a fully blown inflammatory process 
leading to necrosis.  
 
With regards to histologically "normal" appendices and their serotonin contents in 
the enterochromaffin cells being similar to that of the control group, it could be 
hypothesised that the enterochromaffin cells of the appendiceal mucosa were not 
activated and, therefore, serotonin was not released into the bloodstream or 
interstitial tissues [92, 95, 192-194]. As serotonin is known to be one of the factors to 
promote recruitment of inflammatory cells, the unreleased serotonin in the 
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histologically "normal" appendices could be one of the reasons to explain the 
absence of neutrophil infiltration as it was evident on conventional microscopy. The 
stored serotonin in the enterochromaffin cells could not exhibit its vasoconstrictive 
action either [188, 273]. Moreover, since enterochromaffin cells are able to sense an 
increased intraluminal pressure, serotonin contents similar to normal could imply a 
normal intraluminal pressure. Interestingly, 26% of the histologically "normal" 
appendices had evidence of faecolith within their lumen. Thus, it could be speculated 
that either the appendicectomy was performed early and there was not enough time 
for the intraluminal pressure to rise or the presence of faecoliths was not enough to 
cause obstruction of the lumen which eventually would lead to the development of 
acute appendicitis.  However, the clinical data of this work revealed that the duration 
symptoms in patients with histologically "normal" appendices was not statistically 
different from that of patients with inflamed samples and the pre-operative length 
of stay of patients with histologically "normal" appendices was significantly longer 
compared with that of patients with inflamed samples. Hence, one could advocate 
that in patients with histologically "normal" appendices, the appendicectomy was 
performed at a slightly later stage compared with patients with inflamed samples. As 
a result, the intraluminal obstruction should have been well established and the 
serotonin contents significantly reduced in patients with faecoliths. However, the 
difference in the serotonin contents between patients with and without faecolith was 
not statistically significant. Another interesting observation was that 25% of the 
patients with complicated appendicitis also had evidence of faecolith, however the 
findings on conventional microcopy were entirely different compared with those of 
patients with histologically "normal" appendices. Therefore, these findings could 
229 
 
imply that either the histologically "normal" appendices might not represent an early 
stage of acute appendicitis or the presence of faecolith could not be the initial 
stimulus that would eventually lead to acute appendicitis.   
 
The serotonin contents of the subepithelial neuroendocrine cells were also examined 
in this thesis. Despite the fact that statistically notable differences were documented 
between the 4 different groups of patients, the number of subepithelial 
neuroendocrine cells was extremely small. Therefore, the statistical analysis might 
not have provided accurate results that could be used to explain the involvement of 
the subepithelial neuroendocrine cells in the pathogenesis of appendicitis. 
Nevertheless, the expression of interleukins with a key role in the intestinal 
inflammation and nociception was also investigated. Various levels of expression of 
TNF-α, IL-6 and IL-2R have been well demonstrated with immunohistochemistry. 
 
The vast majority of cells stained by the anti-TNF-α antibody was macrophages 
located in the lamina propria of the appendiceal mucosa. The expression of TNF-α in 
specimens with histologically confirmed acute appendicitis, either complicated or 
uncomplicated was significantly higher compared with the control. The difference in 
TNF-α expression between samples with complicated and uncomplicated acute 
appendicitis was not statistically significant. The results of this thesis were in 
agreement with those reported by Wang et al. [129] who demonstrated intense 
cellular TNF-α mRNA expression in the germinal centres and moderate expression in 
the mucosa. The authors did not detect important differences between samples with 
suppurative and non-suppurative appendicitis. However, in this study, a significantly 
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increased TNF-α expression in the histologically "normal" specimens was observed 
compared with the acutely inflamed samples, whereas Wang et al. [129] reported 
that 7 of the 31 histologically "normal" appendices demonstrated similar TNF-α 
mRNA expression to the acute appendicitis specimens. On the other hand, in a study 
that involved 18 paediatric appendices, Murphy et al. [165], demonstrated that the 
gene expression of TNF in patients with acute appendicitis (mild or severe) did not 
vary significantly compared with the control samples. The study included only two 
histologically "normal" specimens. The discrepancy between the results of this thesis 
and those reported by Wang et al. and Murphy et al. could be attributed to the small 
number of patients involved in these studies.  Wang et al. recruited 53 patients and 
Murphy et al. 18 patients whereas in this study TNF-α expression was assessed on 
417 patients. However, it is appreciated that either gene analysis or in situ 
hybridisation using cDNA probes are time-consuming techniques involving complex 
protocols. Moreover, both studies were conducted on paediatric samples whereas 
the present study examined the expression of the inflammatory markers in adults. 
Despite the discrepancy in the results, both this study and that of Wang et al. 
demonstrated elevated levels of TNF-α in histologically "normal" appendices 
suggesting the presence of an inflammatory process. Another factor that could 
influence the outcome of each study and possibly explain the discrepancies between 
the studies was the different research method that was used in each study. In the 
present study, immunohistochemistry was chosen to assess the expression of 
different inflammatory mediators, and it differed significantly from gene expression 
or PCR as it assessed the final product of the gene expression.  The higher expression 
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of a particular gene is not always linked to a higher protein level as gene expression 
can be silenced at mRNA level.   
 
In a similar way, expression of IL-6 showed significant differences between the groups 
of the study. To the best of our knowledge, this was the first study to explore IL-6 
expression in appendiceal tissue. It was observed that both epithelial and 
inflammatory cells of complicated appendicitis samples expressed significantly 
increased IL-6 compared with control and acute appendicitis samples. However, IL-6 
expression between the control samples and those demonstrating features of acute 
appendicitis did not differ significantly for either epithelial or inflammatory cells. 
Interestingly, epithelial cells demonstrated significantly increased IL-6 expression in 
histologically "normal" appendices compared with the control and complicated 
appendicitis samples. On the other hand, non-epithelial IL-6 expression did not differ 
significantly from the complicated appendicitis group.  
 
This study also demonstrated that different levels of IL-2R expression can be well 
described with immunohistochemistry. It was demonstrated that specimens with 
histologically confirmed appendicitis showed significantly increased IL-2R expression 
compared with histologically "normal" and control samples. However, complicated 
appendicitis samples expressed significantly more IL-2R compared with the non-
complicated appendicitis specimens. Histologically "normal" appendices resected 
from patients with suspected appendicitis expressed significantly more IL-2R 
compared with the control samples but significantly less compared with the 
histologically confirmed inflamed specimens (either complicated or uncomplicated). 
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Wang et al. [129] investigated the expression of IL-2 in appendices using in-situ 
hybridisation. They reported that large numbers of IL-2 mRNA expressing cells were 
found in the lamina propria of all histologically confirmed appendices. This finding 
was in agreement with that of the present study, however, Wang et al. did not detect 
significant difference in the IL-2 mRNA expression between samples with suppurative 
and non-suppurative appendicitis. As for TNF-α, the authors reported that 7 of the 
31 histologically "normal" appendices were found to express IL-2 mRNA similar to the 
acutely inflamed appendices. In this study IL-2R expression was notably increased in 
the histologically "normal" appendices but not as high as the acutely inflamed 
samples.  
 
The finding of increased TNF-α, IL-6 and IL-2R in the histologically confirmed inflamed 
appendices could be easily explained as it has been shown that all these three 
markers play a crucial role in the acute inflammatory response [165, 221, 227-229, 
278, 279]. Abnormal growth of intestinal bacteria causes damage to the epithelial 
barrier allowing increased bacterial translocation [280]. Lipopolysaccharides are 
important membrane components of the Gram negative bacteria and given the 
predominance of the Gram negative bacteria in the GI tract, lipopolysaccharides form 
primary targets for the immune system to recognise [228]. Bacterial endotoxins can 
trigger the innate immune response through communication with antigen presenting 
cells (macrophages and dendritic cells) [281]. Activated macrophages are known to 
produce IL-1β, a potent pro-inflammatory mediator, which is able to upregulate the 
expression of the very important pro-inflammatory cytokines such as TNF-α and IL-6, 
further promoting intestinal inflammation [282-286]. Moreover, antigen presenting 
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cells of the intestinal lamina propria are capable of presenting antigens to B and T 
lymphocytes leading to activation of the adaptive immunity [281]. Once T lymphocyte 
activation is facilitated by its antigen receptor, IL-2 is rapidly synthesised [281, 287]. 
This is succeeded by expression of the IL-2 receptor, hence the IL-2/IL-2R interaction 
promotes quick proliferation of the activated T lymphocytes [288] . IL-2 along with IL-
15 also stimulates proliferation of natural killer cells and together with IL-12 enhances 
their cytotoxic activity [289-292]. In a similar way to T lymphocytes, IL-2 stimulates 
expression of IL-2R in B lymphocytes, further enhancing their sensitivity to IL-2,  
promoting antibody secretion from the activated B lymphocytes [293, 294]. 
Therefore, IL-2 could act synergistically with other cytokines in order to affect various 
cells types for the optimal immune response to be achieved. 
 
The finding of increased TNF-α and IL-6 expression in the complicated appendicitis 
samples compared with the uncomplicated acute appendicitis samples could reflect 
a much more prolonged inflammatory status due to the fact that it was not treated 
early. However, clinical data on patients included in this study did not demonstrate 
significant difference in the duration of the symptoms between patients with 
uncomplicated and complicated acute appendicitis. Therefore, complicated acute 
appendicitis could also represent a much more severe inflammatory response 
suggesting a different immunopathogenesis between complicated and 
uncomplicated appendicitis.  
 
The striking finding of significantly increased IL-6 expression in the specimens with 
complicated appendicitis compared with uncomplicated appendicitis samples could 
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be one of the factors to explain the difference in severity of the inflammatory process 
between the two entities [295-299]. It has been shown that IL-6 is a potent pro-
coagulant cytokine stimulating tissue factor (TF) mRNA expression [278]. As a result, 
it could be suggested that increased IL-6 expression could promote local thrombosis 
which could subsequently lead to tissue hypoxia and eventually to gangrene and/or 
perforation of the appendiceal wall.  Increased IL-6 expression has been linked with 
the severity of the inflammatory process as De Hooge et al. [299] reported that 
homozygosity for the IL-6 -174 G-allele was responsible for increased risk of severe 
juvenile arthritis in humans. Moreover, Rivera-Chavez et al. [297] proposed that the 
IL-6-174 single nucleotide polymorphisms (SNPs) could enhance the expression of IL-
6, which in turn could contribute to the severity of acute appendicitis. Ruber et al. 
[295, 300] detected increased levels of the pro-inflammatory cytokines IL-6 and IL-17 
in the plasma of patients with gangrenous appendicitis. On the other hand, Murphy 
et al. [165] demonstrated that the expression of IL-17 was very low in the mild and 
severe acute appendicitis patients. Therefore, although there is strong evidence to 
support that appendicitis is not characterised by Th1 or Th2 immune response, the 
evidence regarding Th17 immune response is conflicting and there is need for further 
research. 
 
TNF-α has also been shown to be a potent pro-inflammatory mediator that has been 
linked with the severity of the inflammatory response. In patients of Hispanic origin 
TNF-α-308 A-allele has been associated to complicated appendicitis but not to 
uncomplicated [229]. TNF-α can also promote local thrombosis and subsequent 
necrosis as it has been demonstrated to promote Tissue factor (TF) expression and 
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decrease the expression of TF expression inhibitors [301]. However, the differences 
in the expression of TNF-α between patients with complicated and uncomplicated 
acute appendicitis were not statistically significant. Therefore, TNF-α in acute 
appendicitis could act synergistically with other cytokines and might not be as crucial 
as that of IL-6 in the development of complicated acute appendicitis.  
 
The clinical data of this study also provided substantial evidence of the severity of the 
inflammatory process in patients with complicated appendicitis. The patients of this 
group were found to have significantly higher body temperature in the pre-operative 
period. Moreover, their white cell count and CRP were also significantly higher 
compared to patients with uncomplicated appendicitis. As discussed earlier, the high 
body temperature could be attributed to the increased expression of IL-6, which is a 
well-known pyrogen [274]. IL-6 is also able to promote the expression of acute face 
proteins as well as proliferation of inflammatory cells [274, 275, 277, 302, 303]. 
Interestingly, the expression of IL-6 in the group of uncomplicated acute appendicitis 
was very similar to that of the control samples as it did not differ statistically. Another, 
striking finding was that the duration of the symptoms between patients with 
complicated and uncomplicate acute appendicitis did not vary significantly. 
Moreover, the severity of pain was found to be significantly higher in patients with 
complicated appendicitis but the presence of localised peritonism did not differ 
between the two groups of patients. On the other hand, previous episodes of right 
iliac fossa pain were only reported by 4% of the patients with complicated 
appendicitis whereas 14% of the patients with uncomplicated appendicitis reported 
previous right iliac fossa pain. In none of the two groups of patients with previous 
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episodes of right iliac fossa pain or presence of localised peritonism the expression of 
the studied inflammatory mediators or any of the clinical parameters was affected.  
Finally, a faecolith was found in 25% of patients with complicated appendicitis and in 
only 10% of patients with uncomplicated appendicitis which was statistically 
significant. Interestingly, the presence of faecolith in patients with either complicated 
or uncomplicated acute appendicitis did not affect the expression of any of the 
studied inflammatory markers or the clinical parameter that were examined. The 
results of this study on the clinical data between the two groups of patients could 
outline some fundamental differences in the presentation as well as the severity of 
the immune response in each of the two entities of the inflammatory spectrum of 
acute appendicitis.  
 
The finding of IL-6 expression being significantly higher in the complicated acute 
appendicitis samples compared to those with uncomplicated appendicitis and the IL-
6 expression of the uncomplicated acute appendicitis samples being very similar to 
that of the normal samples, combined with the clinical data that showed no 
difference in the duration of symptoms to suggest acute appendicitis could possibly 
indicate that some aspects of the immunopathogenesis of the two entities are 
different. This could be further supported by the findings on the severity of pain 
which was significantly higher in the complicated acute appendicitis patients and the 
presence of faecolith which was significantly higher in patients with complicated 
appendicitis. Therefore, complicated appendicitis could not just be the progression 
of an inflammatory process that was left untreated but an entity with different 
immunopathogenesis from that of uncomplicated acute appendicitis.  
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This concept could be supported by an epidemiological study which revealed that 
complicated and uncomplicated acute appendicitis have followed completely 
different epidemiological trends from 1970 to 2004 [279]. Complicated appendicitis 
showed a slow increase in incidence, whereas uncomplicated appendicitis followed 
a U-shaped curve. Therefore, if complicated appendicitis was the consequence of 
delayed management, the trends of the two entities should have been almost parallel 
during the course of the period that they were studied  [279].  
 
On the other hand, given the fact that not only the expression of IL-6, but also the 
expression of TNF-α and IL-2R, was significantly increased in both groups of 
histologically proven acute appendicitis compared to normal tissues, it could also be 
hypothesised that a uniform inflammatory response between complicated and 
uncomplicated acute appendicitis could be present, but at some crucial point during 
the inflammatory response the expression of key inflammatory markers could either 
be selectively upregulated or downregulated to the extent that tissue ischaemia 
ensues which will eventually lead to perforation or gangrene. The presence of 
faecolith within the appendiceal lumen could be one of the factors to lead to necrosis. 
However, the presence of faecolith did not affect the expression of any of the studied 
inflammatory markers or clinical parameters within each group of patients.  
 
Murphy et al. [165] provided some evidence to support this theory. The gene profiles 
that the researchers studied appeared to be very similar in both mild and severe 
appendicitis with the vast majority of the genes that were differentially expressed in 
the mild group, were also differentially expressed in the severe appendicitis group. 
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Therefore, it was demonstrated that a core set of genes was activated at all samples 
irrespective of the degree of inflammation suggesting that there was a uniform 
inflammatory response underlying the pathogenesis of appendicitis. However, 
despite the fact that Murphy et al. [165] were able to demonstrate high expression 
of IL-1 which is a potent proinflammatory mediator, there was no detectable 
induction of TNF.  
 
In this study, although the expression of TNF-α was significantly increased compared 
with the control samples it did not differ compared with samples that had evidence 
of gangrene or perforation. These findings could indicate that despite the very similar 
histological findings in different degrees of inflammation in the acute appendicitis 
spectrum, the actual inflammatory response might be a highly specific process with 
the activation of different inflammatory pathways. However, further research is 
required to identify potential stimuli that would steer the inflammatory process 
towards gangrene or perforation. Although obstruction of the appendiceal lumen 
followed by bacterial overgrowth, increased luminal pressure and subsequent tissue 
ischaemia and eventually necrosis, is generally considered as one of the triggering 
factors of the disease, there is limited amount of evidence to support or refute this 
theory.  The current study demonstrated that 25% of the patients with complicated 
appendicitis had evidence of faecolith in their appendices compared to 10% of 
patients with uncomplicated appendicitis, but neither the expression of the studied 
inflammatory markers nor the clinical parameters that were investigated varied 
significantly between patients with or without faecoliths. Murphy et al. [165] 
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provided similar results as the cytokine expression did not differ between patients 
with and without faecoliths.  
 
Based on the data provided by the current study combined with the very limited 
previously published evidence, one could advocate that the immunopathogenesis of 
complicated appendicitis could be at least partly different form that of uncomplicated 
appendicitis and not just progression of the disease. It could also be supported that 
specific inflammatory markers might be differentially regulated and eventually tissue 
ischaemia ensues. Moreover, the presence of faecolith within the appendiceal 
mucosa might not be such an important factor that could lead to ischaemia as it has 
been thought to be. However, further research is required to strengthen or dispute 
this theory. 
 
This study also provided new evidence regarding the group of histologically "normal" 
appendices resected from patients with a diagnosis of acute appendicitis as it was 
demonstrated that all the studied cytokine markers were notably increased in this 
group of patients. More specifically, the TNF-α expression in the histologically 
"normal" appendices was significantly increased compared with the normal as well 
as histologically proven inflamed appendices. The histologically "normal" appendices 
also demonstrated significantly increased IL-6 expression in the epithelial cells 
compared with the control and the inflamed samples, either complicated or 
uncomplicated. The mucosal and submucosa IL-2R expression of the histologically 
"normal" specimens was significantly increased compared to the control appendices 
but it did not reach the levels of the expression observed in the inflamed samples.  
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The increased expression of both TNF-α and IL-6 which have been shown to be potent 
pro-inflammatory cytokines could suggest the potential disruption of the integrity of 
the appendiceal mucosa and the subsequent evasion of bacterial pathogens such as 
lipopolysaccharides. This would lead to activation of the host defense response as 
part of the innate immunity. This finding taken together with the increased 
expression of IL-2R which is expressed at a slightly latter stage as described previously, 
could suggest a fully activated immune system. The presence of a fully activated 
immune system would give rise to signs and symptoms of varying severity to suggest 
an ongoing inflammatory response. Indeed, this study demonstrated that patients 
who were subsequently found to have histologically "normal" appendices presented 
with the clinical picture of acute appendicitis. Interestingly, the severity of pain as 
well as the presence of nausea/vomiting in patients with histologically "normal" 
appendices did not vary significantly compared with patients with inflamed 
appendices. More than half of the patients with histologically "normal" appendices 
also had features of peritonism on clinical examination. Therefore, according to the 
data of this thesis, the clinical presentation of patients with a subsequently 
histologically "normal" appendix was very similar to that of patients with 
histologically confirmed acute appendicitis which could also be due to an activated 
immune system. 
 
The findings of this study on the expression of the studied inflammatory markers 
could indicate the presence of an inflammatory response at such an early stage where 
there was no evidence of neutrophilic infiltration, which is the hallmark of acute 
inflammation on conventional microscopy. This could be supported by the 
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observation that although IL-2R expression was increased, as it is involved in 
regulating the immune response by promoting lymphocyte proliferation, it did not 
reach as high levels as of that observed in the inflamed samples. The results on the 
clinical data could further support this, as the neutrophil count in patients with 
histologically "normal" appendices apart from being significantly lower compared to 
that in the group of patients with inflamed samples, it was very similar to that of the 
control group. Moreover, the lymphocyte count in the group of patients with 
histologically "normal" appendices was significantly higher compared with any of the 
other group of patients.  
 
It could also be speculated that TNF-α and IL-6 expression was at higher levels during 
the very early stages of the inflammatory process when the antigen presentation 
took place. This could explain the interesting finding of increased TNF-α and epithelial 
cell IL-6 expression in the histologically "normal" appendices compared with the 
histologically proven acutely inflamed samples. The presence of faecolith in 27% of 
the histologically "normal" samples could be at least partially in agreement with this 
as the complicated appendices also featured faecoliths in 28% and the inflammatory 
cell expression of IL-6 between the histologically "normal" and complicated 
appendicitis samples did not differ. These findings could indicate that the initial insult 
to the appendiceal mucosa by the increased intraluminal pressure due to faecolith 
and the subsequent bacterial overgrowth caused a significant rise in the expression 
of both TNF-α and IL-6 as both cytokines have been shown to be part of the innate 




The theory that histologically "normal" appendices resected from symptomatic 
patients could represent an inflammatory response at a very early stage could be 
supported by the findings of Murphy et al. [165] who reported changes in 
inflammatory gene expression before cellular infiltration was present in the 
appendiceal mucosa. Therefore, the findings of this work on the studied cytokines as 
well as the clinical data, taken together with the existing evidence on gene expression, 
could suggest that most of the appendices with an inflammatory process evident only 
at a molecular level, might progress to microscopically typical appendicitis if left 
untreated. On the other hand, such an early inflammatory process could possibly 
resolve spontaneously.  
 
The caveat of this theory was that it could not explain several aspects of the clinical 
presentation of patients with histologically "normal" appendices. An inflammatory 
response at a very early stage in combination with absence of structural damage to 
any of the anatomical layers of the appendiceal wall in patients with histologically 
"normal" appendices would be extremely difficult to give rise to abdominal pain of 
such severity as of that reported by patients with perforated appendicitis. Moreover, 
it would be very challenging to explain why the duration of the symptoms before 
patients with histologically "normal" appendices presented themselves to the 
medical team was very similar to those with histologically proven inflamed samples. 
However, the most intriguing finding that this theory could not really explain was the 
presence of previous episodes of right iliac fossa pain to a significant proportion of 
patients with histologically "normal" appendices. It was found that 23% of patients 
with histologically "normal" appendices experienced several episodes of right iliac 
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fossa pain prior to admission whereas that proportion was 4% and 14% of patients 
with complicated and uncomplicated acute appendicitis respectively. Furthermore, a 
very early inflammatory response that could potentially develop into a 
microscopically evident acute inflammation could not justify a high lymphocyte count 
as this is an indication of a chronic inflammatory status. Finally, according to the data 
presented in this thesis on the presence of faecolith, the proportion of patients with 
faecolith and histologically "normal" appendices was not different to that of patients 
with complicated appendicitis. This finding taken into consideration with the very 
similar duration of symptoms between the different groups of patients, one could 
raise the question why the early inflammatory response did not develop into 
microscopically evident inflammation. Therefore, the interpretation that 
histologically "normal" appendices resected from symptomatic patients could exhibit 
features of such an early inflammatory status that was only evident at a molecular 
level could not account for several aspects of the clinical presentation of those 
patients. Finally, another factor that could refute this theory was that, 
immunohistochemistry, in contrary to gene analysis, assessed the final product of 
gene expression that was biologically active within the tissue and not just the 
expression of certain genes that could be muted at some point downstream. Thus, 
the findings of this study could suggest that the level of the inflammatory process in 
histologically "normal" appendices was beyond molecular level.  
 
Contrary to the widely accepted perception according to which the initial response 
to local infection is pro-inflammatory, recent evidence suggested that many features 
of the acute phase response could be anti-inflammatory as suppression of the 
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inflammatory response has been shown to be beneficial for the host [296].  Rivera-
Chavez et al. [296] described the cytokine profile in the peritoneal fluid and plasma 
of patients with histologically proven appendicitis and demonstrated that peritoneal 
response was characterised by increased expression of both pro- and anti- 
inflammatory cytokines whereas the plasma (systemic) cytokine profile appeared to 
be primarily anti-inflammatory.  
 
As mentioned in the introduction, IL-6 is not only an important pro-inflammatory 
mediator but it can also exhibit anti-inflammatory properties in both local and 
systemic anti-inflammatory responses [223]. It has been shown that during 
endotoxemia the absence of IL-6 resulted in a significantly higher circulating level of 
pro-inflammatory cytokines such as MIP-2, IFN-γ and TNF-α as these cytokines have 
been implicated in the elicitation of toxic syndromes [223]. This was further 
supported by the finding that IL-6 was able to restrict recruitment of neutrophils 
promoting their replacement by mononuclear cells steering the inflammatory 
response towards chronicity [229]. Evidence suggested that this transition was 
directed by IL-6 trans signalling [227, 228].  
 
Moreover, there is evidence to support that TNF-α also has anti-inflammatory 
properties [221, 280]. Noti et al. [221] reported that, during acute intestinal 
inflammation, TNF-α promoted the release of intestinal glucocorticoids which in turn 
can control the activation of intestinal T lymphocytes. Furthermore, TNF-α has been 
shown to induce apoptosis of immune and non-immune cells [306, 307]. Although 
TNF-α-induced apoptosis of T lymphocytes was shown to help terminate or control 
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intestinal inflammation, apoptosis of epithelial cells compromised the integrity of the 
intestinal barrier even further allowing constant activation of intestinal immune cells 
with luminal antigens [217, 306].  
 
This could be supported by the finding of elevated IL-2R expression in the 
histologically "normal" appendices, as IL-2 expression is transient and depends on 
sustained antigenic stimulation [238]. IL-2 and IL-2R are known to be crucial for the 
maintenance of immune homeostasis as shown in studies using IL-2 and IL-2R 
knockout mice. IL-2 apart from playing a significant role in the expansion of activated 
lymphocytes it has been shown to be a vital cytokine in downregulating immune 
responses [240, 308]. Moreover, studies have demonstrated that a major function of 
the IL-2/IL-2R system is associated with the development and function of T regulatory 
cells [309].   
 
Therefore, one could advocate that the markedly increased expression of IL-6 and 
TNF-α in the histologically "normal" appendices could indicate an anti-inflammatory 
profile of the immune response. The anti-inflammatory response could aim to 
suppress an either abnormally long or abnormally regulated inflammatory response. 
IL-2 could act synergistically with IL-6 and TNF-α as it is vital in the homeostasis of the 
immune response [47, 240, 310]. On the other hand, the fact that TNF-α could 
potentially compromise the integrity of the intestinal mucosa [217], it would lead to 
a vicious cycle of repeated inflammation, due to prolonged exposure to bacterial LPS.  
Consequently, several attempts in resolving an inflammatory response could lead to 
a chronic inflammatory status.  
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The clinical data of the current study appeared to support this theory. First and 
foremost, the presence of previous episodes of right iliac fossa pain in patients with 
histologically "normal" appendices was significantly increased compared to patients 
with inflamed appendices. However, on the acute presentation of the patient to the 
medical team, neither the severity of the pain nor the duration of symptoms in 
patients with histologically "normal" samples varied from those with histologically 
proven inflamed samples. This piece of clinical data could suggest that patients with 
histologically "normal" appendices were subjected to either a recurrent 
inflammatory stimulus or the initial inflammatory response never managed to 
successfully treat the initial stimulus. In keeping with a chronic or abnormally long 
inflammatory response was the finding of a significantly increased lymphocyte count 
in patients with histologically "normal" appendices. In a similar way, patients with 
histologically "normal" samples exhibited a significantly low neutrophil to 
lymphocyte ratio. Moreover, although the white cell count of patients with 
histologically "normal" appendices was increased compared with the control group, 
it did not reach the levels observed in patients with histologically proven appendicitis, 
either uncomplicated or complicated. Interestingly, patients with histologically 
"normal" appendices had significantly low levels of C-reactive protein compared with 
the patients of the control as well as the histologically proven appendicitis groups. It 
is acknowledged that C-reactive protein is not a specific marker and the presence of 
malignancy could cause a significant rise in the C-reactive protein concentrations. 
Therefore, the C-reactive protein might not be a reliable inflammatory marker to 
allow for valid conclusions as in the current study the comparison was between 
inflamed samples due to bacterial antigen and malignant cells.  
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With regards to signs suggesting acute appendicitis, 56% of patients with 
histologically "normal" appendices were found to have evidence of peritonism 
compared to 73% of the patients with either uncomplicated or complicated 
appendicitis. This finding highlighted the fact that patients with subsequently 
histologically "normal" appendices did present with features of acute appendicitis. 
As a result, although it was very challenging to assess the degree of inflammation, 
appendicectomy could have been the correct decision from a patient safety point of 
view. It could also indicate that, despite the absence of microscopic evidence of 
inflammation, the severity of symptoms during the acute presentation to the surgical 
team and subsequent admission to hospital, were such that appendicectomy was 
clinically justified.  
 
Another feature that could be linked to a prolonged inflammatory response was the 
surprisingly high proportion of patients with histologically "normal" appendices that 
were found to have faecoliths. It could be speculated that faecoliths could cause 
intermittent or temporary obstruction of the appendiceal lumen giving rise to 
abdominal pain. It could also be suspected that the abdominal symptoms could be 
relieved when the distal pressure in the appendiceal lumen reached the necessary 
levels to expel the faecolith. Therefore, repeated cycles of obstruction could cause 
recurrent episodes of abdominal pain. The recurrent episodes of inflammation could 
compromise the function as well the integrity of the appendiceal mucosa leading to 
a vicious cycle of inflammation, due to entry of bacterial LPS, and tissue repair. This 
theory could be compatible with the clinical finding of recurrent episodes of 
abdominal pain in a large proportion of patients with histologically "normal" 
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appendices. Therefore, the chronic antigenic stimulation of the immune system could 
lead to an abnormally regulated inflammatory response that would exhibit anti-
inflammatory features in order to prevent harmful effects to the host. As a result, it 
could be supported that the fact that some appendices remained histologically 
"normal" having minimal consequences to the host could be due to the increased 
levels of anti-inflammatory cytokines such as IL-6 and TNF-α that downregulated the 
inflammatory response.  
 
The interpretation that increased levels of IL-6 as part of an anti-inflammatory 
response in order to protect the host was supported by the findings of Xing et al. who 
demonstrated that local and systemic IL-6 could modulate an pro-inflammatory 
cytokine profile in various tissues [311]. Apart from another study by Xing et al. [223]  
which demonstrated that IL-6 knockout mice suffered an increased mortality 
following administration of a lethal dose of endotoxin, IL-6 has also been shown to   
exhibit similar action in chronic diseases in an attempt to elicit cellular immune 
responses as well as humoral responses against re-infection [312-315]. 
 
The experimental data of this study taken in combination with the clinical data could 
possibly suggest that the immune response of the patients with subsequently 
histologically "normal" appendices displayed some anti-inflammatory features. This 
could be based on the fact that both TNF-α and IL-6 can exhibit potent anti-
inflammatory actions. In conjunction with raised IL-2R expression, these cytokines 
could aim to control an abnormally long or abnormally regulated inflammatory 
response. The role of IL-6, although very controversial could be of paramount 
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importance as it has been shown to steer the inflammatory response to chronicity 
and inhibit the recruitment of neutrophils [221, 227-229, 240, 307, 308]. These 
findings combined with the clinical finding or significantly increased previous 
episodes of right iliac fossa pain in patients with histologically "normal" appendices 
as well as the increased lymphocyte count and the simultaneous absence of 
neutrophils in the tissue could indicate an abnormally regulated chronic 
inflammatory response. On the other hand, the fact that the expression of different 
inflammatory mediators as well as the clinical parameters between patients with 
faecolith and those without faecolith did not differ significantly, is difficult to explain.  
 
It is appreciated that the current study provided experimental data on the expression 
of four inflammatory markers and clinical parameters originated from a single centre. 
In addition to this, there is not enough published data to take into consideration the 
differential action of several inflammatory cytokines as well as genes and their role 
in the inflammatory profile of the different aspects of appendicitis. Therefore, 
conclusions based on the existing evidence might not be robust and further research 
on this topic is of paramount importance.  
 
Cytokines have also been considered to be important hyperalgesic mediators and, 
therefore, a major cause of abdominal pain in patients with intestinal inflammation 
[288, 316, 317]. Thus, the finding of increased interleukin expression in the group of 
patients with histologically "normal" appendices could be of significant clinical 
relevance. Several studies have suggested that both TNF-α and IL-6 have significant 
influence in nociception [289-293]. The experimental findings of this work were 
250 
 
supported by clinical data as it was apparent that there were significant findings to 
suggest that patients with subsequently histologically "normal" appendices had 
genuine abdominal pain which was very similar to the pain that was experienced by 
patients who had histologically proven acute appendicitis. First and foremost, the 
severity of pain experienced by patients with histologically "normal" appendices did 
not differ significantly from that of patients with histologically proven samples. In 
addition to this, the duration of pain immediately prior to the acute presentation did 
not differ between patients with histologically "normal" and inflamed samples. 
Interestingly, the pre-operative length of stay of patients with histologically "normal" 
appendices was significantly longer compared with patients who had complicated or 
uncomplicated appendicitis. One could suspect that this was due to the fact that the 
surgical team was not convinced about the underlying pathology and subsequently 
the diagnosis. The association of the right iliac fossa pain with evidence of 
neutrophilia in a young patient is highly suggestive of appendicitis. Therefore, the 
absence of neutrophilia along with low C-reactive protein concentrations in patients 
with subsequently histologically "normal" appendices might have puzzled the surgical 
team who decided to observe the patient for a longer period.  Another baffling finding 
was the presence of localised peritonism in 56% of patients with histologically 
"normal" appendices. The absence of peritonism in almost half of these patients 
might have also contributed to the longer pre-operative period for observation 
purposes. On the other hand, it was very difficult to explain the presence of localised 
peritonism in patients without any anatomical damage to the layers of their 
appendices.  Interestingly, the expression of the studied inflammatory markers did 
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not vary between patients with peritonism and those without within the group of 
patients with histologically "normal" appendices.  
 
The argument that at least some of the symptoms suggesting appendicitis could be 
attributed to the increased expression of the studied cytokines could be supported 
by several studies. Ibeakanma and Vanner [316] reported that supernatant from 
biopsies taken from patients with ulcerative colitis induced hyperexcitability of 
nociceptive colonic neurons which was mediated by TNF-α. Hughes et al. [288] 
demonstrated that both TNF-α and IL-6 were increased in supernatants from IBS 
patients with diarrhoea as the main symptom (D-IBS). The receptors of TNF-α, IL-6 
and IL-1β that were located on colonic afferent neurons were able to sensitise colonic 
afferents and therefore, they were linked to the abdominal pain experienced by the 
patients with D-IBD [288]. In a study conducted by Humes et al. [317], patients with 
symptomatic diverticular disease were shown to have increased expression of TNF-α 
and IL-6 which was associated with visceral hypersensitivity to rectal balloon 
distension. The aforementioned studies provided strong evidence that TNF-α and IL-
6 were able to induce hyperalgesia when their expression was upregulated during an 
inflammatory response in the colon. Therefore, the symptom of right iliac fossa pain 
suggesting acute appendicitis in patients with subsequent histologically "normal" 
appendices could be attributed to increased levels of TNF-α and IL-6. However, the 
absence of other signs and symptoms to complete the classical clinical picture of 
acute appendicitis could possibly explain the decision made by the surgical team to 




However, it is suspected that the clinical picture of patients with a subsequent 
histologically "normal" appendix during most of their recurrent admissions would not 
convince the surgical team to proceed with appendicectomy. Thus, these patients 
would either be discharged or treated conservatively with antibiotics. A Cochrane 
review showed that selected patients could be managed conservatively with 
antibiotics [318]. However, the authors concluded that appendicectomy should 
remain the standard treatment. Three major randomised controlled trials have 
supported antibiotic treatment over appendicectomy although the appendicectomy 
rates in patients treated with antibiotics varied from 24% to 48% [319-321]. The 
conservative management as treatment of appendicitis has not been supported by 
the findings of the present study. Faecoliths have been strongly associated with 
complicated appendicitis for which conservative management is contraindicated. In 
a very recent and well-designed randomised control trial although the authors were 
in favor of antibiotic treatment over appendicectomy, 39.1% of the patients who 
were treated with antibiotics needed appendicectomy within the 5-year follow-up 
period [322]. The study included adult patients with CT-proven uncomplicated 
appendicitis only. Interestingly, patients with evidence faecoliths on the CT scan were 
excluded [322]. Therefore, one could advocate that the option of conservative 
management in patients who have been suspected to have appendicitis, but the 
clinical picture does not suggest severe inflammation to warrant emergency 
appendicectomy, might not be effective due to the presence of faecoliths within the 
appendiceal lumen. This could be of significant importance in countries that either 
do not have the infrastructure to perform CT scan for every patient with suspected 
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appendicitis or CT scans are not recommended due to the young age of most patients 
who are suspected to have appendicitis.  
 
Moreover, even in the laparoscopic era where laparoscopy can be used as a 
diagnostic tool, there is not a clear policy or guidance to recommend the resection of 
a macroscopically normal appendix during laparoscopy. Some studies have 
concluded against the removal of a macroscopically normal appendix due to the 
associated risks [126]. However, as faecoliths have been associated with complicated 
appendicitis, either the early resection of an appendix or the resection of a 
macroscopically normal appendix might prevent a later admission with complicated 
appendicitis. Indeed, the randomised control trial by Salminen et al. reported that 
two out of the thirty patients who were treated conservatively with antibiotics and 
needed appendicectomy in the 5-year follow-up period, were found to have 
complicated appendicitis [322]. However, none of the two patients had evidence of 
faecoliths on the CT scan at the time of randomisation. Interestingly, another two 
patients from the same group that needed appendicectomy in the 5-year follow-up 
period were reported to have histologically normal appendices. The latter implied 
that these two patients presented with a clinical picture of acute appendicitis that 
convinced the surgical team to perform appendectomy despite the fact that 
conventional microscopy did not demonstrate any evidence of an inflammatory 
response. In the same study, the overall complication rate was 24.4% in the 
appendicectomy group and 6.5% in the antibiotic group. However, all the patients 
who required appendicectomy underwent an open procedure according to the study 
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design. Nevertheless, it is known that laparoscopic appendicectomy is associated 
with significantly less complications [323].  
 
Another significant finding of the present study and of paramount importance in the 
laparoscopic era was that almost half of the histologically "normal" appendices 
appeared to be inflamed intraoperatively. This finding highlighted that the clinical 
judgement of the severity of inflammation cannot be always trusted.  Interestingly, 
the cytokine levels between the histologically "normal" appendices that appeared 
inflamed and those that appeared normal did not demonstrate significant deference 
strengthening the postulation that the intraoperative diagnosis is not reliable even 
further. Therefore, one could support that patients could present with either a 
classical picture of acute appendicitis and undergo a laparoscopic appendicectomy or 
their signs and symptoms would not be convincing of acute appendicitis and 
following a brief period of observation they would undergo diagnostic laparoscopy 
where their appendix could appear macroscopically normal. These appendices could 
even be histologically "normal" albeit they could still exhibit abnormal levels of 
cytokines responsible for the symptomatology. Therefore, there could be a case to 
remove macroscopically normal appendices in patients undergoing laparoscopy for 
right iliac fossa pain. 
 
In conclusion, to the best of our knowledge this is the first study to use experimental 
data from the entire spectrum of appendicitis in conjunction with clinical data as well 
as results from routine laboratory tests and intraoperative findings in order to further 
explore the pathogenesis of appendicitis.  It provided clear evidence that 
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histologically "normal" appendices resected from patients with right iliac fossa pain 
with a subsequent clinical impression of acute appendicitis exhibited abnormally 
elevated levels of cytokine expression. Moreover, the current study showed that 
patients with a subsequent histologically "normal" appendix could present with signs 
and symptoms suggesting acute appendicitis.  It also described the expression of key 
inflammatory markers and clinical presentation of patients with different 
inflammatory states of the spectrum of appendicitis.   
 
The data of this study suggested that histologically "normal" appendices resected 
from symptomatic patients exhibited features of an activated immune system. As 
discussed earlier, this activation could represent either an inflammatory response at 
very early stages that could not be detected on conventional histopathologic 
examination or it could represent an attempt to resolve an inflammatory response 
the duration of which was abnormally long. The effect of that could be an anti-
inflammatory profile of the immune response. 
 
Finally, the difference in cytokine expression between complicated and non-
complicated appendicitis and the pathological cytokine expression in histologically 
normal appendices could suggest a different immunopathogenesis in these diseases 
and not just disease progression. As mentioned earlier in the discussion, this was 
supported by existing evidence on the epidemiology of complicated and 
uncomplicated appendicitis [279]. This was further supported by the clinical findings 
presented in this thesis. Interestingly, despite the fact that were no differences in the 
duration of symptoms, clinical findings such as body temperature, white cell count, 
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neutrophil count and C-reactive protein were significantly elevated in patients with 
complicated appendicitis. Therefore, it could be speculated that the spectrum of 
appendicitis could consist of entities with different pathogenesis rather than 




CHAPTER 6: Conclusion  
The findings of the present study have established that histologically "normal" 
appendices resected following a clinical impression of acute appendicitis due to right 
iliac fossa pain exhibit abnormally elevated levels of cytokine expression. It has also 
been demonstrated that immunohistochemistry was able to describe significant 
differences in the level of expression of the studied cytokines between different 
degrees of inflammation in appendices resected from symptomatic patients. 
Moreover, immunohistochemistry was able to detect increased levels of cytokine 
expression at a stage where inflammatory infiltrate was not detectable with 
conventional histologic examination. Therefore, the use of immunohistochemistry in 
testing histologically "normal" samples for altered cytokine expression could 
supplement the clinical findings and convert a "negative or unnecessary" 
appendicectomy to a clinically justifiable one.  
 
The work presented in this thesis has documented new and not previously published 
findings. To the best of our knowledge, this is the first study to present experimental 
findings on cytokine expression in conjunction with clinical data from signs and 
symptoms as well as routine laboratory investigations and intraoperative findings 
from patients with appendicitis covering the entire spectrum of the disease.   
 
With regards to the experimental findings it was reported that in histologically 
"normal" appendices: (1) both TNF-α and epithelial IL-6 expression were significantly 
increased compared with the control as well as the inflamed appendices; (2) both 
mucosal and submucosal expression of IL-2R were significantly increased compared 
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with the control samples but not as high as in the inflamed appendices; (3) serotonin 
contents of enterochromaffin and subepithelial neuroendocrine cells did not 
demonstrate significant difference compared with control samples. 
 
 The uncomplicated acute appendicitis samples in comparison with the complicated 
appendicitis specimens demonstrated that: (1) serotonin contents were significantly 
higher in both enterochromaffin and subepithelial neuroendocrine cells; (2) TNF-α 
expression did not differ; (3) IL-6 expression in both epithelial and inflammatory cells 
were significantly lower and (4) IL-2R levels in both mucosa and submucosa were also 
significantly lower. 
 
As far as the clinical data was concerned, patients with histologically "normal" 
appendices in comparison with those with histologically confirmed inflamed samples 
demonstrated that: (1) previous episodes of right iliac fossa pain were significantly 
increased; (2) the duration as well as the severity of abdominal pain did not differ; (3) 
localised peritonism was evident in 56%; (4) the body temperature on admission did 
not differ; (5) the white cell and neutrophil counts were significantly reduced;  (6) the 
lymphocyte count as well as the neutrophil to lymphocyte ratio were significantly 
increased; (7) the C-reactive protein concentrations were significantly reduced; (8) 
the preoperative length of stay was significantly longer and (9) faecoliths were 
evident in 27%. Interestingly, the expression of the studied inflammatory markers as 
well as the clinical parameters did not differ between patients with faecolith and 
those without faecolith in any of the three groups. Regarding the intraoperative 
diagnosis, (10) 51% of the histologically "normal" appendices appeared to be 
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inflamed intraoperatively. However, the expression of the studied inflammatory 
markers as well as the clinical parameters did not vary between the appendices that 
appeared normal and those that appeared inflamed.  
 
The results of this work suggested that histologically "normal" appendices resected 
from symptomatic patients exhibit features of an activated immune system. This 
activation could be due to an inflammatory response at very early stages that was 
not detectable on routine histopathologic examination or an attempt to resolve an 
abnormally long inflammatory response. The latter could imply an immune response 
with anti-inflammatory features and beneficial effects to the host. This was 
supported by the clinical findings of this work as well as published evidence to 
demonstrate that TNF-α, IL-6 and IL-2 can also function as anti-inflammatory 
mediators.  
 
The fundamental differences in cytokine expression between complicated and non-
complicated appendicitis could suggest a different immunopathogenesis in these 
entities and not just disease progression. This was supported by previously reported 
data on the epidemiology of complicated and uncomplicated appendicitis as well as  
clinical data presented in this thesis. Moreover, given the increased expression of the 
studied cytokines in the histologically "normal" appendices one could advocate that 
the different degrees of inflammation of appendicitis could not be due to progression 
of an inflammatory process that has been left untreated. A better understanding in 
the expression of inflammatory genes as well as the expression of their final product 
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such as cytokines, interferons, and receptors is essential for enlightening several 
aspects of the immunopathogenesis of appendicitis.     
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CHAPTER 7: Limitations and future studies 
7.1 Limitations of the present study 
It is appreciated that this study had several limitations. First and foremost, it was a 
single centre study. Although the inclusion criteria were as broad as possible in order 
for the study population to be as close as possible to the true population of patients 
who were diagnosed with acute appendicitis, the experimental data originated from 
just one hospital, the Queen’s Medical Centre in Nottingham in the UK.  Despite the 
fact that it is a large tertiary centre, the number of patients who seek medical advice 
due to right iliac fossa pain could vary significantly between different areas of the UK 
Moreover, the pathogenesis of appendicitis could be significantly different in 
different populations. Genetic factors as well as environmental factors implicated in 
the pathophysiology of acute appendicitis could also differ significantly in patients 
from different geographical locations. Apart from possible variances between 
different patient populations, there might be several hospital factors that could differ 
between different countries or even hospitals within the UK that could influence the 
inflammatory response and consequently the experimental data. Characteristic 
example of this, could be the time that the decision to operate was made. As a result, 
the expression of inflammatory mediators in the tissue could vary significantly. In 
addition to this, the use of antibiotics as treatment for appendicitis might be another 
factor that could potentially alter the inflammatory response. Therefore, in hospitals 
where the use of antibiotics is the first line of treatment for appendicitis, the in-situ 
expression of inflammatory could be significantly different. Thus, as the experimental 
data in the present study originated from patients who were treated in a single centre, 
the conclusions of this study might not apply in different patient populations.  
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Another limitation of the present study was the retrospective nature of it. With 
regards to the clinical data that was collected, the parameters that steered the 
diagnosis towards acute appendicitis, were already documented in patients notes. 
The critical issue with this, was that the study design could not account for certain 
clinical/laboratory tests to be performed at a specific time in the diagnostic process. 
It was attempted to collect data from the day of admission as described in the 
methodology.  However, that was not the case for all the patients in the study and 
therefore some clinical data on some patients was missing. Moreover, the clinical 
data that was used in this study was recorded by different members of the surgical 
team with different levels of experience. Although, the collected data derived from 
entries of the most senior members of the team, even then the levels of seniority did 
vary and that could have influenced some of the results. Typical example of this was 
the documentation of the clinical examination findings and more specifically the 
presence of peritonism. However, the study was conducted in a University Hospital 
that tends to attract senior registrars who already had several years of surgical 
experience. In addition to that, as it was conducted in a tertiary centre the 
consultants were very much involved in patient’s care in order to achieve the best 
possible outcome. Regarding the actual experimental work, the retrospective nature 
of the study did not allow to formulate even more robust inclusion and exclusion 
criteria that could be applied before the appendicectomy took place. In a prospective 
study, the members of the research team could be part of the team that admitted 
the patients, had active involvement in the formulation of the clinical diagnosis as 
well as in the administration of the intervention in order to eliminate heterogeneity. 
However, a prospective study with a large study population would have been 
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significantly more time consuming and would not be possible to be completed in the 
duration of a doctoral course. Moreover, in the given timeframe a prospective study 
would have resulted in a significantly smaller study population. Hence, the present 
study included a large number of patients, which was significantly larger compared 
to any of the previously published studies, but did not allow the members of the 
research team to be directly involved in the clinical aspects of patient management 
peri-operatively in order to control for some cofounding factors and produce even 
more robust results.  
 
Another limitation of this work was the nature of the specimens that formed the 
control group. The vast majority of the control samples was obtained from patients 
with underlying colonic malignancy.  Therefore, the samples might not be entirely 
normal, and the expression of the studied inflammatory mediators could be different 
from that of completely healthy tissues. Although patients with obstructing colonic 
tumours, caecal tumours or with evidence of inflammatory bowel disease were 
excluded, the presence of malignancy is known to be accompanied by a notable 
systemic inflammatory response that could potentially affect the levels of several 
inflammatory mediators even when the tissue appears normal on conventional 
microscopy. On the other hand, one could easily understand that it was impossible 
to find totally healthy appendix specimens for this type of study. Moreover, the mean 
age of the patients who formed the control group was significantly different from 
that of the rest of the study population. It was apparent that this was due to the 
underlying pathology of the control group as colorectal malignancy is prevalent in 
older patients. The inflammatory response in older patients could be significantly 
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different from that in younger and therefore the expression of the studied 
inflammatory mediators could have been different in healthy individuals of younger 
age. However, it was extremely difficult to obtain a significant number of appendix 
samples, as the study design dictated, from either entirely healthy or with benign 
diseases other than inflammatory bowel disease young individuals. 
 
Finally, although the use of immunohistochemistry is a robust way to assess 
expression of inflammatory mediators; a fact that is evident from the number of 
previously published studies that used immunohistochemistry, it could also be 
considered as a limitation of this study as it is a mostly semi-quantitative method. 
The H-scoring system is a widely used method to assess the immunostaining and is 
formulated by two components as described in Chapter 3. As the first component is 
the percentage of the positively stained cells and not the actual number of the 
positively stained cells, it renders the H-score a semi-quantitative method of 
assessing the in-situ levels of the studied markers. Therefore, the calculated 
expression of inflammatory mediators is not the same as the actual one but a very 
close estimate. The use of this scoring method, however, can be very helpful in 
sections where the number of positively stained cells is extremely large and as a 
result the process of counting all the positively cells is close to impossible. The second 
component of the H-score is the intensity of the immunostaining which is 
represented by a number (1 for weak, 2 for medium and 3 for strong). Different 
groups of cells found in different areas in the section may have different intensity of 
immunostaining. The issue with this component of the scoring system lies with the 
subjectivity of the intensity between different researchers. This is the reason why in 
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most published studies either all or a representative and predetermined number of 
sections have been scored by two different researchers and as soon as the two scores 
are within an accepted range the score is finalised. In this study, 
immunohistochemistry for four inflammatory mediators was performed. In order to 
overcome the inherent problem of subjectivity as well as semi-quantification of the 
immunostaining it was decided to quantify the expression of two (TNF-α and IL-2R) 
out of the four markers by painstakingly counting the positively stained cells. The in-
situ levels of serotonin were simultaneously assessed by the author of this thesis and 
a senior Histopathology consultant, Dr A. M. Zaitoun. Both researchers had to agree 
on the score given to each slide. The expression of IL-6 was semi-quantified by the 
author of this thesis using the H-scoring system. 25% of the slides were independently 
assessed by Dr A. M. Zaitoun. As the differences in the scores between the two 
researchers were not significant, the scores obtained by the author of this thesis were 
used in the analysis.  Another way to obtain quantitative data is the use of more 
modern techniques such as the qPCR to assess mRNA expression. However, such 
techniques are much more expensive compared to immunohistochemistry and their 
use in the present study was prohibited due to the limited budget. Moreover, 
fluorescent immunohistochemistry in combination with confocal microscopy would 
add great value to this study. Despite some of the known challenges associated with 
this technique such as the high background signal, it could help to investigate the 
exact distribution of the studied inflammatory markers and more specifically their 
possible co-localisation and how this could differ across the entire spectrum of 
appendicitis. On the other hand, the low cost and ease of reproducibility of 
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immunohistochemistry allowed for a large study population that was significantly 




7.2 Future studies  
Acute appendicitis is the most common surgical emergency and can present as an 
inflammatory spectrum. However, the pathogenesis of appendicitis and the reason 
why it presents as a spectrum remains unknown.  Further and deeper understanding 
of the inflammatory response in patients with appendicitis is crucial. Elucidation of 
the differences in the immune responses that take place in the different aspects of 
the appendicitis spectrum would help clinicians tailor their approach to patients with 
appendicitis.  Therefore, complications due to either a delayed surgical intervention 
in patients who could not be managed conservatively or exposure of to an 
unnecessary operation in patients that could be treated conservatively, can be 
avoided. 
 
First and foremost, a large prospective study is needed that can overcome some of 
the limitations of the present study. In such study the research team would be able 
to recruit patients based on their signs and symptoms upon their presentation and 
not on their Histological diagnosis that was made post-operatively. This method 
would enable researchers to directly interact with patients in order to not only 
diminish the issue of missing data but also minimise heterogeneity. The prospective 
design of the study would also enable the researchers to account for factors that can 
alter the inflammatory response such as administration of antibiotics. Very often, 
patients with either atypical symptoms of appendicitis or very early stages of 
appendicitis are initiated on antibiotics and only referred to the surgical team when 
the abdominal pain is not settling, or the symptomatology of appendicitis becomes 
more apparent. To the best of our knowledge, there is not any published study on 
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appendicitis that compared the in-situ expression of inflammatory mediators in 
patient who were treated with antibiotics pre-operatively and those who were taken 
to theatre without prior administration of antibiotics. Therefore, a prospective study 
design could be very helpful in assessing the effect of antibiotic treatment in the pre-
operative period in relation to the underlying histopathological features of 
appendicitis as well as clinical features such as the presence of faecoliths in the 
appendiceal lumen.  
 
Extension of this work could include documentation of the expression of other 
cytokines (such as IL-1, IL-4, IL-5, IL-8, IL-12, IL-17 and IFN-γ) that are centrally 
involved in the immune response to antigenic stimuli. Even though appendicitis is 
much more common in young adults compared to inflammatory bowel disease, the 
type of inflammatory response is not known. Traditionally, the inflammatory 
response in ulcerative colitis was thought to be an atypical type 2 (Th2) response 
characterised by expression of IL-5 but not IL-4 whereas, Crohn’s disease has been 
associated with type 1 (Th1) cell mediated inflammatory response including the 
expression of IL-12, IFN-γ and TNF-α. However, more recently, evidence of increased 
expression of IL-17 in patients with ulcerative colitis has emerged and therefore, 
ulcerative colitis could be associated with Th17 inflammatory response. Moreover, 
increased expression of IL-8 has been observed in the intestinal mucosa of patients 
with either ulcerative colitis or Crohn’s disease. IL-8 is also known as a neutrophil 
chemotractant interleukin and its expression has been linked with acute appendicitis. 
However, the expression of several key cytokines in the inflammatory response has 
either been examined in a very small number of samples or not been examined at all. 
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More specifically, the expression of different cytokines in histologically "normal" 
appendices remains very poorly investigated. Thus, one could easily understand that 
extensive research is required to fully characterise the inflammatory response in 
acute appendicitis. Immunohistochemistry can be very useful in describing the 
expression of several inflammatory markers in a large number of patients and across 
the entire spectrum of appendicitis. Additionally, immunohistochemistry can be 
combined with immunofluorescence for better understand of the distribution of each 
cytokine as well as the co-localisation of the studied inflammatory markers across the 
entire range of appendicitis.  
 
Nevertheless, further and better understanding of the gene expression in acute 
appendicitis as well as histologically "normal" appendices resected from 
symptomatic patients is crucial. Acute appendicitis is characterised by the infiltration 
of neutrophils into the mucosa of the appendix. However, in the case of altered gene 
expression, whether the observed changes are the result of alterations in the gene 
expression of the resident cells within the appendix or they reflect the genes 
expressed by the infiltrating neutrophils needs to be thoroughly investigated. The 
events that might occur in the earliest stages of inflammation could lead to important 
findings regarding the pathogenesis of appendicitis. Detailed documentation of the 
gene expression in histologically "normal" appendices could establish whether the 
observed alterations took place prior to the infiltration of neutrophils or not. 
Ultimately, delineation of the pathogenesis of this high prevalent disease could lead 
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1 IHC protocol 
Solutions and reagents      
1. Neutral-buffered formalin, 10% (NBF), 1 Liter 
• Distilled H2O 900ml 
• Di-sodium hydrogen phosphate, anhydrous (Na2HPO4) 6.5 grams 
• Sodium di-hydrogen phosphate, monohydrate (NaH2PO4. H2O) 4.0 grams 
• Formaldehyde, 37% solution 100ml 
• Adjust pH to about 7.0 with 1M (Molar: 1mol/L) NaOH or 1M  HCL 
• Final concentrations: 
o Formaldehyde 3.7% 
o Na2HPO4 mM 
o NaH2PO4. H2O 29 mM 
 
2. 10x Citrate Buffer stock, 1 liter 
• Sodium hydroxide 10 g 
• Citric acid 21 g 
• De-ionised water 1000 ml 
• Store at 4 °C in glass container 
 
3. 1x Citrate Buffer working solution, pH 6.0 
• Dilute 1 part of 10x stock solution with 9 parts of de-ionised water 
• Adjust pH to 6.0 using 1M NaOH or 1M HCL as required 
287 
 
• Use within 24 hours 
 
4. 10x Tris Buffer Stock (TBS) pH 7.6 
• Trizma base 6.04 g 
• Sodium Chloride 81 g 
• Hydrochloric acid 1M 36ml 
• Final volume (1L) using de-ionised water 
• Adjust pH to 7.6 using 1M HCL if needed 
 
5. 1x TBS working solution 
• Dilute 1 part of 10x TBS stock solution with 9 of parts de-ionised water 
• Adjust pH to 7.6 using with 1M NaOH if necessary 
• Store working solution at room temperature and use within two weeks 
 
6. Primary antibody detection system 
• The Novolink™ Polymer Detection System will be used for visualisation of the 
primary antibody. The reagents of this detection system are: 
o Peroxidase Block: 3-4% (v/v) Hydrogen peroxidase 
o Protein Block: 0.4% Casein in phosphate-buffered saline, with stabilisers, 
surfactant and 0.2% Bronidox L as a preservative 
o Post Primary: rabbit anti mouse IgG (<10 μg/ml) in 10% (v/v) animal serum 
in tris-buffered saline/0.09% ProClin™ 950 
o Novolink™ Polymer: anti-rabbit Poly-HRP-IgG (<25μg/ml) containing 10% 
(v/v) animal serum in tris-buffered saline/0.09% ProClin™ 950 
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o DAB Chromogen: 1.74% w/v 3,3’ – diaminobenzidine, in a stabiliser 
solution 
o Novolink™ DAB Substrate Buffer (Polymer): buffered solution containing 
≤0.1% hydrogen peroxide and preservative 
o Haematoxylin: <0.1% Haematoxylin 
 
(Source: www.LeicaBiosystems.com)  
 
2 IHC procedure 
1. Tissue preparation 
• Fix tissue in 10% neutral buffered formalin for at least 24 hours. Embed tissue in 
paraffin wax according to embedding machine manufacturer’s instructions. 
Formalin has a very slow diffusion coefficient, so the tissue needs to be no more 
than 1 cm thick. This procedure has already been done by the NHS staff. The initial 
tissue blocks will be melted, and two tissue specimens will be re-embedded into 
a new tissue block which will be labelled appropriately.  
 
2. Tissue sectioning 
• Prepare 5 μm sections on the microtome and place on clean, positively charged 
microscope slides 







• Place slides on the 60°C hotplate for 10 minutes 
• Wash slides 2 times for 5 minutes in xylene 
 
4. Rehydration 
• Wash slides 3 times for 2 minutes in Industrial Methylated Spirit (IMS) 
• Wash slides for 2 minutes in de-ionised water 
• Wash slides for 5 minutes in running water 
 
5. Antigen retrieval  
• Heat slides in 1x citrate buffer working solution, pH 6.0 at 95-100°C for 20 minutes 
(microwave oven: Whirlpool JT359 6th sense) 
• Cool slides with running water for 5 minutes 
 
6. Immunostaining (Novolink™ procedure)  
• Apply 100 μl Peroxidase for 5 minutes 
• Wash slides in TBS 2 times for 5 minutes 
• Apply 100 μl Protein Block for 5 minutes 
• Wash slides in TBS 2 times for 5 minutes 
• Apply 100 μl of primary antibody (optimally diluted in Leica Bond™ antibody 
diluents) and incubate for required time 
• Wash slides in TBS 2 times for 5 minutes 
• Apply 100 μl Post Primary Block for 30 minutes 
•  Wash slides in TBS 2 times for 5 minutes 
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• Apply 100 μl Novolink™ Polymer for 30 minutes 
• Make up DAB working solution; 1:20 DAB Chromogen in Novolink™ DAB Substrate 
Buffer 
• Wash slides in TBS 2 times for 5 minutes 
• Apply 100 μl DAB working solution for 5 minutes 
• Wash slides in TBS 2 times for 5 minutes 
• Apply 100 μl Haematoxylin for 6 minutes 
• Rinse slides in tap water for 5 minutes 
 
7. Dehydrate and mount slides 
• Wash slides 3 times for 2 minutes in IMS 
• Wash slides 2 times for 5 minutes in xylene 
• Mount with mounting medium 
• Apply coverslip 
 
(Source: www.LeicaBiosystems.com)  
 
